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Impedance	  has	  been	  used	  as	  a	  tool	   for	  cardiac	  research	  since	  the	  early	  1940’s.	  
Recently	  there	  have	  been	  many	  advances	   in	  this	   field	   in	  the	  diagnosis	  of	  human	  heart	  
failure	  through	  the	  measurement	  of	  pacemaker	  and	  ICD	  coupled	   impedance	  detection	  
to	   determine	   the	   state	   of	   pulmonary	   edema	   in	   patients	   through	   drops	   in	   lung	  
impedance.	  These	  new	  detection	  methods	  are	  far	  downstream	  of	  the	  initial	  changes	  in	  
physiology,	   which	   signify	   heart	   failure	   risk,	   namely,	   an	   increased	   left	   ventricular	   (LV)	  
end-­‐diastolic	  volume	  (also	  known	  as	  preload).	  This	  dissertation	  presents	  the	  first	  formal	  
validation	   of	   the	   complex	   admittance	   technique	   for	   more	   accurate	   blood	   volume	  
measurement	   in	  vivo	   in	  mice.	   It	  aims	  to	  determine	  a	  new	  configuration	  of	  admittance	  
measurement	   in	   a	   large	   scale	   animal	   model	   (pigs).	   It	   also	   aims	   to	   prove	   that	  
“piggybacking”	   an	   admittance	   measurement	   system	   onto	   previously	   implanted	   AICD	  
and	  bi-­‐ventricular	  pacemakers	  is	  a	  feasible	  and	  practical	  measurement	  that	  will	  serve	  as	  
an	   early	  warning	   system	   for	   impending	   heart	   failure	   through	   the	  measurement	   of	   LV	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preload,	  which	   appears	   before	   the	   currently	  measured	   drop	   in	   lung	   impedance	   using	  
previous	  techniques.	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   1	  
Chapter	  1:	  Admittance	  for	  Heart	  Failure	  Detection	  
1.1 MOTIVATION	  
Heart	  disease	  is	  the	  leading	  cause	  of	  death	  in	  the	  United	  States	  [1].	  Because	  of	  
the	  current	  drive	  to	  treat	   the	  many	  forms	  of	  heart	  disease,	   life	  spans	   in	  patients	  have	  
been	  extended	  and	  a	  shift	  is	  occurring	  from	  heart	  disease	  to	  heart	  failure	  in	  the	  affected	  
population.	  At	  age	  40,	  the	  lifetime	  risk	  of	  developing	  Congestive	  Heart	  Failure	  (CHF)	  is	  1	  
in	  5.	  As	  a	  result,	  a	  large	  portion	  of	  medical	  resources	  are	  currently	  used	  in	  the	  care	  and	  
treatment	  of	  these	  patients.	  
Heart	  failure	  (HF)	  is	  the	  most	  common	  cause	  of	  admission	  to	  the	  hospital	  in	  the	  
United	   States,	   and	   is	   the	   leading	   cause	  of	   death	   in	   the	  nation.	   In	   2009,	   the	  American	  
Heart	  Association	  estimates	  that	  more	  than	  $37	  billion	  was	  spent	  on	  HF	  in	  the	  U.S.	  alone	  
in	  direct	  and	  indirect	  costs;	  and	  1	  in	  8	  deaths	  mention	  HF	  on	  the	  death	  certificate	  [2].	  As	  
the	   U.S.	   population	   ages	   and	   the	   number	   of	   persons	   surviving	   long-­‐term	   with	  
cardiovascular	  disease	   increases,	   the	  number	  of	  persons	  with	  heart	   failure	   is	  expected	  
to	   grow	   dramatically,	   as	   are	   the	   number	   and	   cost	   of	   hospital	   admissions	   for	   heart	  
failure.	  
Despite	   the	   established	   ability	   of	   pharmacotherapy	   to	   reduce	   hospitalizations,	  
and	  the	  accepted	  importance	  of	  dietary	  sodium	  restriction	  and	  daily	  weight	  monitoring,	  
the	   expected	   benefit	   of	   these	   therapies	   is	   not	   being	   realized.	   Episodic	   office-­‐based	  
management	  by	  physicians	  is	  often	  inadequate	  to	  provide	  needed	  long-­‐term	  continuity	  
of	  care,	  especially	   in	  older	  persons	  with	  multiple	  co-­‐morbid	  conditions	   taking	  multiple	  
prescribed	  drugs.	  Clinician	  under-­‐prescribing	  and	  under-­‐dosing	  of	  medications;	  patient	  
non-­‐adherence	  to	  drug	  regimens,	  self-­‐monitoring	  of	  diet	  and	  weight,	  and	  lack	  of	  regular	  
monitoring	   by	   healthcare	   providers	   contribute	   to	   many	   heart	   failure	   hospital	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admissions.	  It	  is	  estimated	  that	  50%	  of	  HF	  admissions	  may	  be	  avoidable.	  Since	  many	  of	  
these	  patients	  will	  be	  receiving	  AICDs	  and	  bi-­‐ventricular	  pacemakers,	  “piggybacking”	  a	  
solution	  onto	  these	  devices	  will	  provide	  information	  regarding	  heart	  failure	  status	  that	  is	  
needed	  to	  reduce	  both	  the	  number	  of	  hospitalizations,	  and	  the	  billions	  of	  dollars	  in	  cost	  
for	  these	  hospitalizations.	  
1.2 BACKGROUND	  
Conductance	  measurements	   have	   been	   available	   as	   an	   invasive	   tool	   to	   detect	  
instantaneous	   left	   and	   right	   ventricular	   volume	   since	   1981	   [3,	   4]	   and	   a	   number	   of	  
relevant	  publications	  have	  come	  from	  our	  group	  at	  The	  University	  of	  Texas	  at	  Austin	  [5-­‐
11].	   Tetrapolar	   electrodes	   are	   typically	   placed	   on	   a	   catheter	   located	  within	   the	   heart	  
chamber	   (i.e.,	   the	   left	  ventricle,	   LV)	   to	  determine	   instantaneous	  volume.	  Conductance	  
systems	  generate	  an	  electric	  field	  using	  a	  current	  source,	  and	  volume	  is	  estimated	  from	  
the	  instantaneous	  voltage	  signal.	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Figure	  1:	  Tetrapolar	  catheter	  measurement	  of	  volume	  within	  the	  myocardium.	  
	  There	  is	  considerable	  debate	  in	  the	  scientific	  community	  about	  which	  equation	  
to	   use	   for	   the	   conversion	   of	   conductance	   to	   volume,	   although	   most	   agree	   that	   the	  
relationship	  between	   conductance	   and	   volume	   is	   nonlinear.	   Further,	   the	   conductance	  
technique	   is	   limited	  as	  the	  conductance	  measured	   is	  a	  combination	  of	  both	  blood	  and	  
surrounding	   myocardium,	   while	   only	   the	   blood	   conductance	   is	   desired	   to	   estimate	  
volume.	   The	   myocardium	   is	   often	   called	   the	   “parallel	   conductance”	   because	   in	   the	  
electrical	   model	   of	   an	   LV	   catheter	   measurement,	   the	   myocardium	   is	   essentially	   in	  
parallel	  with	  the	  blood	  and	  the	  current	  source.	  	  
Making	  this	  measurement	  in	  humans	  in	  vivo	  is	  complicated	  because	  any	  catheter	  
entry	   into	  the	  LV	  has	  an	  associated	  risk	  of	  causing	  emboli,	  which	  can	   lead	  to	  a	  stroke.	  
However,	  there	  has	  previously	  been	  no	  way	  to	  interrogate	  the	  instantaneous	  volume	  of	  
the	   LV	   using	   the	   conductance	   information	   without	   inserting	   a	   catheter.	   Conductance	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electrodes	  have	  not	  been	  previously	  placed	  on	  the	  LV	  epicardium	  to	  interrogate	  the	  LV	  
blood	   volume.	   This	   dissertation	   proposes	   the	   use	   of	   an	   admittance/impedance	  
measurement	   system	   to	   separate	   the	   blood	   and	   muscle	   components	   from	   the	  
combined	  voltage	  signal	  to	  estimate	  LV	  preload	  from	  previously	  implanted	  AICD	  and	  bi-­‐
ventricular	  pacemakers,	  for	  the	  first	  time.	  
1.2.1 Conductance	  to	  Volume	  Conversion	  Equations	  
The	   basis	   of	   volume	   estimation	   from	   conductance	   measurement	   is	   rooted	   in	  
Electromagnetic	   Field	   Theory	   and	   can	   be	   explained	  with	   a	   simplified	   derivation.	   Start	  
with	  the	  basic	  definition	  of	  equivalence	  resistance	  in	  a	  uniform	  electric	  field:	  




The	  LV	  chamber	  will	  change	  in	  cross-­‐sectional	  dimension	  as	  the	  heart	  beats	  (A(t))	  which	  
will	  provide	  a	  time-­‐varying	  resistance	  signal	  (R(t)).	  
	   ! ! =
!"
!(!)	   (2) 	  
The	  changing	  volume	  of	   the	  heart	   can	  be	  estimated	   from	  the	   field	   strength	  sensed	  at	  
the	   voltage	   contacts.	   This	   is	   described	   as	   the	   cross-­‐sectional	   area	   of	   the	   LV	   chamber	  
multiplied	   by	   the	   length	   between	   the	   voltage	   contacts	   (a	   constant,	   in	   the	   case	   of	   a	  
catheter	  measurement).	  	  
	   !"# = A(t)×!   (3) 	  
At	   this	   point	   one	   can	   rearrange	   equations	   (2)	   and	   (3)	   to	   produce	   Equation	   (4)	   below	  
[12].	  
	                                                                                 !"# =   
!!!
!
! − !! 	  	  	  	  (Baan’s	  Equation)	   (4) 	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The	  extra	  term	  α	   is	  a	  geometric	  correction	  factor	  for	  the	  assumptions	  made	  about	  the	  
linearity	  of	  the	  field	  lines	  that	  justify	  the	  use	  of	  Equation	  (1),	  and	  is	  generally	  assumed	  to	  
be	  dependent	  on	  the	  field	  shape.	  The	  E	  field	  direction	  with	  respect	  to	  the	  LV	  major	  axis	  
is	   along	   the	  myocardial	  wall,	  making	   the	  muscle	   a	   “parallel”	   conductance	  GP.	   In	  most	  
cases	   GP	   is	   considered	   to	   be	   limited	   to	   the	   surrounding	   myocardium,	   because	   the	  
conductivity	  of	  myocardium	  is	  much	  lower	  than	  that	  of	  blood,	  and	  because	  care	  is	  taken	  
to	   make	   sure	   that	   the	   electrode	   spacing	   is	   small	   enough	   to	   constrain	   the	   field	   to	  
essentially	  within	  the	  heart,	  but	  mostly	   in	  the	  blood	  pool.	  For	  example,	   longer	  current	  
electrode	  spacing	  creates	  a	   larger	  sensing	  field	  and	  these	   longer	  spacings	  are	  used	  for	  
larger	  hearts.	  	  	  
There	   are	   two	   major	   criticisms	   of	   Baan’s	   formulation.	   The	   first	   is	   that	   α,	   the	  
calibration	  factor	  in	  Baan’s	  equation,	  is	  not	  a	  constant	  but	  instead	  changes	  dynamically	  
as	  the	  moving	  heart	  wall	  changes	  the	  shape	  of	  the	  applied	  electric	  field	  [13].	  The	  second	  
is	  that	  as	  the	  LV	  contracts	  and	  fills,	  the	  cardiac	  muscle	  moves	  closer	  to	  and	  farther	  away	  
from	  the	  catheter,	   so	  subtracting	  a	  constant	  GP,	  as	   in	  Equation	   (4),	  probably	  does	  not	  
adequately	  compensate	  for	  the	  parallel	  muscle	  conductance	  [13].	  The	  latter	  problem	  is	  
exacerbated	   by	   the	   aortic	   valve	   being	   off	   center	   relative	   to	   the	   midline	   of	   the	   LV	  
chamber	  in	  mammalian	  hearts.	  This	  forces	  the	  miniaturized	  PV	  catheter	  to	  be	  closer	  to	  
the	   septum	   than	   the	   midline	   [14].	   Additionally,	   preload	   reduction	   used	   to	   generate	  
load-­‐independent	   measures	   of	   contractility	   is	   anticipated	   to	   further	   exacerbate	   any	  
error	  from	  the	  currently	  practiced	  constant	  measure	  of	  parallel	  conductance.	  All	  volume	  
conversion	  techniques	  are	  based	  on	  Baan’s	  Equation	  (4),	  and	  are	  differentiated	  by	  how	  
they	  treat	  the	  gain	  calibration	  (calculation	  of	  α)	  and	  offset	  calibration	  (calculation	  of	  GP).	  
These	  differences	  are	  discussed	  next.	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1.2.1.1 α	  Calibration	  
Baan’s	   formulation	   assumes	   the	   field	   to	   be	   completely	   uniform;	   therefore	   the	  
term	  α	  is	  set	  to	  1	  [3,	  15].	  This	  is	  referred	  to	  in	  the	  text	  as	  “no	  calibration.”	  Baan	  argues	  
that	  when	  looking	  at	  the	  end-­‐systolic	  pressure	  volume	  relationship	  (ESPVR)	  to	  calculate	  
measures	  of	  contractility,	  having	  an	  α	  =	  1	  is	  adequate	  as	  long	  as	  inter-­‐animal	  comparison	  
is	  not	  necessary	   [4].	  This	  may	  be	  true,	  but	  only	  because	  the	  slope	  of	   the	  ESPVR	   is	  not	  
dependent	  on	  accurate	  absolute	  volume	  measurement,	  but	  rather	  on	  accurate	  volume	  
difference	  measurement.	  	  
The	  simplest	  form	  of	  calibration	  is	  known	  as	  cuvette	  calibration,	  and	  is	  a	  direct	  1	  
to	  1	  mapping	  from	  conductance	  to	  volume.	  The	  calibration	  is	  performed	  by	  measuring	  
the	   conductance	  of	   blood	   in	   non-­‐conductive	   cuvettes	   of	   known	   volume.	   The	   volumes	  
should	   span	   the	   range	   of	   volume	   being	   measured	   in	   vivo.	   Because	   the	   volumes	   are	  
known,	  a	  plot	  is	  then	  constructed	  of	  volume	  vs.	  conductance,	  and	  the	  slope	  of	  the	  line	  
of	  best	  fit	  through	  all	  the	  data	  points	  is	  used	  for	  the	  value	  α.	  This	  fit	  line	  is	  then	  used	  for	  
subsequent	   conversion	   of	   conductance	   to	   volume.	   Figure	   2	   below	   shows	   a	   typical	  
cuvette	  calibration,	  and	  accompanying	  Finite	  Element	  model	  work	  which	  confirms	  it	  [Yi	  
Mao,	  unpublished	  observation].	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Figure	  2:	  A	  typical	  cuvette	  calibration	  and	  matching	  Finite	  Element	  Model.	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A	  more	  robust	  calibration	  of	  α	  is	  the	  stroke	  volume	  (SV)	  calibration.	  This	  method	  
chooses	  a	  value	  of	  α	   that	  will	   force	  the	  SV	  of	   the	  converted	  volume	  signal	   to	   the	  true	  
value	   of	   SV	   (derived	   from	   flow-­‐probe	   measurements	   or	   echocardiography	   data)	   at	  
baseline.	  Once	  the	  SV	  is	  known,	  α	  can	  then	  be	  calculated	  using	  Equation	  (5)	  below:	  
	   ! =
!!! !!"# − !!"#
!!!"#!!
	   (5) 	  
where	  GBED-­‐GBES	  is	  the	  peak	  to	  peak	  change	  in	  conductance	  at	  baseline,	  and	  SVtruth	  is	  the	  
measured	   true	   stroke	   volume	   at	   baseline.	   If	   the	   value	   of	   SVtruth	   changes	   during	  
intervention,	  the	  values	  of	  GBED	  and	  GBES	  will	  also	  change,	  leaving	  α	  relatively	  unchanged.	  
There	   is	   a	   fourth	   type	   of	   calibration	   for	   α,	   which	   is	   also,	   in	   essence,	   a	   SV	  
calibration;	   but	   also	   takes	   into	   account	   the	   relative	   values	   of	   GBED	   and	   GBES	   when	  
calculating	  the	  final	  volume.	  It	  is	  “nonlinear”	  in	  the	  sense	  that	  the	  α	  term	  is	  no	  longer	  a	  






!!!!!	   (6) 	  
where	  γ	  is	  a	  new	  constant	  defined	  quadratically	  as:	  
	   ! =





! = !!!"#!! − !!! !!"# − !!"#   
! = −!!!"#!!  × !!"# + !!"#   
! = !!!"#!!×!!"#×!!"#.	  
(8) 	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Equations	   (6)-­‐(8)	   are	   known	   collectively	   as	  Wei’s	   equation,	   and	   have	   been	   previously	  
published	  [16]	  and	  validated	  [17].	  
1.2.1.2 GP	  calibration	  	  
Another	  major	  source	  of	  error	  in	  catheter	  measurements	  of	  blood	  volume	  is	  the	  
effect	   of	   the	   myocardium	   and	   surrounding	   structures	   on	   the	   blood	   volume	  
measurement,	  GP.	  In	  Baan’s	  equation	  this	  term	  is	  a	  calculated	  constant.	  The	  calculation	  
of	  GP	  is	  another	  distinguishing	  factor	  between	  the	  different	  methods	  of	  conductance	  to	  
volume	  conversion.	  	  
Currently,	  the	  most	  popular	  way	  to	  calculate	  a	  constant	  GP	  is	  through	  injection	  of	  
a	   hypertonic	   saline	   (HS)	   bolus	   of	   high	   conductivity	   (σ	   ≈	   1-­‐1.6	   S/m).	   The	   bolus	   of	   HS	  
transiently	  changes	  the	  conductivity	  of	  blood	  in	  vivo	  as	  it	  passes	  through	  the	  circulatory	  
system,	   and	   eventually	   into	   the	   LV.	   The	   blood	   conductance	   minima	   (GBES)	   are	   then	  
plotted	   against	   the	  maxima	   (GBED)	   and	   back-­‐projected	   to	   determine	   the	   point	   where	  
GBED	  =	  GBES	  This	  point	  is	  the	  value	  of	  GP;	  the	  point	  where	  the	  blood	  volume	  is	  zero,	  and	  
conductance	   is	  unchanging.	   The	  method	   is	  outlined	   in	  more	  detail	   in	  previous	   studies	  
[5].	  	  	  	  
Contrary	   to	   the	   assumptions	   of	   the	   HS	   method	   above,	   it	   has	   recently	   been	  
proven	  that	  the	  parallel	  conductance	  from	  the	  myocardium	  does	  vary	  during	  the	  cardiac	  
cycle	  [13],	  and	  this	  finding	  has	  been	  verified	  by	  other	  authors	  as	  well	  [5,	  6,	  11,	  13].	  This	  
leads	   to	  error	   in	   the	   calculation	  of	   volume	  during	   the	   transition	  between	  VED	  and	  VES,	  
and	   even	   greater	   errors	   during	   loading	   changes	   on	   the	   heart	   that	   might	   increase	   or	  
decrease	  volumes	  at	  systole	  and	  diastole.	  To	  date,	  there	  is	  only	  one	  method	  that	  does	  
take	  into	  account	  the	  dynamic	  nature	  of	  GP,	  and	  this	  is	  the	  admittance	  method.	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The	  admittance	  method	  makes	  use	  of	  the	  native	  capacitive	  properties	  unique	  to	  
myocardium	   to	   identify	   its	   contribution	   to	   the	   measured	   signal	   so	   that	   it	   can	   be	  
removed	   in	   real	   time	   without	   the	   need	   for	   hypertonic	   saline	   injection.	   The	   basis	   of	  
measuring	   admittance	   (magnitude	   and	   phase)	   rather	   than	   conductance	   (magnitude	  
only)	   is	   that	  at	   frequencies	  around	   f	  =	  20	  kHz,	   it	  has	  been	  shown	   that	  blood	   is	  purely	  
resistive	  and	  has	  no	  measurable	  capacitance,	  but	  myocardium	  has	  both	  capacitive	  and	  
resistive	  properties	   (Figure	  3,	  above)	   [7,	  10,	  13].	  This	  observation	  allows	  separation	  of	  
	  
Figure	   3:	   A	   simplified	   diagram	   to	   explain	   how	   phase	   (θ)	   is	  measured	   is	   shown.	   The	   conductance	  
electrodes	  are	  demonstrated	  as	  planar	  metal	  electrodes	  surrounding	  homogenous	  media	  of	  either	  
blood,	  myocardium,	   or	   both.	   	   	   The	   solid	   line	   is	   input	   current	   (µA),	   and	   the	   dotted	   line	   is	   output	  
voltage	  (mV):	  A.	  Measurement	  of	  blood	  only,	  provides	  no	  phase	  shift	  (θ).	  B.	  Combination	  of	  blood	  
and	  muscle	   has	   some	  phase	   θ,	   and	   a	   somewhat	   larger	   amplitude	   output	   voltage	   (implying	   lower	  
total	  admittance	  magnitude,	  Y	  =	  I/V.	  C.	  Pure	  muscle	  results	  in	  the	  largest	  phase	  shift	  θ	  and	  largest	  
amplitude	  output	  voltage	  (low	  admittance	  magnitude).	  Phase	  measurement	  allows	  the	  separation	  
of	  blood	  and	  muscle	  (B)	  in	  real	  time.	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the	  admittance	  of	  the	  myocardium	  from	  the	  combined	  admittance	  signal,	  using	  electric	  
field	  theory.	  	  
For	   a	   vector	   electric	   field,	   E,	   in	   homogeneous	   tissue,	   the	   conductance	   and	  
capacitance	  between	  the	  electrodes	  that	  establish	  the	  field	  are	  given	  by:	  	  
	   ! =
!
! =
! !   ∙ !!!
− ! ∙ !!!!!!
= !"	   (9) 	  
	   ! =
!
! =
!   ! ∙ !!!
− ! ∙ !!!!!!
= !"	   (10) 	  
where:	  G	  =	  conductance	  (S),	  I	  =	  current	  (A),	  V	  =	  potential	  (V),	  σ	  =	  electrical	  conductivity	  
(S/m),	  k	  =	  the	  field	  geometry	  factor	  (1/m),	  C	  =	  capacitance	  (F),	  and	  Q	  =	  charge	  (C).	  The	  
integration	   is	   from	   one	   electrode	   to	   the	   other	   along	   a	   vector	   pathway,	   L,	   and	   the	  
surface,	   S,	   encloses	   all	   of	   the	   current	   from	   the	   source	   electrode.	   For	   a	   homogeneous	  
medium	  the	  measured	  conductance	  and	  capacitance	  are	  related	  by	  a	  simple	  ratio:	  




	  Equation	  (11)	  is	  the	  central	  principle	  of	  the	  admittance	  method.	  The	  important	  
ratio	   of	   σ/ε	   is	   determined	   by	   a	   surface	   probe	   measurement	   of	   the	   properties	   of	  
myocardium,	  which	  is	  described	  in	  detail	  by	  Raghavan	  et	  al.	  [7].	  
Briefly,	  the	  imaginary	  part	  of	  the	  admittance	  is	  defined	  as	  	  
	   !" ! = ! !"# ! = !!!"#$%&'()! +   !!!"#!!"!# 	  
(12) 	  
Therefore,	  once	  the	  (purely	  imaginary)	  catheter	  contribution	  has	  been	  determined	  and	  
subtracted	  through	  calibration	  in	  saline,	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The	  real	  part	  of	  the	  admittance	  is	  
	   !" ! = ! cos ! = !!"##$ + !!"#$%&'()!.	   (14) 	  
Consequently,	  	  
	   !!"##$ = ! cos ! − !!"#$%&'()!	   (15) 	  
where	  	  
	   !!"#$%&'()! =
!
! !!"#$%&'()!	   (16) 	  
	  
Based	   on	   these	   equations,	   one	   can	   determine	   the	   instantaneous	   values	   of	   parallel	  
conductance	   GP,	   and	   therefore	   blood	   conductance	   (GB).	   An	   example	   of	   how	   this	   is	  
accomplished	  in	  experiment	  is	  detailed	  in	  Section	  2.2.2.	  
1.2.2 Heart	  Failure	  Pathology	  
The	  backward	   heart	   failure	   concept	   was	   first	   proposed	   in	   1832,	   and	   contends	  
that	  when	  the	  LV	  fails	  to	  discharge	  its	  contents,	  blood	  accumulates	  and	  pressures	  rise	  in	  
the	  atrium	  and	  venous	  system	  emptying	   into	   it	   [18].	  The	   inability	  of	  the	  LV	  to	  shorten	  
against	  a	  load	  alters	  the	  relationship	  between	  end-­‐systolic	  pressure	  and	  volume	  so	  that	  
LV	   end-­‐systolic	   volume	   rises.	   The	   following	   sequence	   then	   occurs,	   which	   at	   first	  
maintains	   cardiac	   output,	   but	   ultimately	   leads	   to	   clinical	   deterioration	   –	   (a)	   LV	   end	  
diastolic	   volume	   and	   pressure	   increase,	   (b)	   the	   volume	   and	   pressure	   rise	   in	   the	   left	  
atrium,	  (c)	  the	  left	  atrium	  contacts	  more	  vigorously	  (Starling’s	  Law),	  (d)	  the	  pressure	  in	  
the	  pulmonary	  veins	  and	  capillary	  beds	  behind	  the	  LV	  rise,	  (e)	  transudation	  of	  fluid	  from	  
the	   pulmonary	   capillary	   beds	   into	   the	   pulmonary	   interstitial	   space	   increases,	   (f)	   the	  
elevation	   of	   LV,	   left	   atrial,	   and	   pulmonary	   venous	   pressures	   results	   in	   backward	  
	   13	  
transmission	   of	   pressures	   into	   the	   pulmonary	   arterial	   circuit	   and	   leads	   to	   pulmonary	  
hypertension,	   and	   finally,	   (g)	   right	   heart	   failure	   then	   occurs	   as	   a	   consequence	   of	   left	  
heart	  failure.	  
Further,	  as	   the	  LV	   fails,	   it	  will	   remodel	   to	  accommodate	   the	   increased	   load,	   to	  
reduce	  chamber	  pressures.	  Preload	   is	  an	   important	  determinant	  of	   the	  progression	  of	  
heart	  failure.	  It	  is	  defined	  as	  “the	  stretch	  of	  the	  individual	  sarcomere”	  [18].	  This	  stretch	  
is	   most	   practically	   estimated	   via	   the	   end-­‐diastolic	   ventricular	   volume,	   diameter,	   and	  
end-­‐diastolic	   pressure.	   For	   example,	   an	   increased	   end-­‐diastolic	   ventricular	   volume	   or	  
diameter,	  or	  a	  higher	  end-­‐diastolic	  pressure,	  would	  imply	  a	  larger	  preload.	  Increased	  LV	  
preload	   is	   more	   easily	   detected	   than	   pressure	   elevation	   since	   the	   diastolic	   pressure-­‐
volume	   relation	   is	   relatively	   flat	   and	   produces	   a	   larger	   change	   in	   volume	   for	   a	   given	  
change	   in	   pressure.	   This	   relationship	   is	  more	   evident	   as	   the	   LV	   remodels	   and	   dilates	  
since	  the	  diastolic	  ventricular	  pressure-­‐volume	  relation	  flattens	  in	  heart	  failure	  [19].	  An	  
increase	  in	  preload	  will	  also	  precede	  an	  elevation	  in	  right	  heart	  systolic	  pressures,	  due	  to	  
the	   length-­‐tension	   relationship	   of	   cardiac	   muscle,	   i.e.,	   –	   muscle	   is	   stretched	   before	  
generating	  greater	  systolic	  pressures	  [20].	  Based	  on	  these	  arguments,	  it	  can	  be	  assumed	  
that	  an	  increasing	  LV	  preload	  (increasing	  LV	  end-­‐diastolic	  Volume,	  or	  LVEDV)	  will	  be	  the	  
most	  sensitive	  measure,	  and	  earliest	  indicator	  of	  impending	  CHF.	  	  
1.2.3 Clinical	  Significance	  
Heart	   failure	   is	   a	   problem	   that	   greatly	   affects	   populations	   having	   implanted	  
devices	   such	   as	   ICDs	   and	   pacemakers.	   	   Periodic	   LVEDV	   detection	   provides	   a	   way	   to	  
detect	  impending	  heart	  failure	  before	  the	  disease	  debilitates	  the	  patient	  by	  progressing	  
to	  other	  parts	  of	  the	  body.	  It	  is	  orders	  of	  magnitude	  cheaper	  in	  total	  cost	  than	  any	  other	  
alternative	  of	  volume	  measurement	  when	  the	  pre-­‐existing	  need	  for	  an	  implanted	  device	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is	  considered.	  The	  major	  cost	  for	  LV	  volume	  detection	  using	  admittance	  will	  be	  the	  one	  
time	  cost	  of	  the	  pacemaker/AICD	  itself,	  and	  will	  provide	  real	  time	  information	  that	  can	  
be	  used	  for	  telemedicine.	  This	  decreases	  costs	  substantially	  both	  directly	  for	  the	  treating	  
hospital,	  physician,	  and	  patient,	  but	  also	   indirectly,	   in	  resources	  such	  as	  hospital	  beds,	  
and	  personnel	  for	  treatment	  [21].	  In	  addition,	  the	  patient	  will	  receive	  treatment	  earlier,	  
and	  quality	  of	   life	  will	   improve	  not	  only	  because	  of	  prevention	  of	   symptoms,	  but	  also	  
because	  telemedicine	  will	  allow	  a	  reduction	  in	  the	  length	  of	  hospital	  stay.	  
1.2.4 Competing	  technologies	  
There	  are	  two	  proposed	  “piggybacked”	  heart	  failure	  warning	  systems	  placed	  on	  
bi-­‐ventricular	   pacemakers	   and	   AICDs	   to	   reduce	   hospital	   admissions.	   First,	   Chronicle®	  
measures	  right	  heart	  pressures	  in	  an	  attempt	  to	  monitor	  increases	  that	  are	  indicative	  of	  
heart	   failure	   [22-­‐24].	   Second,	   Optivol®	   uses	   lung	   impedance	   (conductance)	  
measurements	   as	   an	   indication	   of	   pulmonary	   edema	   [25-­‐28].	   However,	   both	   are	  
downstream	  measures	  of	  what	  will	  be	  an	  earlier	  indicator	  of	  impending	  heart	  failure	  –	  
left	  ventricular	  (LV)	  preload	  or	   left	  ventricular	  end-­‐diastolic	  volume	  (LVEDV).	  There	  are	  
currently	   no	   proposed	   technologies	   that	   can	   perform	   chronic	   left	   ventricular	   volume	  
measurements	   in	  part	  because	   implanted	  devices	   inside	   the	   left	  heart	   lead	   to	  arterial	  
embolism	  and	  stroke.	  
1.3 SPECIFIC	  AIMS	  
The	   specific	   aims	   of	   this	   dissertation	   are:	   1.	   To	   validate	  Admittance	   and	  Wei’s	  
equation	  as	  the	  standard	  for	  catheterized	  heart	  volume	  measurement,	  both	  in	  small	  and	  
large	   animal	   models.	   2.	   To	   design	   through	   the	   use	   of	   computational	   modeling	   and	  
experimentation,	   new	   configurations	   of	   admittance	  measurement	   that	  will	  mimic	   the	  
standard	   pacemaker	   configuration,	   and	   3.	   To	   investigate	   through	   experiment	   the	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efficacy	   of	   an	   epicardial	   lead	   configuration	   for	   the	   detection	   of	   increased	   LV	   end-­‐
diastolic	  volume.	  
	  
1.4 CHAPTER	  OVERVIEW	  
The	  traditional	  problems	  of	  the	  dynamic	  nature	  of	  GP	  and	  α	  are	  addressed	  with	  
the	   advent	   of	  Wei’s	   equation,	   whose	   validation	   is	   the	   focus	   of	   the	   Chapter	   2	   of	   this	  
dissertation.	   Chapter	   3	   deals	   with	   the	   extension	   of	   these	   principles	   to	   a	   larger	   scale	  
animal	  model	   to	  prove	   its	  viability	  as	  a	  measurement	   in	  human-­‐sized	  hearts,	  and	  also	  
discusses	  the	  potential	  advantages	  and	  drawbacks	  of	  using	  more	  than	  four	  electrodes.	  	  
Chapter	  4	  deals	  with	   the	   theory	  of	  how	   to	  make	   the	  admittance	  measurement	   in	   the	  
new	   epicardial	   catheter	   configuration	   along	   with	   a	   discussion	   of	   surgical	   positioning	  
error,	   and	   Chapter	   5	   deals	   with	   the	   validation	   of	   this	   new	   measurement	   through	  
experiment	  in	  vivo	  in	  pigs.	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Chapter	  2:	  Experimental	  Validation	  of	  Admittance	  and	  Wei’s	  Equation	  
2.1 INTRODUCTION	  
To	   confidently	   perform	   an	   indirect	   volume	   measurement	   of	   any	   kind,	   it	   is	  
necessary	   to	   provide	   results	   against	   a	   known	   volume	   standard,	   usually	   MRI	   or	  
ultrasound	  echo.	  Previously,	  the	  measurement	  of	  admittance	  for	  volume	  determination	  
was	  validated	  through	  comparison	  with	  the	  previous	  standard	  method	  for	  conductance	  
catheter	   determination	   [5],	   referred	   to	   in	   this	   dissertation	   as	   the	   “traditional	  
conductance	   technique”.	   But	   traditional	   conductance	   is	   a	   flawed	   method	   at	   both	   a	  
practical,	  and	  a	  theoretical	  level	  for	  two	  major	  reasons:	  1)	  The	  “gain	  term”	  1/α	  in	  Baan’s	  
equation	   is	  not	   a	   constant,	   but	   instead	   changes	  dynamically	   as	   the	  moving	  heart	  wall	  
changes	  the	  shape	  of	  the	  applied	  electric	  field,	  and	  2)	  As	  the	  LV	  contracts	  and	  fills,	  the	  
cardiac	  muscle	  moves	   closer	   to	   and	   farther	   away	   from	   the	   catheter,	   so	   subtracting	   a	  
constant	   GP	   (as	   in	   Baan’s	   equation)	   does	   not	   adequately	   compensate	   for	   the	   parallel	  
muscle	   conductance.	   For	   these	   reasons,	   a	   study	   to	   validate	   the	  admittance	   technique	  
against	   a	   known	   standard	   must	   be	   performed	   using	   a	   better	   standard	   for	   volume	  
measurement.	  
2.2 METHODS	  
2.2.1 LV	  Catheter	  Calibration	  
LV	  catheter	  calibration	  is	  necessary	  to	  determine	  the	  relative	  contribution	  of	  the	  
catheter	  to	  the	  impedance	  measurement.	  The	  catheter	  and	  instrument	  both	  produce	  an	  
additional	   phase	   shift,	   because	   they	   introduce	   additional	   capacitance	   to	   the	   volume	  
measurement.	   The	   key	   to	   separation	   of	   muscle	   and	   blood	   signals	   lies	   in	   the	   phase	  
measurement,	   so	   a	   calibration	   is	   performed	   to	   determine	   the	   artifact	   phase	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contribution.	  The	  calibration	  performed	  allows	  quantification	  of	  both	  the	  catheter	  –	  and	  
instrument	  –	  related	  phase	  and	  their	  effects	  on	  admittance	  magnitude.	  
The	   admittance	   system	   is	   calibrated	   by	   measuring	   the	   admittance	   magnitude	  
and	   phase	   angle	   of	   both	   the	   tetrapolar	   and	   epicardial	   catheters	   immersed	   in	   varying	  
conductivity	  saline	  solutions	  (1000,	  2000,	  4000,	  8000,	  10000,	  and	  12000	  μS/cm).	  Saline	  
is	   chosen	   for	   the	   calibration	  because	   it	  will	   not	  produce	  a	  measureable	  phase	   shift	   at	  
this	   frequency,	   and	   because	   it	   is	   easy	   to	   produce	   solutions	   in	   the	   required	   range	   of	  
conductivity.	   The	   range	   of	   conductivity	   of	   solutions	   is	   determined	   by	   including	   the	  
smallest	  and	   largest	  values	  of	  conductivity	  expected	   in	  the	   in	  vivo	  mouse	  heart,	  which	  
ranges	  from	  1600	  μS/cm	  for	  myocardium	  to	  approximately	  10000	  μS/cm	  for	  blood.	  The	  
admittance	  measurement	   is	   a	   parallel	   combination	   of	   the	   two.	   Thus,	   the	   admittance	  
system	  phase	  calibration	   is	  designed	  to	  cover	  this	  entire	  range.	  The	  containers	   for	  the	  
saline	   solutions	   are	  much	   greater	   in	   diameter	   than	   the	   distance	   between	   the	   voltage	  
electrodes,	  so	  that	  the	  electric	  field	  produced	  by	  the	  current	  is	  essentially	  unconstrained	  
by	  the	  sides	  of	  the	  container.	  The	  values	  measured	  for	  admittance	  magnitude	  and	  phase	  
are	  therefore	  independent	  of	  the	  shape	  of	  the	  saline	  container,	  and	  only	  dependent	  on	  
the	  measurement	  hardware	  and	  the	  conductivity	  of	  the	  solution.	  	  	  
Additionally,	   the	   relationship	   between	   G	   and	   σ	   is	   determined	   from	   this	  
calibration	   information	  via	  Equation	  (9).	   It	   is	   important	  to	  make	  sure	  that	  the	  value	  of	  
the	   field	   form	   factor	   (k)	   is	   constant	   with	   changing	   conductivity,	   because	   k	   should	   be	  
dependent	   only	   on	   the	   field	   geometry,	   which	   should	   not	   change	   as	   the	   conductivity	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changes	  in	  a	  cuvette	  of	  large	  size.1	  Variability	  in	  k	  could	  indicate	  that	  there	  are	  strange	  
interface	  effects	  at	  work,	  or	  that	  the	  catheter	  is	  damaged	  in	  some	  way.	  
2.2.2 Muscle	  Properties	  Measurement	  Calibration	  
Muscle	  properties	  are	  measured	  using	  a	  surface	  probe	  that	  rests	  on	  the	  surface	  
of	   the	   myocardium	   and	   has	   a	   field	   that	   penetrates	   only	   the	   tissue	   and	   not	   into	   the	  
underlying	  blood	  pool.	  The	   theory	   is	  outlined	   in	  Equations	   (11)	   through	   (14),	  with	   the	  
exception	   that	   the	   real	   part	   of	   the	   admittance	   in	   this	   calibration	   only	   includes	   the	  
conductance	  of	  the	  muscle.	  	  
The	   field	   does	   not	  
penetrate	   into	   the	   blood	   below	  
because	   the	   purposeful	   design	  
of	   the	   surface	   probe	   current	  
electrode	   spacing	   confines	   the	  
field	   to	   the	   myocardium.	   The	  
penetration	   depth	   is	   directly	  
dependent	   only	   on	   the	   conductivity	   of	  muscle	   and	   the	   electrode	   spacing.	   Using	   FEM	  
simulation,	   a	   spacing	   is	   chosen	   for	   the	   surface	   probe	   electrodes	   that	   matches	   the	  
thickness	   of	   the	   myocardium	   of	   interest,	   and	   the	   conductivity	   of	   muscle	   (normally	  
around	  0.15-­‐0.2	  S/m)	  [29].	  The	  electrode	  effective	  depth	  of	  penetration	   is	  determined	  
experimentally	   in	   saline	   over	   a	   non-­‐conducting	   substrate,	   such	   as	   a	   glass	  microscope	  
slide	  [30].	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Obviously	  this	  does	  not	  apply	  in	  a	  traditional	  cuvette	  calibration	  (a	  currently	  very	  popular	  technique),	  
where	  calibration	  involves	  determining	  the	  change	  in	  conductance	  vs.	  field	  constriction	  in	  varying	  sizes	  of	  
cuvettes.	  
	  
Figure	  4: Tetrapolar	  surface	  probe	  used	  for	  epicardial	  admittance	  
measurements,	  to	  determine	  the	  εm/σm	  ratio;	  mouse	  size.	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2.2.3 Admittance	  vs.	  Hypertonic	  Saline	  Conductance	  vs.	  Cuvette	  vs.	  Echo	  
Protocol	  
Mice	  were	  anesthetized	  by	  administration	  of	  1-­‐2%	  Isoflurane	  and	  were	  allowed	  
to	   breathe	   spontaneously	   with	   100%	   supplemental	   O2.	   The	   right	   carotid	   artery	   was	  
entered	   and	   a	   tetrapolar	  micro-­‐manometer	   catheter	   (Scisense,	   Inc.,	   London,	   Ontario)	  
was	  advanced	  into	  the	  LV	  of	  the	  intact	  beating	  mouse	  heart.	  The	  right	  jugular	  vein	  was	  
cannulated	  for	  later	  administration	  of	  10	  µl	  of	  3%	  hypertonic	  saline	  to	  determine	  steady	  
state	   parallel	   conductance.	   A	   total	   of	   n	   =	   8	   mice	   were	   studied.	   The	   position	   of	   the	  
tetrapolar	  catheter	   in	  the	  LV	  was	  guided	  by	  simultaneous	  imaging	  with	  a	  transthoracic	  
echocardiogram	   (VisualSonics,	   Toronto,	   Canada).	   The	   initial	   position	   for	   placement	   of	  
the	  tetrapolar	  catheter	  was	  the	  off-­‐center	  location	  (see	  Figure	  5B).	  	  
	  
Figure	  5:	  Representative	  mouse	  echo.	  A.	  Center	  positioned	  catheter	  guided	  by	  echo.	  A1.	  Long	  axis	  view	  A2.	  M-­‐Mode	  
view.	  B.	  Off-­‐center	  positioned	  catheter	  guided	  by	  echo.	  B1.	  Long	  axis	  view	  B2.	  M-­‐Mode	  view.	  M-­‐Mode	  views	  quantify	  
catheter	  to	  myocardium	  distances	  in	  mm.	  White	  double-­‐headed	  arrows	  in	  long	  axis	  view	  indicate	  the	  line	  of	  M-­‐Mode	  
measurement.	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In	   the	   off-­‐center	   position,	   instantaneous	   LV	   PV	   relations	   were	   monitored	   to	  
assure	   that	   a	   physiologic	   loop	   was	   obtained	   before	   acquiring	   data	   for	   both	   the	  
admittance	  and	  conductance	  raw	  signals.	  Final	  acceptance	  of	  the	  catheter	  position	  was	  
based	   upon	   both	   echocardiography	   and	   the	   appearance	   of	   the	   loop.	   Data	   acquisition	  
consisted	  of	   simultaneous	   LV	  pressure,	   conductance	   (no	  phase)	   stimulated	   at	   20	   kHz,	  
and	  complex	  admittance	  (magnitude	  and	  phase)	  also	  at	  20	  kHz,	  and	  echocardiographic	  
images	  plus	  ECG	  for	  later	  calculation	  of	  end-­‐diastolic	  volume	  (EDV),	  end-­‐systolic	  volume	  
(ESV),	  and	  stroke	  volume	   (SV).	  An	  operating	   frequency	  of	  20	   to	  25	  kHz	  maximizes	   the	  
observable	  muscle	  signal	  [7].	  All	  data	  were	  sampled	  at	  1	  kHz.	  
	  	  Subsequently,	  the	  tetrapolar	  catheter	  was	  re-­‐positioned	  to	  be	  in	  the	  center	  of	  
the	   left	   ventricular	   cavity	   (see	   Figure	   5A),	   with	   final	   positioning	   confirmed	   by	   both	  
echocardiography	   and	   a	   physiologic	   LV	   PV	   loop.	   Data	   acquisition	   for	   simultaneous	   LV	  
pressure,	   conductance,	   admittance,	   and	   echocardiographic	   images	   plus	   ECG	   for	   later	  
calculation	  of	  EDV,	  ESV,	  and	  SV	  were	   repeated.	  A	  10	  µl	  bolus	  of	  3%	  hypertonic	   saline	  
was	  administered	  n=3	  times	  per	  mouse	  via	  the	  right	  jugular	  vein,	  for	  later	  determination	  
of	  steady	  state	  parallel	  conductance,	  as	  previously	  described	  [5]	  
2.2.4 Dobutamine	  Studies	  
A	   study	  was	   performed	   in	   n=6	  mice	   (C57BlkS/J,	   female,	   body	  weight	   23±2.5g,	  
8.7±3	  mos.)	   to	   determine	   the	   relative	   sensitivity	   of	   the	   admittance	   and	   conductance	  
techniques	   to	   a	   contractility	   change	   induced	   by	   dobutamine	   infusion.	   Mice	   were	  
anesthetized	  by	  administration	  of	  urethane	   (1000	  mg/kg	   IP)	  and	  etomidate	   (25	  mg/kg	  
IP).	  Complex	  admittance	  (magnitude	  and	  phase)	  and	  conductance	  (magnitude	  only)	  with	  
left	  ventricular	  pressure	  were	  obtained	  at	  steady	  state	  and	  during	  occlusion	  of	  the	  IVC	  at	  
both	   baseline	   and	   during	   administration	   of	   5μg/kg/min	   of	   dobutamine	   through	   the	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jugular	  vein.	  Data	  acquisition	   for	  dobutamine	  was	  started	  5	  minutes	  after	   initiation	  of	  
the	  IV	  infusion.	  Volume	  data	  were	  calibrated	  using	  flow	  probe-­‐derived	  stroke	  volume	  at	  
the	   end	   of	   each	   experiment,	   and	   subsequently	   converted	   to	   left	   ventricular	   volume	  
using	   both	   Baan’s	   equation,	   and	   Wei’s	   equation.	   Parallel	   conductance	   GP	   for	   Baan’s	  
equation	  was	  calculated	  as	  the	  constant	  mean	  value	  of	  the	  admittance-­‐derived	  parallel	  
conductance	   GP(t)	   to	   avoid	   blood	   conductivity	   changes	   due	   to	   the	   injection	   of	  
hypertonic	  saline.	  
2.2.5 Aortic	  Banding	  and	  Heart	  Failure	  
In	   a	   separate	   experiment,	   n=6	   mice	   underwent	   aortic	   banding	   for	   1	   week	   to	  
increase	   the	   afterload	   (increase	   arterial	   resistance)	   on	   the	   LV,	   thereby	   changing	   the	  
shape	  of	   the	   LV	   chamber	  over	   time.	  Muscle	  properties	  were	  examined	  as	   above,	   and	  
volume	  was	   determined	   using	   the	   admittance	  method	   and	   compared	   to	   echo	   in	   this	  
disease	  model.	  
2.2.6 Statistics	  
EDV	  and	   ESV	  derived	  by	  Wei’s	   equation	  using	   admittance	   transient	  GP(t)	  were	  
compared	  with	  echo	  data	  for	  EDV	  and	  ESV	  at	  both	  the	  centered	  and	  off-­‐center	  positions	  
using	  a	   two-­‐sample	   right-­‐tailed	   student’s	   t-­‐test.	  All	   calculations	  were	  performed	  using	  
Matlab	   software	   (The	   Mathworks	   Inc.,	   Natick	   MA).	   EDV	   and	   ESV	   derived	   by	   Baan’s	  
equation	  using	  hypertonic	  saline	  GP	  were	  also	  compared	  with	  echo	  data	  using	  the	  same	  
methods	   at	   both	   the	   centered	   and	   off-­‐center	   positions.	   These	   analyses	   are	   also	  
presented	   as	   Bland-­‐Altman	   plots.	   Enhancement	   in	   contractility	   in	   response	   to	  
dobutamine	   between	   baseline	   and	   drug	   infusion	   for	   both	   Baan’s	   equation	   (SV	  
calibration	   of	   α)	   and	   Wei’s	   equation	   using	   admittance	   GP(t)	   were	   compared	   with	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student’s	   t-­‐tests.	   	   The	   alteration	   in	  myocardial	   properties	   between	   control	   and	   aortic	  
banded	  mice	  were	  also	  compared	  with	  student’s	  t-­‐tests.	  
2.2.7 Echocardiographic	  Calculations	  
2.2.7.1 EDV	  and	  ESV	  
End-­‐diastole	  was	  defined	  as	   just	  after	   the	  peak	  of	   the	  R	  wave	  on	  the	  ECG,	  and	  
end-­‐systole	  was	  defined	  as	  minimum	  LV	  volume.	  A	   long	  axis	   view	  was	   taken	   for	  both	  
end-­‐systole	   and	   end-­‐diastole,	   and	   the	   volume	   measured	   was	   determined	   using	   the	  
cardiac	  analysis	  package	   from	   the	  Vevo	  770	   software	   (VisualSonics,	   Toronto,	  Canada).	  
The	  long	  axis,	  and	  a	  single	  short	  axis	  within	  a	  long	  axis	  view	  were	  measured	  (see	  Figure	  
5A1	  and	  B1),	  the	  second	  short	  axis	  was	  assumed	  to	  be	  of	  equal	  length.	  Volume	  was	  then	  
computed	   using	   the	   prolate	   ellipse	   method	   [31,	   32].	   SV	   was	   determined	   as	   the	  
difference	  between	  EDV	  and	  ESV,	  and	  was	  used	  in	  the	  calculation	  of	  both	  conductance	  
and	  admittance	  derived	  LV	  volume.	  
2.2.7.2 Center	  and	  Off-­‐center	  Catheter	  Positions	  
Both	   center	   and	   off-­‐center	   positions	   were	   studied	   since	   placement	   of	   the	  
miniaturized	  PV	  catheter	  across	  the	  aortic	  valve	  in	  vivo	  forces	  catheter	  placement	  near	  
the	  septum	  and	  off	  the	  true	  LV	  center	  [14].	  Thus,	  without	  echo	  guidance,	  the	  off-­‐center	  
position	  may	  be	  the	  position	  most	  often	  used	  by	  investigators.	  	  
To	  allow	  for	  comparison	  between	  a	  centered	  position	  and	  an	  off-­‐center	  catheter	  
position,	  the	  distance	  between	  the	  LV	  free-­‐wall	   (LVFW)	  and	  the	  center	  of	  the	  catheter	  
was	  measured,	  as	  was	  the	  distance	  between	  the	  center	  of	  the	  catheter	  and	  the	  septum	  
(SEP).	   An	   example	   of	   these	   measurements	   is	   displayed	   in	   Figure	   5A2	   and	   B2.	   The	  
percentage	  deviation	  from	  the	  center	  was	  calculated	  as:	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   !"# = !"# 1− 2×
!"#$
!"#$ + !"# ×100%	  
(17) 	  
In	   this	   calculation,	  a	  value	  of	  100%	   indicates	   that	   the	  catheter	  position	  coincides	  with	  
the	  inner	  myocardial	  wall,	  and	  a	  value	  of	  0%	  indicates	  that	  the	  catheter	  is	  in	  the	  center	  
of	  the	  ventricle.	  Catheter	  positions	  that	  are	  symmetric	  around	  the	  long	  axis	  result	  in	  the	  
same	  percentage	  deviation	  from	  the	  center.	  
2.3 RESULTS	  
2.3.1 Myocardial	  Properties	  Measurement	  
The	   conductivity	   and	   permittivity	   of	   myocardium	   were	   measured	   in	   separate	  
experiments	   in	   n=7	   mice	   in	   an	   open	   chest	   preparation	   as	   described	   in	   [33].	   The	  
permittivity	   of	   myocardium	   derived	   from	   these	   measurements	   at	   20	   kHz	   was	   εm	   =	  
(11800	  ±	  2700)	  *ε0	  F/m,	  and	  the	  electrical	  conductivity	  of	  myocardium	  was	  measured	  at	  
σm	   =	   0.160	   ±	   0.046	   S/m.	   These	   results	   were	   used	   in	   calculations	   related	   to	   the	  
admittance	  –	  conductance	  –	  echocardiography	  comparisons.	  
In	   an	   additional	   n=9	   mice,	   the	   impact	   of	   left	   ventricular	   hypertrophy	   (aortic	  
banding	  for	  1	  week)	  on	  myocardial	  properties	  was	  determined.	  Heart	  weight	  (86±4	  mg	  
control,	   124±7	  mg	  banded	  p<0.0001)	   and	   LV	  weight	   (70±7	  mg	   control	   vs.	   109±10	  mg	  
banded	  p<0.001)	  increased	  with	  banding.	  In	  n=4	  banded	  mice,	  εm	  =	  (16726	  ±	  9492)	  *	  ε0	  
F/m,	  an	  increase	  of	  (7450	  ±	  6703)	  *	  ε0	  F/m	  from	  age	  and	  sex	  matched	  controls	  (n=5,	  p	  <	  
0.05).	  	  The	  myocardial	  conductivity	  showed	  no	  change	  from	  banded	  σm	  =	  0.184	  ±	  0.042	  
S/m	  to	  control	  σm	  =	  0.185	  ±	  0.029	  S/m,	  p=NS.	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2.3.2 Hemodynamic	  and	  Echocardiographic	  Parameters	  for	  Admittance	  –	  
Conductance	  Comparison	  
For	  n=8	  mice,	   the	  body	  weight	   ranged	   from	  19	   to	  30	   g	   (mean	  =	  26.5	  ±	  3.5	   g),	  
heart	  weight	  ranged	  from	  85	  to	  152	  mg	  (mean	  =	  123.8	  ±	  21.2	  mg),	  and	  LV	  weight	  ranged	  
from	   67	   to	   107	  mg	   (mean	   =	   90.8	   ±	   14.6	  mg).	   The	  mean	   left	   ventricular	   peak	   systolic	  
pressure	  was	  102	  ±	  10	  mmHg,	  and	   the	  heart	   rate	  was	  407	  ±	  28	  bpm.	  The	  mean	  echo	  
end-­‐diastolic	   volume	  was	  40.9	  ±	  12.1	  μl,	   and	   the	  mean	  echo	  end-­‐systolic	   volume	  was	  
14.1	  ±	  5.5	  μl.	   The	  echocardiographic	   SV	  used	   in	   the	   calculation	  of	  both	  alpha	   (α)	   and	  
gamma	  (γ)	  had	  a	  mean	  value	  of	  26.8	  ±	  7.2	  μl.	  
The	  parallel	  conductance	  calculated	  by	  the	  hypertonic	  saline	  method	  was	  476	  ±	  
182	  μS,	  and	  by	  the	  admittance	  technique	  ranged	  dynamically	  from	  552	  ±	  79	  μS	  at	  end-­‐
systole	   to	   346	   ±	   67	   μS	   at	   end-­‐diastole.	   The	   mean	   off-­‐center	   α	   was	   0.22	   ±	   0.15	   as	  
determined	   from	   echo	   SV,	   and	   it	   was	   1.01	  with	   cuvette	   (centered).	   The	  mean	   γ	   was	  
1350	   ±	   389	   μS.	   The	   location	   of	   the	   catheter	   position	   relative	   to	   the	  wall	   is	   shown	   in	  
Table	   1.	   The	   center	   technique	   was	   closer	   to	   the	   true	   mid-­‐line	   than	   the	   off-­‐center	  
position	   (p	  <	  0.0001)	  based	  on	   the	  M-­‐mode	  echo	  measurements.	   Typical	   examples	  of	  
echo	  center	  and	  off-­‐center	  catheter	  positions	  are	  shown	  in	  Figure	  5.	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2.3.3 Wei’s	  Equation	  Using	  Admittance	  is	  More	  Accurate	  than	  Baan’s	  Equation	  
Using	  HS	  and	  Either	  SV	  or	  Cuvette	  Calibration	  With	  Off-­‐Center	  Catheter	  
Placement	  	  
The	  off-­‐center	  derived	  PV	   loops	   from	  Wei’s	  equation,	  Baan’s	  equation	  with	  SV	  
calibration	  (α	  =	  0.22	  ±	  0.15),	  and	  Baan’s	  equation	  with	  cuvette	  calibration	  (α	  =	  1)	  for	  all	  
n=8	  mice	   are	   shown	   in	   Figure	   6.	   As	   is	   visually	   apparent	   in	   5	   of	   these	   8	  mice,	   the	   SV	  
calibrated	  conductance	  derived	  PV	  loops	  are	  to	  the	  right	  of	  echo	  (mice	  #	  2,	  4,	  5,	  7,	  8),	  
and	  the	  cuvette	  calibrated	  conductance	  loops	  are	  to	  the	  left	  of	  echo	  (mice	  #	  1,	  2,	  3,	  6,	  
7).	   In	  contrast,	  all	  of	  the	  Wei’s	  equation	  with	  admittance	  loops	  are	  similar	  to	  the	  echo	  
derived	   volumes.	   The	   end-­‐diastolic	   and	   end-­‐systolic	   volumes	   derived	   using	   Wei’s	  
equation	  (α(GB)	  ≈	  0.7-­‐0.9)	  show	  significantly	  less	  absolute	  error	  (-­‐2.49	  ±	  15.33	  µl	  error	  ES	  
and	  ED)	  than	  the	  same	  quantities	  calculated	  using	  SV	  calibrated	  conductance	  (α	  ≈	  0.1-­‐
0.3)	  (35.89	  ±	  73.22	  µl	  error	  ES	  and	  ED)	  or	  cuvette	  calibrated	  conductance	  (α	  =	  1)	  (-­‐29.10	  
Table	  1:	  Catheter	  position	  for	  each	  mouse.	  *Percentages	  represent	  
positional	  deviation	  from	  center.	  0%	  =	  center,	  100%	  =	  wall.	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±	   31.53	   µl	   error	   ED,	   and	   -­‐7.53	   ±	   16.23	   µl	   error	   ES),	   taking	   the	   echo	   volumes	   as	   the	  
standard	  of	  comparison	  (p	  <	  0.03).	  	  
These	  results	  are	  shown	  in	  graphical	  format	  as	  Bland-­‐Altman	  plots	  in	  Figure	  7A.	  
The	  Bland-­‐Altman	  plot	   shows	   that	  most	  of	   the	  error	   lies	   in	   the	   low	  repeatability	   (high	  
standard	   deviation)	   of	   measurements	   when	   relying	   on	   Baan’s	   equation	   with	   SV	  
calibration.	  	  A	  consistently	  small	  absolute	  volume	  and	  stroke	  volume	  are	  observable	  in	  
results	   from	   Baan’s	   equation	   with	   cuvette	   calibration,	   which	   is	   consistent	   with	  
observations	  in	  the	  literature	  [34,	  35].	  These	  results	  show	  that	  when	  the	  catheter	  is	  not	  
placed	   in	   an	   optimal,	   i.e.,	   central	   position,	   admittance	   provides	   an	   advantage	   in	  
accuracy.	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Figure	  6:	  Pressure-­‐Volume	  loops	  from	  mice	  with	  catheter	  positioned	  off-­‐center.	  The	  solid	  lines	  represent	  the	  end-­‐
systolic	  and	  end-­‐diastolic	  echo	  reference.	  The	  solid	  loops	  were	  derived	  with	  Wei’s	  equation	  and	  admittance	  where	  
α(GB(t))	  is	  determined	  instantaneously,	  and	  ranges	  between	  0.7	  and	  0.9	  during	  the	  cardiac	  cycle;	  the	  dot-­‐dash	  
loops	  were	  derived	  using	  Baan’s	  method	  of	  hypertonic	  saline	  with	  cuvette	  calibration	  (α	  =	  1);	  the	  dash	  loops	  were	  
derived	  using	  Baan’s	  method	  of	  hypertonic	  saline	  with	  echo	  SV	  calibration	  (α	  =	  0.1	  –	  0.3).	  As	  is	  visually	  evident,	  the	  
admittance	  technique	  in	  combination	  with	  Wei’s	  equation	  was	  closer	  to	  echo.	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2.3.4 Wei’s	  Equation	  Using	  Admittance	  is	  as	  Accurate	  as	  Baan’s	  Equation	  Using	  
HS	  and	  SV	  or	  Cuvette	  Calibration	  with	  Centered	  Catheter	  Placement	  	  
For	  the	  same	  8	  mice,	  when	  the	  catheter	  was	  shifted	  to	  the	  central	  position	  and	  
the	   same	   measurements	   were	   taken,	   the	   same	   trend	   was	   observed:	   every	   Wei’s	  
equation/admittance	   PV	   loop	   gave	   a	   smaller	   volume	   than	   those	   derived	   from	   Baan’s	  
equation	  α	  =	  0.22	  ±	  0.15 with	  HS,	  and	  larger	  than	  every	  PV	  loop	  from	  Baan’s	  equation	  
with	  α	  =	  1	  using	  cuvette	  calibration	  (Figure	  6).	  However,	  the	  difference	  in	  error	  between	  
Wei’s	   equation	   and	   echo	   measurement,	   and	   between	   both	   calibration	   methods	   for	  
Baan’s	   equation	  and	  echo,	  were	  not	   found	   to	  be	   statistically	   significant	   in	   either	   case	  
with	  one	  exception:	   in	  the	  end	  diastolic	  measurements	  from	  cuvette	  calibration,	  Wei’s	  
equation	  shows	  lower	  error	  (p	  <	  0.03).	  The	  closeness	  of	  these	  three	  results	  may	  be	  due	  
to	   the	   removal	   of	   equivalent	   amounts	   of	   parallel	   conductance	   when	   the	   tetrapolar	  
catheter	  is	  centered	  with	  echo	  guidance,	  where	  the	  average	  GP	  using	  hypertonic	  saline	  is	  
476	   ±	   182	   µS	   vs.	   admittance’s	   average	   GP(t)	   of	   448	   ±	   60	   µS.	   The	   mean	   of	   an	  
instantaneously	  varying	  parallel	  conductance	  and	  an	  example	  real-­‐time	  signal	  are	  shown	  
in	  Figure	  8A.	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Figure	  7:	  Bland-­‐Altman	  plot	  of	  echo	  vs.	  admittance	  volume.	  The	  volume	  difference	  of	  each	  method	  vs.	  echo	  is	  plotted	  
on	  the	  y-­‐axis	  vs.	  the	  mean	  of	  echo	  and	  each	  method	  on	  the	  x-­‐axis	  in	  these	  Bland	  Altman	  plots	  in	  n=8	  mice	  for	  both	  
End-­‐Systolic	  (circle)	  and	  End-­‐Diastolic	  (x)	  volume	  measured	  at	  A.	  the	  off-­‐center	  position	  comparing	  A1.	  Volume	  from	  
Baan’s	   Equation	   	   using	   hypertonic	   saline	   	   vs.	   Echo	   volume	   (Average	   Error	   for	   ESV	   =	   -­‐7.54	  ±	  16.23	  µl,	   and	   EDV	   =	  
-­‐29	  ±	  15.33	  µl),	  A2.	  Volume	  from	  Wei’s	  Equation	  using	  admittance	  vs.	  echo	  volume,	  (Average	  Error	  for	  ESV	  and	  EDV	  
are	  equivalent,	  Error	  =	  -­‐2.49	  ±	  15.33	  µl),	  A3.	  Volume	  from	  Baan’s	  Equation	  with	  echo	  SV	  calibration	  using	  hypertonic	  
saline	  (Average	  Error	  for	  ESV	  and	  EDV	  are	  equivalent,	  Error	  =35.89	  ±	  73.22	  µl);	  and	  B.	  the	  same	  three	  plots	  with	  the	  
catheter	  at	  the	  center	  position.	  B1.	  Average	  error	  for	  cuvette-­‐calibrated	  conductance	  ESV	  =	  -­‐7.54	  ±	  16.23	  µl,	  and	  EDV	  
=	   -­‐29	  ±	  15.33	  µl	  B2.	  Average	  error	   for	  Admittance	  ESV	  and	  EDV	  are	  equivalent,	   Error	   =	  -­‐6.64	  ±	  24.3	  µl.	  B3.	  Average	  
error	  for	  SV-­‐calibrated	  conductance	  ESV	  and	  EDV	  are	  equivalent,	  Error	  =	  -­‐20.96	  ±	  38.42	  µl.	  
Solid	  lines	  represent	  means	  and	  dashed	  lines	  represent	  the	  95%	  confidence	  intervals.	  †Less	  error	  than	  SV-­‐calibrated	  
conductance	  (p	  <	  0.03	  in	  a	  student’s	  t-­‐test).	  ‡Less	  error	  than	  cuvette-­‐calibrated	  conductance	  (p<0.03)	  	  
	  
	   30	  
2.3.5 IVC	  Occlusions	  Show	  Dynamic	  Removal	  of	  a	  Non-­‐Constant	  Parallel	  
Conductance	  
	  In	   additional	   mice	   (n=4)	   IVC	   occlusions	   were	   performed	   to	   demonstrate	   the	  
ability	   of	   the	   admittance	   technique	   to	   dynamically	   separate	   blood	   conductance	   and	  
myocardium	   conductance.	   Figure	   8A	   shows	   the	   typical	   separation	   of	   the	   blood	   and	  
myocardial	  components	  during	  IVC	  occlusion	   in	  a	  single	  mouse	  using	  conductance	  and	  
admittance	   techniques,	   and	   all	   four	   mice	   showed	   the	   same	   phenomenon.	   The	  
observation	  from	  this	  figure,	  which	  represents	  a	  departure	  from	  traditional	  conductance	  
theory,	   is	   that	  during	  an	   IVC	  occlusion	  the	  amount	  of	  myocardium	   in	   the	  sensing	   field	  
increases	  while	  the	  blood	  component	  of	  conductance	  still	  decreases	  and	  dominates	  the	  
total	  conductance	  signal.	  Traditional	  conductance	  methods	  assume	  a	  constant	  value	  for	  
parallel	  conductance,	  which	   is	  demonstrated	  to	  be	  an	   inaccurate	  assumption	  by	  these	  
data.	  	  
	  	  Preload	  reduction	  is	  commonly	  utilized	  to	  generate	  measures	  of	  left	  ventricular	  
function	   such	   as	   the	   end-­‐systolic	   elastance	   (Ees),	   diastolic	   chamber	   compliance,	   and	  
others.	   It	   is	  hypothesized	  that	  calculated	  values	  of	  Ees	  and	  other	  parameters	  would	  be	  
affected	   by	   the	   change	   from	   traditional	   conductance	   with	   Baan’s	   equation,	   to	  
admittance	  with	  Wei’s	  equation.	  Thus,	  the	  impact	  of	  these	  two	  techniques	  on	  calculated	  
hemodynamic	   parameters	   was	   analyzed	   for	   an	   identical	   transient	   occlusion	   of	   the	  
inferior	   vena	   cava	   from	   a	   single	  mouse.	   Results	   are	   shown	   in	   Figure	   8B.	   Despite	   the	  
similarity	   in	   conductances	   in	   Figure	   8C,	   the	   appearance	   of	   the	   loops	   in	   Figure	   8B	   is	  
significantly	  different.	  	  
	  	  Additionally,	   there	   was	   an	   increase	   in	   measures	   of	   contractility	   using	   the	  
admittance	   technique.	   Ees	   rose	   from	   3.4	   to	   15.4	   mmHg/µl;	   maximum	   elastance	   rose	  
from	   12	   to	   25	   mmHg/µl,	   and	   preload	   recruitable	   stroke	   work	   rose	   from	   52	   to	   95	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mmHg·∙µl,	   conductance	   to	   admittance,	   respectively.	   Further,	   there	  was	   an	   increase	   in	  
chamber	  stiffness	  from	  0.061	  sec-­‐1	  with	  conductance	  to	  0.076	  sec-­‐1	  by	  admittance.	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Figure	  8:	  Example	  data	  from	  a	  single	  mouse	  during	  an	  identical	  preload	  reduction	  analyzed	  
by	  constant	  GP	  subtraction	  with	  Baan’s	  equation	  (SV	  calibration	  of	  α),	  and	  admittance	  with	  
Wei’s	  equation	  are	  shown.	  	  A.	  The	  dynamic	  parallel	  conductance	  (GM)	  computed	  by	  the	  
admittance	  technique,	  is	  contrasted	  with	  the	  constant	  GM	  subtracted	  by	  the	  conductance	  
technique.	  The	  corrected	  conductance	  of	  blood	  (GB)	  from	  admittance	  technique	  is	  also	  
shown	  for	  reference.	  B.	  The	  data	  demonstrate	  differences	  in	  volumes	  and	  measures	  of	  
contractility	  ESPVR	  for	  conductance	  PES	  =	  3.360	  ·∙	  (VES	  –	  0.942),	  and	  admittance	  
PES	  =	  15.425	  ·∙	  (VES	  –	  15.566).	  Also	  shown	  are	  the	  EDPVR	  for	  conductance	  
PED	  =	  4.797	  ·∙	  10
-­‐1	  ·∙	  exp	  (0.061	  ·∙	  VED)	  and	  admittance,	  PED	  =	  7.366	  ·∙	  10
-­‐1	  ·∙	  exp	  (0.076	  ·∙	  VED)	  
C.	  The	  corrected	  conductance	  signals	  derived	  when	  admittance	  is	  used	  (a	  dynamic	  removal	  
of	  parallel	  conductance),	  vs.	  conductance	  (a	  constant	  removal	  of	  parallel	  conductance).	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2.3.6 	  Wei’s	  Equation	  Using	  Admittance	  is	  more	  Sensitive	  to	  the	  Detection	  of	  
Inotropic	  Stimulation	  	  	  
The	   hemodynamic	   response	   of	   n=6	   mice	   was	   determined	   at	   baseline	   and	  
following	   5	  minutes	   of	   steady	   infusion	   of	   5	   μg/kg/min	   of	   iv	   dobutamine.	   	   Heart	   rate	  
increased	  from	  384	  ±	  47	  to	  523	  ±	  75	  (p<0.05).	  Pmax	  was	  unchanged	  from	  97	  ±	  13	  to	  98	  ±	  
11mm	  Hg	  (p=NS).	  dP/dtmax	  increased	  from	  5,821	  ±	  1,802	  to	  12,309	  ±	  3,832	  mm	  Hg	  sec-­‐1	  
(p<0.01),	   and	   dP/dtmin	   decreased	   from	   -­‐5,703	   ±	   1,491	   to	   -­‐7,505	   ±	   825	   mm	   Hg	   sec-­‐1	  
(p<0.05).	  
	  	  	  To	  evaluate	  the	  impact	  on	  parameters	  derived	  using	  Wei’s	  equation	  and	  Baan’s	  
equation	  (both	  using	  SV	  calibration)	  during	  the	  identical	  IVCO,	  linear	  Ees	  and	  dP/dt-­‐EDV	  
were	   determined	   in	   these	   same	   mice.	   	   Ees	   is	   commonly	   used	   as	   a	   measure	   of	   the	  
strength	  of	   the	  heart.	   Ees	   increased	   from	  4.9	  ±	  1.4	   to	  12.5	  ±	  6.6	  using	  Wei’s	  equation	  
(p<0.05),	   and	   from	   3.3	   ±	   1.2	   to	   8.8	   ±	   5.1	  mmHg	   ·∙	   µl-­‐1	   using	   Baan’s	   equation	   (p=NS),	  
implying	   that	   Wei’s	   equation	   can	   pick	   up	   a	   strengthening	   of	   the	   heart	   while	   Baan’s	  
equation	  may	  not.	  	  A	  representative	  example	  is	  shown	  in	  Figure	  9.	  Similarly,	  the	  dP/dt	  –	  
EDV	  relationship	  increased	  from	  158	  ±	  127	  to	  542	  ±	  320	  using	  admittance	  (p<0.05),	  and	  
from	  117	  ±	  78	  to	  263	  ±	  123	  mmHg	  ·∙	  sec-­‐1	  ·∙	  µl-­‐1	  using	  Baan’s	  equation	  (p=NS).	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Figure	   9:	   Representative	   example	   demonstrating	   that	   admittance	   (with	  Wei’s	  
equation,	   upper	   panel)	   is	   more	   sensitive	   in	   the	   detection	   of	   an	   increase	   in	  
inotropy	  in	  response	  to	  iv	  dobutamine	  than	  Baan’s	  equation	  (SV	  calibration	  of	  α,	  
lower	   panel)	   during	   the	   identical	   IVCO	   in	   a	   single	  mouse.	   Similar	   results	  were	  
found	  in	  n=6	  mice	  (see	  text	  for	  discussion).	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2.4 DISCUSSION	  
The	   results	   of	   this	   chapter	   compare	   the	   V(t)	   determined	   by	   Baan’s	   equation	  
using	  GP	   from	  HS	  with	  SV	  or	  cuvette	  calibration,	   to	  V(t)	  determined	  by	  Wei’s	  equation	  
using	   admittance.	   In	   summary,	   it	   has	   been	   demonstrated	   that	   (1)	   more	   accurate	  
volumes	  can	  be	  achieved	  with	  Wei’s	  equation	  using	  admittance	  when	  the	  catheter	  is	  in	  
the	  off-­‐center	  position	  than	  Baan’s	  equation	  using	  SV	  or	  cuvette	  calibration,	  (2)	  that	  the	  
parallel	  conductance,	  GP,	  varies	  between	  end-­‐systole	  and	  end-­‐diastole,	  and	  even	  more	  
significantly	   during	   IVC	   occlusion,	   (3)	   the	   advantages	   of	   using	   a	   dynamically-­‐changing	  
α which	  is	  dependent	  on	  GB(t),	  and	  (4)	  improved	  sensitivity	  in	  the	  detection	  of	  inotropic	  
stimulation	   with	  Wei’s	   equation	   and	   GP(t)	   calculated	   using	   admittance,	   compared	   to	  
Baan’s	  equation	  and	  GP	  calculated	  using	  HS	  with	  SV	  calibration	  of	  α.	  	  	  
2.4.1 Dynamic	  Parallel	  Conductance	  Calculation	  	  
In	  an	  early	  study	  by	  Lankford	  et	  al.,	  parallel	  conductance	  was	  demonstrated	  to	  
be	  constant	  between	  end-­‐diastole	  and	  end-­‐systole	  [36].	  Historically,	  this	  study	  was	  the	  
theoretical	  basis	  for	  the	  acceptance	  of	  hypertonic	  saline	  injection	  determination	  of	  GP	  in	  
the	  literature.	  However,	  myocardium	  has	  a	  both	  a	  conductive	  and	  a	  dynamic	  capacitive	  
component	   [10,	  11].	  This	   concept	   is	  not	   reflected	   in	   the	  assumptions	  or	  conclusion	  of	  
Lankford’s	   study,	   nor	   in	   any	   traditional	   conductance	   technique	   where	   phase	   is	   not	  
measured	   [4,	   12,	   14,	   35,	   37-­‐39].	   Mathematically	   speaking,	   the	   GP	   calculated	   using	  
admittance	   is	   a	   closer	   approximation	   to	   the	   true	   value	   of	   GP	   than	   traditional	  
conductance,	  because	  it	  takes	  into	  account	  the	  complex	  nature	  of	  myocardium	  YP	  =	  GP	  +	  
jωCP,	  and	  therefore	  includes	  measurable	  changes	  during	  the	  cardiac	  cycle.	  The	  current	  
results	   (Figure	   8A)	   and	   Wei’s	   previous	   study	   [11]	   imply	   that	   parallel	   conductance	   is	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changing	   even	   between	   end-­‐diastole	   and	   end-­‐systole,	   as	   predicted	   by	   electric	   field	  
theory	  [40].	  	  
2.4.2 Calculation	  of	  the	  Gain	  Term	  α	  	  
In	   the	   early	   conductance	   literature,	   the	   value	   of	   α	  was	   not	   calculated.	   	  α was	  
assumed	  to	  be	  equal	  to	  1,	  as	  described	  by	  Baan	  et	  al	  [4]	  and	  more	  recently	  by	  Uemura	  
et	  al	  [41].	  The	  purpose	  of	  the	  term	  α	   is	  to	  calibrate	  the	  stroke	  volume	  of	  the	  resulting	  
conductance	  signal	  to	  match	  a	  standard	  of	  comparison	  (usually	  a	  flow	  probe,	  or	  echo).	  
However,	   because	   α	   is	   dependent	   on	   the	   field	   geometry,	   and	   field	   geometry	   is	  
constantly	   changing	   throughout	   the	   cardiac	   cycle, α	   is	   not	   a	   constant.	   As	   shown	   in	  
Figure	  10	  during	  an	  IVC	  occlusion	  in	  a	  single	  mouse,	  the	  value	  of	  α	  differs	  depending	  on	  
which	  calibration	  method	  is	  used.	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For	  example,	  using	  Wei’s	  equation,	  the	  dynamic	  nature	  of	  α	  is	  evident	  between	  systole	  
and	  diastole,	  and	  also	  down	  the	  IVC	  occlusion	  ramp.	  In	  contrast,	  both	  other	  calibration	  
procedures	   using	   flow	   or	   echo	   calibration	   (α	   =	   0.79	   for	   centered	   position)	   and	   the	  
volume	  cuvette	  method	   (α	  =	  1)	  –	  as	   recommended	  by	  manufacturers	  of	   the	  currently	  
used	  commercial	  mouse	  conductance	  systems	  –	  use	  a	  constant	  value	  for	  α.	  The	  impact	  
of	  using	  a	  variable	  α	   is	   that	  the	  volume	  equation	  will	  more	  closely	  model	  the	  changes	  
which	  the	  field	  sees,	  as	  opposed	  to	  assuming	  a	  constant	  shape	  of	  the	  electric	  field.	  
2.4.3 Limitations	  of	  Cuvette	  Calibration	  
Review	   of	   the	   literature	   (122	   publications)	   revealed	   that	   63%	   of	   murine	  
conductance	  studies	  utilize	   the	  volume	  cuvette	  as	   the	  calibration	  method	  of	  choice	  to	  
	  
Figure	  10:	  α	  plotted	  versus	  time	  from	  each	  of	  the	  three	  calibration	  methods	  during	  the	  same	  IVC	  occlusion	  as	  Figure	  
9.	  The	  dynamic	  nature	  of	  Wei’s	  α	  is	  demonstrated	  to	  be	  in	  contrast	  with	  constant	  α	  as	  derived	  with	  either	  the	  
cuvette	  or	  SV	  calibrated	  conductance	  techniques	  (using	  a	  flow	  probe	  to	  determine	  SV	  to	  calculate	  α).	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directly	  convert	  voltage	  to	  absolute	  volume	  [42].	  However,	  recent	  studies	  [34,	  35]	  have	  
shown	   that	   cuvette-­‐calibrated	   left-­‐ventricular	   volumes	   are	   consistently	   smaller	   than	  
those	   derived	   with	   a	   standard	   such	   as	   MRI,	   confirmed	   as	   well	   in	   the	   current	   study.	  	  
Volume	  cuvettes	  have	  an	  electrically	  insulating	  boundary	  at	  the	  myocardial	  wall,	  which	  
cramps	  the	  field	  causing	  an	  artificially	  high	  value	  of	  α	  (implying	  a	  small	  stroke	  volume).	  
This	  high	  value	  of	  α	  causes	  small	  resultant	  volume	  estimates,	  and	  small	  resultant	  stroke	  
volumes	  (See	  Figure	  6).	  	  
2.4.4 Limitations	  of	  a	  constant	  α 	  
A	  correction	   for	   the	  SV	  error	   introduced	  by	   the	  volume	  cuvette	   is	   to	   force	   the	  
final	  SV	  to	  be	  the	  same	  as	  an	  independent	  measure.	  However,	  forcing	  only	  the	  SV	  to	  the	  
independently	   verified	   value	   in	   an	   off-­‐center	   position	   will	   reduce	   the	   value	   of	   α,	  
increasing	   the	   “gain	   factor”	   (α-­‐1)	   of	   the	   volume	   equation.	   	   The	   benefit	   to	   the	  
conductance	   technique	   is	   an	   accurate	   SV,	   but	   the	   detriment	   is	   an	   inflation	   of	   all	  
volumes.	  As	  shown	   in	  Figure	  6,	  although	  all	  SV	  are	  more	  physiologic	  when	  α	  =	  0.22	  ±	  
0.15,	  in	  mouse	  #2,	  7,	  and	  8,	  there	  is	  an	  inflation	  of	  volumes	  to	  an	  unphysiologic	  value.	  
Although	   Figure	   6	  was	   generated	   from	   the	   off-­‐center	   position	   of	   the	  miniaturized	   PV	  
catheter,	   this	   is	   often	   the	   location	   of	   a	   catheter	   in	   the	   heart	  without	   echo	   guidance,	  
since	  the	  aortic	  valve	  is	  off-­‐center	  relative	  to	  the	  middle	  of	  the	  LV	  chamber.	  	  
2.4.5 Dynamically	  Changing	  α	  (Wei’s	  Equation)	  	  
The	  advantage	  of	  using	  a	  dynamic	  value	  for	  α	  is	  that	  more	  realistic	  volumes	  are	  
obtained.	  As	  shown	  in	  Figure	  6,	  incorporating	  a	  dynamic	  value	  for	  α provided	  absolute	  
volumes	  closest	  to	  the	  echo	  standard.	  Wei’s	  equation	  provides	  a	  nonlinear	  conductance	  
to	  volume	  relationship	  which	  has	  been	  noted	  in	  some	  recent	  papers	  [35].	  However,	  the	  
most	  significant	  improvement	  is	  that	  Wei’s	  α(GB)	  is	  a	  function	  of	  blood	  conductance	  GB	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(see	   Equation	   6)	   and	   γ.	   The	   derived	   value,	   γ,	   represents	   the	   value	   of	   conductance	   at	  
saturation	   (where	   the	   catheter	   is	   placed	   in	   an	   arbitrarily	   large	   pool	   of	   conductive	  
solution),	   so	   the	   expression	   α(GB)	   incorporates	   the	   changing	   geometry	   of	   the	   electric	  
field	   as	   the	   heart	   beats.	   This	   advantage	   of	   the	   γ-­‐formulation	   will	   be	   particularly	  
important	  when	  performing	  changes	  in	  loading	  conditions,	  such	  as	  IVC	  occlusion.	  	  
2.4.6 Wei’s	  Equation	  Using	  Admittance	  GP(t)	  Improves	  Volume	  Estimates	  for	  
Off-­‐Center	  Placement	  of	  the	  PV	  Catheter	  	  
One	  assumption	  of	  Baan’s	   equation	   is	   that	   the	   tetrapolar	   catheter	   is	   placed	   in	  
the	   center	   of	   the	   left	   ventricle.	   However,	   the	   off	   center	   location	   of	   the	   aortic	   valve	  
relative	   to	   the	   mid-­‐LV	   chamber	   in	   mammalian	   hearts	   forces	   the	   miniaturized	   PV	  
catheter	   to	   be	   closer	   to	   the	   septum	   [14].	   Only	   the	   use	   of	   an	   independent	   imaging	  
modality,	  such	  as	  echo,	  will	  allow	  a	  miniaturized	  PV	  catheter	  to	  be	  moved	  closer	  to	  the	  
true	  center	  of	   the	  LV.	  Echocardiography,	  however,	   is	  not	   routinely	  used	   to	   center	   the	  
conductance	  catheter.	  In	  the	  current	  study,	  despite	  the	  use	  of	  echo	  guidance,	  the	  mean	  
central	  placement	  was	  actually	  14	  ±	  9%	  at	  end-­‐diastole,	  where	  0%	  was	  true	  center	  and	  
100%	  is	  the	  LV	  free	  wall	  or	  septum.	  In	  addition,	  as	  the	  heart	  moves,	  one	  cannot	  assume	  
that	   the	   catheter	   position	   stays	   at	   the	  midline.	   Some	   investigators	   estimate	   that	   the	  
catheter	   shifts	   by	   50-­‐70%	   of	   the	   ventricular	   radius	   [43].	   Thus,	   placement	   of	   the	  
tetrapolar	  catheter	  in	  an	  off-­‐center	  position	  is	  a	  common	  source	  of	  error.	  
In	   the	   present	   study,	   the	   off-­‐center	   tetrapolar	   catheter	   Wei’s	   equation	   using	  
admittance	   GP(t)	   shows	   statistically	   less	   error	   than	   traditional	   conductance	  
measurements	   taken	   simultaneously	   in	   a	   closed	   chest	  mouse,	  with	   simultaneous	  high	  
frequency	  echocardiography	  used	  as	  the	  standard	  for	  true	  left	  ventricular	  volume.	  One	  
explanation	   is	   that	   admittance	   provides	   a	   measure	   of	   instantaneous	   parallel	  
conductance	  while	  all	  previous	  methods	  cannot.	  This	  is	  particularly	  evident	  in	  Figure	  8A,	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during	   occlusion	   of	   the	   inferior	   vena	   cava,	   where	   the	   myocardial	   component	   of	   the	  
admittance	  signal	  is	  shown	  to	  vary	  both	  between	  end-­‐diastole	  and	  end-­‐systole,	  as	  well	  
as	  during	  the	  occlusion	  ramp.	  	  
Additionally,	  the	  use	  of	  a	  dynamic	  value	  for	  α	  that	  is	  dependent	  on	  the	  value	  of	  
conductance	   shows	   a	   more	   physiologic	   range	   for	   the	   absolute	   volume,	   while	   still	  
matching	  the	  stroke	  volume	  of	  an	  independent	  method	  (usually	  flow	  probe	  or	  echo).	  In	  
Baan’s	  equation,	  the	  α	  term	  is	  dependent	  only	  on	  the	  conductance-­‐derived	  SV.	  In	  Wei’s	  
equation	  however,	  the	  α(GB)	  term	  is	  dependent	  on	  both	  the	  SV,	  and	  the	  current	  values	  
of	  conductance.	  Figure	  8B	  and	  Figure	  8C	  demonstrate	  that	  this	  conclusion	  is	  only	  in	  part	  
due	   to	   the	   differences	   in	   parallel	   conductance	   removal.	   In	   addition,	   the	   calculated	  
volume	  ranges	  are	  quite	  different	  in	  Figure	  8B,	  while	  the	  conductances	  shown	  in	  Figure	  
8C	  are	  similar,	  implying	  that	  the	  difference	  in	  the	  volumes	  is	  due	  to	  a	  difference	  in	  α as	  
well.	  
As	  with	  any	  linear	  relationship,	  the	  slope	  α	  and	  the	  y-­‐intercept	  GP,	  are	  the	  only	  
two	  points	  of	  control	  for	  the	  calibration	  of	  the	  volume	  signal	  using	  Baan’s	  equation.	  This	  
makes	  the	  accuracy	  of	  Baan’s	  equation	  with	  hypertonic	  saline	  dependent	  on	  obtaining	  
the	   correct	   values	  of	  α	   (which	  magnifies	  problems	  of	   using	   a	   constant	  α)	   and	   correct	  
values	   of	   parallel	   conductance	   determined	   with	   hypertonic	   saline	   (which	   has	   a	   high	  
relative	  error	  in	  the	  mouse)	  [4,	  37].	  
2.4.7 Change	  in	  Myocardial	  Properties	  with	  Hypertrophy	  	  
The	   results	   of	   this	   chapter	   demonstrate	   that	   the	  permittivity	   (εm)	   increases	   by	  
about	   41%	   with	   LV	   hypertrophy	   induced	   by	   aortic	   banding	   for	   1	   week,	   while	   the	  
myocardial	   conductivity	   (σm)	   did	   not	   change.	   The	   conductivity	   permittivity	   ratio	   (σ/ε),	  
which	   is	   used	   in	   the	   central	   equation	   for	   admittance	   (the	   conductance	   capacitance	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relationship),	   changes	   in	   these	   same	   mice	   from	   69	   S/µF	   in	   control	   to	   17	   S/µF	   in	   LV	  
hypertrophy.	   It	   is	   known	   that	   larger	  myocytes	   have	   a	   greater	  membrane	   capacitance	  
[44].	   	   The	   measurement	   of	   capacitance	   in	   the	   electrode	   field	   increases	   during	   LV	  
hypertrophy,	  thus	  a	  higher	  permittivity	   is	   inferred	  from	  the	  measurement.	   	   In	  the	  bulk	  
tissue	  measurement,	   the	   increased	  permittivity	   detected	   is	   likely	   a	   summation	  of	   this	  
increase	  in	  capacitance.	  Thus,	  it	  is	  critical	  to	  measure	  this	  σ/ε	  ratio	  in	  each	  group	  of	  mice	  
with	  a	  different	  myocardial	  disease	  if	  the	  admittance	  technique	  is	  to	  derive	  LV	  volume	  
accurately.	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Chapter	  3:	  Large	  Scale	  LV	  Catheter	  Volume	  Measurement	  and	  Modeling	  
3.1 INTRODUCTION	  
Large	   scale	   LV	   catheter	   volume	   measurement	   was	   invented	   well	   before	   the	  
technique	   was	   miniaturized	   in	   mice,	   and	   the	   multi-­‐electrode	   measurement	   of	  
admittance	   is	   a	   natural	   extension	   of	   the	   tetrapolar	   technique	   in	  mice.	   To	   date,	   there	  
have	   been	   no	   publications	   proving	   that	   the	   admittance	   technique	   is	   valid	   in	   a	   larger	  
animal	   model.	   The	   reason	   this	   type	   of	   experiment	   has	   not	   yet	   been	   performed	   is	  
because	  there	  are	  rarely	  situations	  where	  it	  is	  preferable	  to	  use	  a	  larger,	  and	  therefore	  
much	  more	   expensive	   animal	   such	   as	   a	   dog	  or	   pig	   for	   genotype	   research	  or	   for	   large	  
scale	   pharmacology	   trials.	   In	   order	   to	   extend	   the	   results	   from	  mice	   to	   humans,	   it	   is	  
necessary	   to	   at	   least	   validate	   the	   admittance	   technique	   by	   using	   electromagnetic	  
modeling.	  	  
Baan’s	   first	   experiments	   in	   dogs	   included	   the	   use	   of	   a	   multipolar	   catheter	  
(pictured	   in	   Figure	   11)	   which	   works	   on	   the	   principle	   of	   superposition.	   This	   type	   of	  
catheter	  is	  the	  most	  common	  type	  of	  catheter	  used	  in	  large	  animals	  because	  of	  his	  work	  
	  
Figure	  11:	  A	  Multipolar	  catheter	  with	  segments	  chosen	  as	  in	  Baan’s	  first	  study	  [4].	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in	  this	  area.	  Baan	  suggested	  the	  use	  of	  a	  5	  segment	  measurement	   in	  the	   left	  ventricle	  
where	  the	  total	  conductance,	  G(t),	  could	  be	  described	  by	  the	  sum	  of	  all	  of	  the	  individual	  
segment	  conductances:	  





  	   (18) 	  
The	  term	  G1(t)	  in	  this	  equation	  is	  a	  correction	  factor	  used	  in	  Baan’s	  experiments	  for	  the	  
conductance	  missed	   from	  the	  space	  between	  the	   first	  stimulating	  electrode	  1	  and	  the	  
first	   sensing	   electrode	   2	   (see	   Figure	   11).	   The	   same	   current	   stimulating	   electrodes	   are	  
used,	  but	  multiple	  voltage	   sensing	  electrodes	  are	  used	   in	  between.	  The	  voltage	   signal	  
determined	   between	   each	   pair	   is	   then	   summed	   to	   determine	   the	   total	   conductance	  
measured	   between	   electrodes	   2	   and	   7.	   At	   first	   glance,	   the	   relation	   appears	   incorrect	  
from	   a	   circuit	   analysis	   standpoint	   –	   conductances	   in	   series	   do	   not	   add.	   However,	   the	  
relation	  actually	  sums	  individual	  volume	  segments,	  and	  so	  is	  correct.	  
The	   following	  numerical	   study	  models	   a	   12	   electrode	   catheter	   using	   the	   Finite	  
Element	  Method,	  and	  explains	  the	  effects	  of	  using	  a	   larger	  type	  of	  catheter	  to	  make	  a	  
measurement	  of	  admittance.	   In	   the	  previous	   studies	   in	  Chapter	  2,	  a	   single	   segment	   is	  
measured	  instead	  of	  multiple	  segments	  because	  only	  one	  is	  necessary,	  and	  in	  a	  mouse-­‐
sized	   heart	   making	   a	   multipolar	   catheter	   is	   challenging	   and	   expensive.	   Using	   fewer	  
segments	   leads	   to	   less	   instrumentation,	   and	   reduces	   the	   complexity	   and	   cost	   of	   the	  
admittance	  measurement	  system,	  therefore,	  only	  a	  single	  segment	  is	  modeled	  using	  the	  
standard	  multipolar	  catheter	  to	  determine	  the	  feasibility	  of	  the	  measurement.	  A	  single	  
segment	  also	  has	  the	  advantage	  of	  allowing	  direct	  comparison	  between	  previous	  results	  
in	  mice,	   and	   results	   in	   larger	   animals.	   This	   study	   is	  modeled	   after	   a	   study	   previously	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done	  in	  mice	  by	  Wei	  et	  al.	  [16],	  but	  using	  this	  larger	  catheter	  and	  more	  unused	  (floating)	  
electrodes.	  	  
3.2 METHODS	  
The	   type	   of	   catheter	   modeled	   is	   a	   standard	   commercial	   6	   French	   (1.9mm	  
diameter)	  12	  electrode	  catheter	  (Millar	  Instruments	  Model	  SPC-­‐562-­‐1,	  Houston,	  TX)	  for	  
use	   in	   animals	  with	   a	   7	  mm	  electrode	   spacing	   The	  exception	   is	   the	   first	   3	   electrodes,	  
which	  are	  3	  mm	  apart,	  as	  shown	  in	  Figure	  12.	  This	  catheter	  geometry	  is	  usually	  used	  to	  
perform	   volume	   studies	   on	   pigs	   or	   dogs.	   Only	   6	   electrodes	   are	   shown	   in	   the	  model,	  
because	  6	  electrodes	  are	  all	  that	  are	  needed	  to	  span	  the	  left	  ventricle,	  which	  is	  one	  of	  
the	   most	   common	   places	   to	   catheterize	   in	   cardiac	   research.	   The	   catheter	   is	   most	  
sensitive	   to	   changes	   in	   field	   geometry	   between	   the	   sensing	   electrodes,	   so	   the	   more	  
proximal	  electrodes	  are	  omitted.	  Often,	  researchers	  are	  also	  interested	  in	  the	  left	  atrial	  
volume,	   which	   explains	   the	   existence	   of	   the	   other	   electrodes.	   If	   the	   most	   distal	  
electrode	  is	  number	  1,	  and	  the	  electrodes	  are	  numbered	  consecutively,	  electrodes	  1	  and	  
6	  are	  current	  stimulation	  electrodes,	  while	  electrodes	  2	  and	  5	  are	   for	  voltage	  sensing.	  
Electrodes	  3	  and	  4	  are	  not	  used	  in	  this	  measurement,	  because	  adding	  the	  extra	  channels	  
for	   voltage	   measurement	   requires	   extra	   instrumentation,	   and	   it	   is	   preferable	   to	   cut	  
down	  the	  amount	  of	  instrumentation	  used	  for	  later	  miniaturization.	  
Even	  though	  only	  4	  electrodes	  are	  used	   in	   the	  measurement	   (2	   for	  stimulation	  
via	   a	   current	   source,	   and	   2	   for	   voltage	   measurement),	   the	   other	   electrodes	   are	   not	  
omitted	   from	   the	   geometry.	   The	   walls	   of	   the	   cuvette	   are	   moveable	   to	   simulate	   a	  
standard	  cuvette	  calibration	  at	  0.1,	  0.2,	  0.5,	  1,	  2,	  5,	  10,	  20,	  50,	  100,	  and	  200	  mL.	  


















Figure	  12:	  FEM	  Model	  2D	  axisymmetric	  geometry;	  distal	  section	  of	  the	  catheter.	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The	  mesh	  shown	  in	  Figure	  13	  was	  refined	  near	  the	  electrodes	  automatically	  by	  
the	  meshing	  software	  because	  of	  the	  smaller	  geometry	  present.	   It	   is	  also	  necessary	  to	  
further	   refine	   the	  mesh	   near	   the	   electrodes	   because	   the	   area	   near	   the	   electrode	  will	  
have	  the	  most	  non-­‐uniform	  current	  density.	  The	  mesh	  refinement	  is	  shown	  in	  detail	   in	  
Figure	   14	   below.	   The	   number	   and	   size	   of	   elements	   in	   the	  model	   varies	   based	   on	   the	  
geometry	  supplied	  by	  the	  size	  of	  the	  saline	  container,	  but	  the	  minimum	  element	  quality	  
is	  found	  in	  the	  largest	  cuvette,	  and	  furthest	  from	  the	  source	  electrodes	  of	  the	  catheter,	  






Figure	  13:	  2D	  axisymmetric	  mesh	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Table	  2:	  Mesh	  Properties	  
    
number of mesh points 5109 
number of elements 10028 
number of boundary elements 756 
minimum element quality 0.5793 




Figure	  14:	  Closer	  view	  of	  one	  electrode,	  refined	  mesh.	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3.3 FINITE	  ELEMENT	  MODEL	  (FEM)	  DEFINITION	  
The	  quasi-­‐static	  meridional	  electric	  currents	  mode	  in	  Comsol	  is	  used	  to	  solve	  the	  
geometry.	  The	  governing	  equation	  for	  this	  model	  combines	  Gauss’	  Electric	  Law	  and	  the	  
Continuity	  Equation	  [11]:	  
	   −∇ ⋅ σ+ jωϵ!ϵ! ∇! = 0	  
(19) 	  
where	  σ	  is	  the	  electrical	  conductivity	  (S/m),	  ω	  is	  the	  angular	  frequency	  (rad/s),	  εr	  is	  the	  
relative	  permittivity,	  ε0	  is	  the	  permittivity	  of	  free	  space	  (F/m),	  and	  V	  is	  the	  electric	  scalar	  
potential	  (V).	  	  
The	  electrical	  properties	  used	  in	  the	  model	  are	  in	  Table	  3	  below.	  In	  a	  cuvette,	  the	  
walls	   of	   the	   container	   are	   normally	   made	   of	   plastic,	   which	   are	   approximated	   in	   the	  
model	   as	   an	   electric	   insulating	  boundary.	   The	   catheter	   body	   is	  made	  of	   plastic	   and	   is	  
placed	  in	  saline	  of	  conductivity	  σ	  =	  1	  S/m,	  which	  is	  close	  to	  the	  conductivity	  of	  blood.	  
3.4 BOUNDARY	  CONDITIONS	  
The	   governing	   equation	   assumes	   the	  model	  will	   be	   submerged	   in	   an	   insulated	  
space,	   so	   the	   boundary	   condition	   for	   the	   cuvette	   wall	   is	   set	   as	   an	   electric	   insulation	  
boundary,	  
	   ! ⋅ σ+ jωϵ!ϵ! ∇! = 0	  
(20) 	  
Table	  3:	  Electrical	  Properties	  
  σ (S/m) ε (F/m) ε_r 
blood (37° C) 1 7.08E-10 80 
normal saline (20° C) 1.6 7.08E-10 80 
catheter body 0 1.95E-11 2.2 
electrode 9.09E+06 8.85E-12 1 
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In	  the	  AC/DC	  quasi-­‐static	  mode	  in	  Comsol,	  there	  are	  only	  two	  ways	  to	  model	  the	  
electrode	  stimulation	  on	  the	  boundary.	  The	  first	   is	  as	  a	  current	  source	  by	  defining	  the	  
current	  density	  as	  a	  constant,	  and	  then	  second	  is	  by	  defining	  the	  voltage	  as	  a	  constant	  
along	   the	   boundary.	   Even	   though	   the	   stimulating	   electrodes	   are	   actually	   current	  
sources,	  it	  is	  not	  sufficient	  to	  set	  the	  current	  density	  to	  a	  constant	  value.	  This	  is	  because	  
by	  setting	  the	  current	  density	  to	  a	  single	  value,	  we	  are	  assuming	  that	  the	  current	  density	  
will	  be	  uniform	  across	  the	  entire	  surface,	  which	  is	  not	  true	  because	  of	  the	  fringing	  field.	  
Instead,	  the	  model	  uses	  an	  ODE	  setting	  to	  force	  the	  voltage	  to	  be	  equal	  to	  a	  value	  that	  
minimizes	  the	  equation	  
	   ∫ !!
→
⋅ ! !   − !! = 0	  	   (21) 	  
where	  I0	  is	  the	  desired	  stimulating	  current,	  while	  Jn	  is	  the	  current	  density	  flowing	  out	  of	  
the	  source	  electrode.	  The	  integral	  is	  taken	  in	  Comsol	  as	  an	  integration	  coupling	  variable	  
active	  only	   in	   the	  domain	  of	   the	  electrode.	  The	   result	  of	  Equation	   (21)	   is	   to	   stimulate	  
using	  a	   current	  of	   the	  user’s	   choosing	   (I0),	  while	  not	   forcing	   the	  current	  density	   to	  be	  
uniform.	   On	   the	   stimulating	   electrodes,	   the	   boundary	   condition	   is	   set	   as	   a	   voltage	  
source,	  where	  V	  is	  forced	  to	  be	  a	  source	  at	  a	  frequency	  of	  19218	  Hz,	  close	  to	  the	  20	  kHz	  
used	  in	  many	  commercial	  conductance	  measurement	  instruments.	  V	  was	  not	  forced	  to	  
be	  exactly	  20	  kHz	  because	  practically	  speaking,	  it	  is	  easier	  to	  build	  an	  instrument	  with	  a	  
frequency	   of	   stimulation	   that	   matches	   a	   common	   crystal	   oscillator	   frequency.	   In	  
practice,	   the	   20	   kHz	   measurement	   is	   achieved	   by	   using	   a	   crystal	   oscillator	   with	   a	  
frequency	  of	  19218	  Hz.	  
At	   the	   time	   of	   writing,	   COMSOL	   has	   introduced	   a	   new	  method	   for	   creating	   a	  
constant	  current	  source,	  which	  ties	   in	   to	   the	  power	  of	  SPICE	  models.	   	  A	  SPICE	   file	  can	  
now	  apparently	  be	  written	  which	  achieves	  the	  same	  effect	  as	  Equation	  (21).	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3.5 FIELD	  UNIFORMITY	  AND	  ITS	  EFFECT	  ON	  VOLUME	  MEASUREMENT	  
The	  high	  conductivity	  of	  the	  electrodes	  that	  are	  unused	  in	  the	  system	  forces	  the	  
current	  density	  to	  increase	  near	  the	  surface	  of	  the	  metal.	  This	  is	  an	  important	  point	  that	  
is	   often	   overlooked	   in	   catheter	   measurement.	   Were	   the	   electrodes	   not	   present,	   the	  
field	  would	  be	  completely	  uniform	  near	  the	  center	  of	  the	  catheter	   in	  a	  relatively	  small	  
cuvette	  like	  the	  one	  in	  Figure	  15A.	  
As	   seen	   in	   Figure	   15A,	   as	   the	   volume	   of	   the	   cuvette	   measured	   between	   the	  
voltage	   electrodes	   decreases,	   the	   uniformity	   of	   the	   field	   improves,	   allowing	   a	   closer	  
estimate	   of	   true	   volume	   than	   in	   Figure	   15B,	   where	   the	   current	   field	   spreads	   out	   to	  
occupy	   the	   full	   volume	   of	   the	   container.	   This	   phenomenon	   is	   the	   reason	   for	   the	  
nonlinear	   relationship	   between	   conductance	   and	   volume.	   The	   fact	   that	   there	   is	   a	  
nonlinear	  relationship	  makes	  sense	  because	  as	  the	  volume	  of	  a	  container	  increases,	  the	  
conductance	  signal	  measured	  will	  eventually	  reach	  a	  finite	  maximum.	  The	  point	  where	  
the	   conductance	   will	   no	   longer	   increase	   even	   though	   the	   volume	   can	   increase	   is	  
	  
(A) 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   	   	   	  	  	  	  	  	  	  	  	  (B)	  
Figure	  15	  A:	  1	  mL	  cuvette	  and	  B:	  100	  mL	  cuvette	  current	  density	  (streamlines)	  and	  developed	  potential	  maps.	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designated	  G	   infinity,	   or	   the	   conductance	   of	   a	   volume	  of	   infinite	   size.	   This	   concept	   is	  
illustrated	  with	  data	  from	  the	  model	  in	  Figure	  16.	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The	  analytical	  solution	  is	  calculated	  with	  a	  constant	  α,	  scaled	  to	  match	  the	  lower	  
volume	   data.	   Had	   the	   unused	   electrodes	   not	   been	   present,	   the	   lower	   volume	   data	  
would	  be	  exactly	   linear.	  The	   relationship	  between	   the	  conductance	  and	   the	  volume	   is	  
nonlinear,	  which	  directly	  implies	  that	  α	  is	  nonlinear.	  This	  nonlinearity	  can	  be	  seen	  again	  
in	  Figure	  17,	  where	  the	  model	  results	  are	  fit	  to	  a	  quadratic	  curve.	  The	  point	  where	  α	  =	  0	  
is	  G	  infinity,	  and	  it	  is	  obvious	  from	  the	  linear	  fit	  that	  the	  value	  would	  be	  overestimated	  
were	  α	  assumed	  to	  be	   linear.	  Some	  work	  has	  been	  done	  that	  shows	  that	   the	  value	  of	  
alpha	   approaches	   1	   at	   low	   conductances	   [16,	   45].	   This	   work	   was	   done	   on	   a	   mouse	  
catheter,	  where	  there	  were	  no	  intermediate	  unused	  electrodes.	  This	  fact,	  in	  addition	  to	  
the	  difference	  in	  spacing	  between	  electrodes,	  is	  enough	  to	  reduce	  the	  value	  of	  α	  to	  0.3	  
as	  G	  approaches	  0	  in	  these	  FEM	  model	  results.	  
	   	  
	  
Figure	  16:	  Nonlinearity	  of	  the	  Conductance-­‐Volume	  Relationship	  in	  large	  
animals	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It	  is	  interesting	  to	  note	  here	  that	  many	  researchers	  still	  use	  a	  constant	  value	  of	  α	  
in	  larger	  animal	  models	  because	  they	  are	  unaware	  that	  there	  is	  a	  nonlinear	  dependence	  
to	  α.	  The	  effect	  is	  only	  less	  pronounced	  in	  small	  volumes	  compared	  to	  the	  length	  L	  from	  
Equation	  (4),	  Baan’s	  Equation,	  because	  the	  smaller	  the	  volume	  relative	  to	  the	  size	  of	  the	  
catheter	  spacing,	  the	  closer	  a	  linear	  relationship	  can	  approximate	  the	  true	  nature	  of	  α.	  	  
3.6 MODELING	  CONCLUSIONS	  
The	  nonlinearity	  of	  alpha	  is	  confirmed	  in	  larger	  animals	  by	  these	  results.	  It	  can	  be	  
concluded	  from	  these	  data	  that	  it	  is	  inaccurate	  to	  use	  a	  constant	  or	  even	  linearly-­‐varying	  
value	   for	   α	   for	   any	   size	   animal,	   but	   especially	   so	   in	   dogs,	   pigs,	   and	   humans.	   The	  
existence	   of	   extra	   unused	   electrodes	   was	   shown	   to	   substantially	   alter	   the	   current	  
density	  near	  the	  catheter,	  and	  could	  therefore	  be	  a	  significant	  factor	  when	  interpreting	  
results.	  The	  value	  of	  α	  will	  never	  equal	  1	  because	  of	  the	  effect	  of	  the	  unused	  electrodes	  
	  
Figure	  17:	  The	  Alpha	  –	  Conductance	  graph	  is	  nonlinear	  in	  large	  animals	  as	  well	  as	  in	  small	  
animal	  model.	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on	   the	   field.	   This	   is	   of	   particular	   importance	   because	   so	   many	   assume	   that	   at	   small	  
volumes	   it	   has	   a	   value	   of	   exactly	   1	   (which	   is	   correct	   only	   for	   models	   with	   no	   extra	  
electrodes).	   The	   model	   can	   be	   used	   to	   determine	   if	   the	   volume	   being	   measured	   is	  
within	  the	  linear	  region	  for	  a	  given	  assumption	  of	  constant	  alpha,	  and	  also	  to	  determine	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Chapter	  4:	  Epicardial	  Preload	  Measurement	  Theory	  and	  Modeling	  
4.1 INTRODUCTION	  
The	   possibility	   of	   an	   epicardial	   measurement	   of	   preload	   is	   exciting	   clinically	  
because	  of	  the	  possibility	  of	  detecting	  congestive	  heart	  failure	  much	  earlier	  than	  current	  
devices.	   This	   chapter	   deals	   with	   the	   modeling	   and	   feasibility	   of	   using	   impedance	   to	  
measure	  LV	  End	  Diastolic	  Volume	  (LVEDV),	  or	  preload,	  to	  detect	  the	  onset	  of	  congestive	  
heart	   failure.	   The	   first	   section	   deals	   with	   the	   differences	   with	   the	   circuit	   model	   and	  
explains	   why	   the	   measurement	   is	   couched	   in	   terms	   of	   an	   impedance	   measurement	  
(! = !
!
)	   instead	  of	  an	  admittance	   (!)	  measurement.	  The	   second	  section	  estimates	   the	  
sensitivity	   of	   this	   measurement	   to	   a	   positional	   placement	   error	   by	   the	   surgeon	  
implanting	   a	   device	   designed	   to	   measure	   this	   impedance.	   Modeling	   using	   the	   Finite	  
Element	  Method	  is	  used	  to	  estimate	  the	  error	  in	  this	  methodology.	  	  	  
4.2 CIRCUIT	  MODEL	  
An	  electrical	  model	  of	  the	  measurement	  is	  required	  to	  provide	  a	  means	  of	  
separating	  the	  muscle	  component	  from	  the	  blood	  component	  with	  epicardial	  placement	  
of	  the	  admittance	  electrodes.	  A	  traditional	  conductance	  catheter	  model	  with	  fixed	  
electrodes	  uses	  a	  parallel	  combination	  of	  !!,	  !!,	  and	  !"!!	  which	  forms	  the	  complex	  
admittance	  ! = !! + !! + !"!!	  (Previously	  described	  in	  Chapter	  2).	  However,	  the	  
epicardial	  electrode	  placement	  creates	  the	  condition	  where	  the	  measured	  blood	  and	  
muscle	  are	  now	  in	  series	  and	  not	  in	  parallel.	  Thus,	  a	  new	  model	  is	  developed	  below.	  For	  
mathematical	  convenience,	  it	  is	  formulated	  using	  impedance,	  ! 	  where	  ! = 1 !   	  
(Figure	  18).	  	  In	  the	  new	  model,	  the	  equivalents	  of	  !!,	  !!,	  and	  !"!!are	  the	  inverse	  of	  
!!,	  !!,	  and	  1/(  !"!!),	  respectively.	  
	   56	  
Figure	   18b	   shows	   that	   as	   the	   stimulation	   current	   passes	   from	   an	   electrode	  
placed	  on	  the	  LV	  free	  wall	  epicardium	  (as	  part	  of	  the	  bi-­‐ventricular	  pacer),	  through	  the	  
blood,	  and	   then	   through	   the	  septum,	  one	  can	  approximate	   the	  different	   layers	  as	   the	  
boundaries	  between	  homogenous	  tissues	  of	  specific	  electrical	  impedance.	  	  For	  example,	  
because	   blood	   does	   not	   produce	   a	   measureable	   phase	   shift	   at	   frequencies	   of	   20kHz	  
[33],	   it	   can	   be	   represented	   as	   a	   single	   resistance,	   or	   Rb	   (Figure	   18a).	   	   Additionally,	  
because	  muscle	   has	   both	   capacitance	   and	   resistance	   [33],	   it	   can	   be	   represented	   as	   a	  
resistor	  and	  a	  capacitor	  in	  parallel,	  Rm,	  and	  1/ωCm,	  also	  shown	  in	  Figure	  18a.	  	  The	  circuit	  
model	  assumes	  that	  the	  stimulation	  current	  flows	  through	  a	  combination	  of	  blood	  and	  
muscle	   in	   series,	   and	   capacitive	   and	   resistive	   properties	   of	   muscle	   in	   parallel,	   and	   is	  
described	  in	  Equation	  (21).	  The	  circuit	  model	  is	  valid	  because	  the	  conductivity	  of	  blood	  is	  
about	  3	   times	  higher	   than	   the	  conductivity	  of	  muscle,	  making	   the	  series	  path	   through	  
the	   blood	   pool	   preferable	   for	   the	  majority	   of	   the	   current	   field.	   	   Because	   the	   current	  
	  
Figure	  18:	   Epicardial	   circuit	  model	   (a)	   The	  electrical	  model	  of	   the	  measurement	   required	   to	   separate	   the	  muscle	  
component	   from	   the	   blood	   component	   with	   epicardial	   placement	   of	   the	   admittance	   electrodes	   is	   shown	   (b)	  
Depiction	  of	  an	  AICD/bi-­‐ventricular	  pacemaker	  upon	  which	  the	  circuit	  diagram	  is	  based.	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passes	  through	  a	  muscle	  layer	  twice	  (LV	  free	  wall	  and	  septum),	  and	  these	  muscle	  layers	  
are	  in	  	  
series,	   they	   can	   be	   represented	   by	   a	   single	   equivalent	   resistance	   and	  
capacitance.	  
4.3 IMPEDANCE	  (! )	  SEPARATION	  OF	  BLOOD	  AND	  MUSCLE	  COMPONENTS	  
The	  derivation	  below	  demonstrates	   the	  method	   to	  derive	   LV	   volume	   from	   the	  
epicardial	  admittance	  approach	  for	  the	  first	  time.	  The	  circuit	  model	  shown	  in	  Figure	  18a	  
can	  be	  mathematically	  displayed	  as	  Equation	  (21),	  where:	  ! 	  is	  complex	  impedance	  (Ω),	  
!!	   is	   blood	   resistance	   (Ω),	   !!	   is	   cardiac	   muscle	   resistance	   (Ω),	   !! 	   is	   catheter	  
capacitance	   (F),	   and	   !!	   is	   cardiac	   muscle	   capacitance	   (F),	   !	   is	   −1,	   and	   ! = 2!"	  
(where	  !	  is	  the	  frequency	  of	  stimulation,	  20	  kHz),	  and	  ||	  means	  that	  the	  two	  quantities	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To	   separate	   the	   blood	   and	   muscle	   components	   in	   a	   traditional	   conductance	  





|| !! + !!||
1
!"!!
	   (22) 	  
	   58	  
of	   phase	   contribution	   from	   the	   catheter	   capacitance	   (!!)	   for	   varying	   conductivity	  
solutions,	  and	  remove	  it.	  	  However,	  in	  the	  epicardial	  Admittance	  measurement	  there	  is	  
also	  a	  varying	  length	  between	  the	  current	  carrying	  electrodes	  that	  complicates	  the	  issue	  
of	  calibration.	  For	  the	  preliminary	  derivation,	  I	  have	  assumed	  !! 	  to	  be	  small	  in	  Equation	  
(25),	   allowing	   its	   impedance	   1/(!"!!)	   to	   be	   large	   in	   the	   parallel	   combination	   (and	  
therefore	  neglected).	  	  
Therefore,	   assuming	   !! 	   to	   be	   small	   (high	   impedance),	   makes	   the	   parallel	  
combination	  mostly	  dependent	  on	  the	  blood	  and	  tissue,	  Equation	  (25)	  becomes:	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   (31) 	  
The	   imaginary	   part	   of	   ! 	   is	   negative	   because	   the	   reactance	   is	   capacitive,	   making	  !! 	  
positive.	  	  Then,	  	  
	   	  	  
!! = !" ! −
!!
1+ !!!!! !
.	   (32) 	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The	  procedure	   for	   calculating	   the	   separated	  blood	  and	  muscle	   resistances	   follows	   the	  
derivation	  above.	  	  
First,	   a	   separate	   surface	   probe	   experiment	   (Figure	   4,	   explained	   in	   Chapter	   2)	  
determines	  the	  values	  of	  σm	  and	  εm	  to	  use	  in	  Equation	  (28).	  
Second,	  the	  real	  and	  imaginary	  parts	  of	  the	  measurement	  are	  found	  using	  	  
	  
!" ! = |! |× cos ! 	   (33) 	  
and	  
	  
!" ! = |! |× sin ! .	   (34) 	  
Third,	  the	  results	  of	  steps	  1	  and	  2	  are	  used	  to	  solve	  for	  !!,	  !!,	  and	  !!,	  using	  Equations	  
(29),	  (31),	  and	  (32),	  respectively.	   	  	  
Once	  !!	  is	  determined,	  the	  blood	  volume	  can	  be	  calculated	  directly	  from	  Baan’s	  
Equation	  (4),	  assuming	  that	  the	  length,	  L,	  is	  known.	  Here,	  the	  length	  used	  is	  the	  distance	  
between	  the	  electrodes	  along	  the	  short	  axis.	  	  Obviously,	  this	  information	  is	  not	  available	  
in	   a	   patient,	   so	   in	   preliminary	   results	   the	   variable	   α	   (in	   Baan’s	   equation)	   was	   scaled	  
arbitrarily	  to	  provide	  direct	  comparison	  of	  fiduciary	  points	  on	  the	  volume	  trace.	  	  	  
4.4 CONFOUNDING	  VARIABLES	  
The	  theory	  behind	  a	  normal	  conductance	  measurement	  explains	  that	  as	  the	  LV	  
chamber	  fills	  with	  blood,	  the	  total	  blood	  resistance	  decreases	  due	  to	  the	  increase	  in	  the	  
cross	   sectional	   area	   of	   blood	   (because	   of	   the	   increased	   blood	   volume).	   This	   same	  
phenomenon	   should	   be	   present	   in	   the	   measurement	   of	   blood	   volume	   when	   using	  
epicardial	   electrodes	   as	  well.	   However,	   there	   is	   also	   a	   variable	   distance	   between	   the	  
stimulating	   and	   sensing	   electrodes	   in	   the	   impedance	  measurement	   suggested	   in	   this	  
chapter,	   which	   will	   affect	   the	   impedance	   signal	   inversely.	   Therefore,	   as	   the	   length	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increases	  between	  the	  apical	  and	  lateral	  electrodes,	  the	  resistance	  of	  the	  blood	  should	  
increase,	   but	   as	   more	   blood	   fills	   the	   ventricle,	   the	   cross	   sectional	   area	   will	   increase,	  
increasing	  the	  parallel	  pathways	  for	  current,	  which	  will	  cause	  the	  resistance	  to	  decrease.	  
It	   is	   possible	   that	   because	   the	   length	   and	   the	   area	   are	   related,	   that	   the	   time-­‐varying	  
resistance	  measured	  may	  not	  be	  sensitive	  to	  volume	  because	  of	  counteracting	  effects.	  
However,	   it	   is	   also	   quite	   possible	   that	   because	   both	   change	   as	   the	   heart	   beats,	   the	  
effect	  of	  the	  change	  in	  cross	  sectional	  area	  could	  be	  minimized	  by	  looking	  at	  the	  points	  
where	  the	  heart	  is	  largest	  (at	  end	  diastole).	  	  Because	  there	  is	  not	  an	  agreed-­‐upon	  model	  
of	  heart	  dilatation	  due	  to	  heart	  failure,	  this	  phenomenon	  cannot	  be	  modeled	  accurately	  
without	  perfect	  information	  about	  a	  real	  heart	  geometry	  occurring	  during	  heart	  failure.	  
It	  is	  therefore	  demonstrated	  experimentally	  in	  Chapter	  5.	  
4.5 GEOMETRY	  OF	  FEM	  ANALYSIS	  
The	   volume	   of	   the	   heart	   can	   be	   approximated	   as	   a	   prolate	   ellipsoid	   if	   the	  
assumption	  that	  the	  two	  short	  axes	  are	  equal	  is	  made.	  The	  volume	  of	  a	  prolate	  ellipsoid	  





!!	   (35) 	  
where	  A	  is	  the	  diameter	  of	  the	  minor	  axis,	  and	  B	  is	  the	  diameter	  of	  the	  major	  axis.	  	  Both	  
A	   and	   B	   are	   measured	   by	   sonomicrometry	   in	   vivo	   in	   Chapter	   5	   experiments.	   The	  
geometry	  of	  the	  FEM	  solution	  is	  a	  3-­‐D	  model	  that	  is	  a	  simplified	  LV-­‐RV	  chamber	  based	  
on	   prolate	   ellipsoids.	   This	   geometry	   is	   used	   for	   volume	   computation	   in	   2-­‐axis	  
echocardiographic	  crystal	  models	  and	   is	  used	  to	  make	  a	  rough	  estimate	  of	  the	  type	  of	  
signal	  sensitivity	  expected	  due	  to	  surgical	  error	  in	  placement	  of	  the	  electrodes.	  
	  To	  determine	  the	   impact	  of	  each	  mm	  of	  non-­‐ideal	  placement	  of	   the	  epicardial	  
admittance	  electrodes	  on	  the	  final	  determination	  of	  LV	  volume,	  the	  following	  modeling	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study	   was	   performed.	   Using	   3-­‐dimensional	   Finite	   Element	   Modeling	   (FEM)	   the	  
measurement	  of	  impedance	  was	  analyzed	  in	  the	  heart	  shown	  above,	  using	  a	  simplified	  
prolate	   ellipsoid	   model.	   Spherical	   electrodes	   of	   the	   same	   diameter	   as	   those	   on	  
AICD/biventricular	  pacer	  leads	  were	  placed	  on	  the	  LV	  free	  wall	  (Left	  side	  of	  the	  model	  in	  
Figure	  19)	  and	  the	  right	  ventricular	  septum	  (Right	  side	  of	  the	  model	   in	  Figure	  19).	  The	  
same	  modeling	  equations	  as	  in	  Chapter	  4	  were	  used	  in	  COMSOL	  to	  provide	  a	  quasi-­‐static	  
solution	  for	  the	  given	  geometry.	  
An	  example	  of	  the	  potential	  current	  density	  streamline	  plot	  is	  shown	  below	  in	  Figure	  20.	  
	  
Figure	  19:	  3D	  model	  geometry	  of	  FEM	  for	  catheter	  positioning	  study	  (Posterior	  view	  of	  an	  
idealized	  heart)	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4.6 SENSITIVITY	  TO	  SURGICAL	  POSITIONING	  ERROR	  
The	   rate	   of	   success	   of	   bi-­‐ventricular	   lead	   placement	   in	   multi-­‐center	   patient	  
studies	   is	   high,	   ranging	   between	   91	   to	   95%	   in	   a	   total	   of	   985	   heart	   failure	   patients	  
attempted	  [21].	  	  Thus,	  technical	  issues	  related	  to	  lead	  placement	  will	  not	  be	  prohibitive	  
in	  the	  long	  term	  transition	  of	  the	  admittance	  epicardial	  heart	  failure	  detection	  system	  to	  
patients.	   	   Further,	   the	   coronary	   venous	   anatomies	   of	   porcine	   and	   human	   hearts	   are	  
similar,	  and	  thus	  the	  results	  will	  be	  applicable	  to	  patients.	  	  	  
The	   hypothesis	   of	   this	   modeling	   study	   was	   that	   electrode	   placement	   at	   an	  
imprecise	  position	  on	  the	  LV	  free	  wall	  would	  not	  significantly	  alter	  the	  available	  signal	  
(i.e.,	  the	  sensitivity	  to	  correct	  electrode	  placement	  is	  acceptably	  low).	  This	  was	  verified	  
by	  fixing	  the	  RV	  septum	  leads	  and	  varying	  the	  position	  of	  the	  LV	  free	  wall	  leads	  on	  the	  
	  
Figure	  20:	  Potential	  Current	  Density	  streamline	  plot	  of	  FEM	  results	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epicardial	   surface	   by	   15	   mm.	   The	   results,	   shown	   in	   Figure	   21,	   demonstrate	   that	   the	  
sensitivity	  to	  lead	  misplacement	  in	  the	  model	  is	  roughly	  1%	  per	  mm	  for	  the	  measures	  of	  
admittance	  (both	  magnitude	  and	  phase);	  and	  considerably	  smaller	  than	  the	  signal	  swing	  
expected	  from	  the	  heart's	  motion	  between	  end-­‐diastole	  and	  end-­‐systole	  (approximately	  
40%	  between	  electrode	  pairs	   in	   the	  RV	  and	  on	   the	   LV	   free-­‐wall).	   Therefore,	   it	   can	  be	  
concluded	   that	   the	   error	   from	   imprecise	   electrode	   placement	   secondary	   to	   the	   sub-­‐
optimal	  placement	  of	  LV	  free	  wall	  pacing	  leads	  as	  dictated	  by	  coronary	  venous	  anatomy	  




	   	  
	  
Figure	  21:	  Results	  of	  Electrode	  positioning	  sensitivity	  experiment.	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Chapter	  5:	  Epicardial	  Volume	  in	  vivo	  Experiments	  
5.1 INTRODUCTION	  –ANIMAL	  MODEL	  OF	  CONGESTIVE	  HEART	  FAILURE	  
The	   best	   animal	  models	   for	   creating	   congestive	   heart	   failure	   in	   the	   laboratory	  
are	  chronic	   implanted	  trials,	  but	   these	   take	  months	   to	  complete,	  which	   increases	  cost	  
prohibitively.	   There	   are	   two	  popular	  models	   for	   creating	   heart	   failure	   in	   animals.	   The	  
first	   is	  accomplished	  by	  inserting	  a	  pacing	  wire	  and	  inducing	  a	  mild	  tachycardia	  for	  a	  1	  
month	   (or	  more)	   period	  of	   time	  which	   eventually	   causes	   the	  heart	   to	   decompensate.	  
This	   model	   of	   heart	   failure	   is	   unlike	   the	   type	   of	   heart	   failure	   that	   occurs	   in	   humans	  
because	   it	   does	   not	   include	   ischemic	   injury	   to	   the	   coronaries,	   as	   normally	   occurs	   in	  
human	  heart	   failure.	  The	  second	  animal	  model	  of	  heart	   failure	  addresses	  this	   issue	  by	  
requiring	  injection	  of	  microspheres	  over	  a	  longer	  period	  of	  time	  (1	  to	  2	  months),	  which	  
causes	  emboli	   in	   the	  coronaries,	  more	  closely	   resembling	   the	  cause	  of	  heart	   failure	   in	  
humans.	  	  
There	   are	   obvious	   problems	   with	   both	   of	   these	   models	   of	   heart	   failure,	   the	  
foremost	  being	   that	   the	  stage	  of	  heart	   failure	   induced	   is	  not	  easily	  controlled,	  making	  
objective	   measurement	   of	   preload	   difficult.	   Additionally,	   proof	   of	   concept	   of	   this	  
measurement	   can	   be	   done	   much	   more	   easily	   and	   cheaply	   in	   an	   acute	   study,	   which	  
determines	   the	   feasibility	  of	  an	  epicardial	   impedance	  measurement	  as	  a	  surrogate	   for	  
preload.	   The	   focus	   of	   this	   chapter	   is	   an	   acute	   study	   that	   shows	   the	   feasibility	   of	   an	  
epicardial	  admittance	  measurement	  for	  the	  detection	  of	  volume	  increase.	  The	  endpoint	  
is	   to	   justify	   the	   cost	   of	   a	   longer	   term	   closed	   chest	   study,	  which	  will	  more	   definitively	  
prove	  that	  the	  measurement	  would	  be	  useful	  in	  humans.	  
In	   the	   study,	   the	  validity	  of	   this	  approach	   is	  demonstrated	  by:	   (a)	  detecting	  LV	  
dilation	  with	   blood	   conductance	   in	   response	   to	   IV	   Neosynephrine	   comparable	   to	   the	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standard	   of	   endocardial	   crystals,	   (b)	   detecting	   LV	   dilation	   with	   blood	   conductance	   in	  
response	   to	   occlusion	   of	   the	   left	   anterior	   descending	   coronary	   artery,	   while	   RV	  
pressures	  did	  not	  change,	  and	  (c)	  demonstrating	  that	  saline	  placed	  in	  the	  chest	  cavity	  to	  
simulate	   pleural	   effusion	   is	   not	   a	   source	  of	   significant	   artifact	   in	   the	  measurement	   of	  
epicardial	  admittance.	  By	  the	  conclusion	  of	  this	  chapter,	  the	  reader	  should	  be	  convinced	  
that	  the	  admittance	  method	  outlined	  in	  Chapter	  2	  can	  be	  applied	  to	  moving	  source	  and	  
sense	   electrodes	   while	   instantaneously	   removing	   the	   myocardial	   component	   to	  
generate	  a	  final	  LV	  blood	  conductance	  signal.	  
5.2 METHODS	  
5.2.1 Calculation	  Theory	  
5.2.1.1 Epicardial	  Lead	  Blood	  Conductance	  Measurement	  
Tetrapolar	  intracardiac	  measurements	  are	  explained	  in	  detail	  in	  Chapter	  2.	  Briefly,	  
Conductance	  systems	  generate	  an	  electric	  field	  using	  a	  current	  source,	  and	  volume	  is	  
determined	  from	  the	  instantaneous	  voltage	  signal	  that	  results.	  The	  most	  striking	  
difference	  between	  an	  epicardial	  measurement	  and	  the	  traditional	  catheter	  
measurement	  is	  the	  location	  of	  the	  electrodes.	  Conductance	  electrodes	  have	  not	  been	  
previously	  placed	  on	  the	  LV	  epicardium	  to	  interrogate	  the	  LV	  blood	  volume,	  as	  has	  been	  
done	  in	  the	  current	  study	  (Figure	  22).	  	  	  
The	  relationship	  between	  measured	  blood	  conductance	  and	  LV	  blood	  volume	  is	  
determined	  primarily	  by	  the	  shape	  of	  the	  current	  field	  in	  the	  blood	  pool	  and	  
surrounding	  myocardium.	  In	  general,	  in	  a	  uniform	  electric	  field	  approximation	  it	  is	  seen	  
that	  the	  measured	  time-­‐dependent	  resistance,	  Rb,	  is	  proportional	  to	  the	  separation	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distance,	  L(t),	  and	  inversely	  proportional	  to	  the	  cross-­‐sectional	  area	  of	  the	  field,	  A(t);	  
and	  the	  converse	  for	  the	  measured	  blood	  conductance,	  Gb:	  
!! =
!" !
! ! 	  
!! =
! !
!" ! 	  
	  Some	  of	  the	  measurement	  electrode	  positions	  will	  produce	  a	  blood	  conductance	  
primarily	  sensitive	  to	  the	  cross-­‐sectional	  area	  change,	  while	  others	  are	  primarily	  
sensitive	  to	  the	  separation	  distance.	  	  As	  the	  cross-­‐sectional	  area	  of	  the	  LV	  increases,	  
there	  is	  a	  corresponding	  increase	  in	  blood	  conductance.	  Thus,	  for	  the	  purposes	  of	  the	  
current	  study,	  only	  area-­‐dependent	  electrode	  configurations	  were	  studied.	  	  
	  
Figure	  22.	  Pacemaker	  electrode	  positioning.	  (a)	  Bi-­‐plane	  left	  ventriculogram	  from	  a	  patient	  with	  CHF	  and	  a	  
previously	  implanted	  AICD/bi-­‐ventricular	  pacer	  demonstrating	  how	  the	  leads	  span	  the	  left	  ventricle	  (LV)	  
blood	  from	  the	  RV	  septum	  to	  the	  lateral	  LV	  epicardium.	  (b)	  The	  admittance	  electric	  field	  lines	  from	  the	  
RV	  septum	  to	  the	  lateral	  LV	  epicardium.	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5.2.1.2 Dynamic	  Muscle	  Conductance	  Removal	  
Epicardial	  Admittance	  is	  a	  measurement	  taken	  in	  the	  complex	  plane,	  and	  has	  both	  a	  
magnitude,	   ! (Siemens)	  and	  a	  phase,	  ∠ ! 	  (degrees).	  The	  values	  for	  admittance	  are	  a	  
combination	  of	  both	  the	  muscle	  and	  blood	  conductance,	  and	  the	  muscle	  susceptance	  
(!"),	  for	  both	  are	  present	  in	  the	  current	  field.	  The	  process	  for	  separating	  admittance	  
into	  blood	  and	  muscle	  conductance	  was	  outlined	  previously	  for	  the	  case	  of	  a	  tetrapolar	  
catheter	  where	  the	  blood	  and	  muscle	  are	  in	  parallel	  [17].	  The	  method	  for	  separating	  
blood	  and	  muscle	  into	  their	  constituent	  components	  follows	  the	  derivation	  shown	  in	  
Chapter	  4.	  These	  important	  formulae	  are	  used	  in	  the	  study,	  and	  are	  repeated	  below:	  
!! =









where	  Rm	  is	  the	  resistance	  of	  muscle	  (Ω),	  and	  Rb	  is	  the	  resistance	  of	  blood	  (Ω),	  εm	  is	  the	  
permittivity	  of	  muscle	  (F/m),	  and	  σm	  is	  the	  conductivity	  of	  muscle	  (S/m).	  The	  derivations	  
for	  the	  above	  formula	  are	  in	  Chapter	  4.	  The	  complex	  impedance	  ! 	  can	  be	  separated	  
into	  real	  (!"{! })	  and	  imaginary	  parts	  (!"{! }).	  The	  properties	  of	  the	  myocardium	  σm	  
and	  εm	  can	  be	  calculated	  using	  a	  surface	  probe	  measurement	  [17,	  33].	  In	  an	  epicardial	  
measurement	  the	  field	  generated	  is	  mostly	  transverse,	  while	  in	  a	  surface	  probe	  
measurement	  (and	  in	  a	  traditional	  LV	  catheter	  measurement),	  the	  field	  is	  mostly	  
longitudinal.	  This	  difference	  has	  been	  measured	  by	  others,	  and	  was	  corrected	  in	  the	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data	  by	  multiplying	  by	  a	  factor	  of	  2,	  because	  longitudinal	  σ	  is	  2	  times	  larger	  than	  
transverse	  σ	  [46,	  47].	  	  The	  penetration	  depth	  for	  the	  surface	  probe	  used	  to	  measure	  the	  
porcine	  myocardial	  properties	  was	  3.6	  mm,	  which	  will	  not	  extend	  into	  the	  LV	  blood	  
volume	  beneath.	  
5.2.1.3 LV	  Volume	  Measurement	  with	  2	  Dimensional	  Sonomicrometry	  
The	  standard	  of	  volume	  measurement	  used	  in	  this	  study	  was	  two	  dimensional	  (2D)	  
sonomicrometry	  crystals.	  	  2D	  sonomicrometry	  is	  an	  acceptable	  alternative	  in	  large	  
animal	  hearts	  when	  the	  two	  short	  axes	  are	  equal	  in	  distance	  [31,	  32,	  48],	  and	  this	  aspect	  
ratio	  is	  maintained	  during	  acute	  LV	  dilation.	  	  The	  porcine	  myocardium	  is	  prone	  to	  
arrhythmias,	  and	  there	  is	  significant	  trauma	  associated	  with	  placing	  the	  third	  crystal	  
plane	  through	  the	  septum.	  Consequently,	  2D	  sonomicrometry	  is	  the	  practical	  approach.	  
The	  two	  dimensions	  measured	  included	  the	  anterior-­‐posterior	  and	  apex-­‐base	  planes	  via	  
pairs	  of	  2	  mm	  piezo-­‐electric	  ultrasonic	  transducers	  positioned	  on	  the	  endocardial	  
surface	  through	  a	  stab	  wound	  through	  the	  LV	  myocardium	  and	  secured	  with	  a	  purse-­‐
string	  suture.	  The	  two	  crystal	  pairs	  were	  attached	  to	  a	  digital	  sonomicometer	  
(Sonometrics	  Corporation,	  London,	  Ontario,	  Canada)	  and	  the	  digital	  output	  was	  then	  
transformed	  into	  volume	  by	  fitting	  the	  points	  to	  a	  prolate	  ellipsoid	  [31,	  32,	  48].	  
5.2.2 Experimental	  Protocol	  
This	  study	  was	  conducted	  in	  compliance	  with	  the	  United	  States	  Food	  and	  Drug	  
Administration	  (FDA)	  Good	  Laboratory	  Practices	  Regulations	  (21	  CFR	  Part	  58),	  following	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approval	  of	  the	  animal	  use	  committee	  at	  the	  University	  of	  Texas	  Health	  Science	  Center	  
at	  San	  Antonio.	  For	  the	  n	  =	  15	  Yorkshire	  Pigs	  studied,	  the	  body	  weight	  ranged	  from	  42	  kg	  
to	  78	  kg	  (mean	  =	  60	  ±	  12.6	  kg),	  14	  were	  male	  and	  1	  was	  female.	  	  Pigs	  were	  sedated	  with	  
Telazol	  4	  mg/kg	  IM,	  intubated	  and	  anesthesia	  was	  maintained	  with	  1-­‐2%	  Isoflurane	  with	  
100%	  oxygen.	  The	  right	  neck	  was	  dissected	  to	  gain	  access	  to	  the	  jugular	  vein	  and	  carotid	  
artery.	  	  A	  sternotomy	  was	  performed	  and	  the	  pericardium	  was	  partially	  opened.	  
Amiodarone,	  150	  mg	  IV,	  was	  given	  over	  30	  min,	  and	  repeated	  30	  min	  later.	  Following	  
full	  loading	  of	  Amiodarone,	  a	  Lidocaine	  infusion	  was	  initiated	  at	  1	  µg/min	  for	  the	  
remainder	  of	  the	  protocol.	  	  Although	  there	  was	  anticipated	  myocardial	  depression	  from	  
this	  approach,	  there	  was	  greater	  concern	  that	  the	  porcine	  model	  has	  a	  low	  ventricular	  
fibrillation	  threshold.	  A	  more	  complete	  description	  of	  the	  protocol	  can	  be	  found	  in	  the	  
Appendix.	  
5.2.3 Instrumentation	  Overview	  
The	   epicardial	   lead	   measurement	   protocol	   requires	   instrumentation	   in	   the	  
following	  locations	  sewn	  onto	  the	  myocardial	  surface	  itself.	  In	  practice,	  it	  was	  found	  to	  
be	  easier	   to	  sew	  the	  admittance	  electrodes	   to	  a	   felt	  backing,	  and	   then	  suture	   the	   felt	  
backing	  to	  the	  myocardial	  surface,	  to	  prevent	  arrhythmia	  due	  to	  trauma	  on	  the	  surface	  
of	  the	  heart	  from	  multiple	  stitches.	  The	  locations	  of	  all	  myocardial	  surface	  instruments	  
are	  shown	  in	  Figure	  23	  below.	  The	  epicardial	   impedance	  electrodes	  are	  each	  spaced	  1	  
cm	   apart	   because	   this	   is	   a	   common	   spacing	   for	   intraventricular	   catheters,	   and	   also	  
allows	  for	  simulation	  of	  surgical	  error	  when	  placing	  the	  electrodes.	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Figure	  23:	  Detailed	  experimental	  electrode	  positioning.	  The	  positions	  of	  each	  of	  the	  8	  electrodes	  are	  represented	  
by	  the	  trapezoids	  above.	  The	  sonomicrometry	  crystals	  were	  placed	  after	  the	  epicardial	  leads,	  as	  close	  as	  possible	  to	  
the	  2nd	  and	  3rd	  crystal,	  to	  represent	  the	  position	  of	  the	  entire	  group	  as	  the	  heart	  beats.	  	  
	  
Platinum-­‐Platinum	  black	  electrodes	  were	  chosen	  for	  the	  experiment	  because	  of	  
their	  low	  electrode	  interface	  impedance	  (Medtronic,	  Minneapolis,	  MN).	  Electrode	  
locations	  were	  chosen	  to	  simulate	  the	  approximate	  positions	  of	  an	  RV	  AICD	  endocardial	  
lead,	  and	  the	  bi-­‐ventricular	  lead	  on	  the	  lateral	  LV	  epicardium.	  	  The	  anterior	  electrodes	  
were	  sewn	  parallel	  to	  the	  distal	  LAD	  to	  simulate	  the	  RV	  AICD	  lead,	  and	  the	  posterior	  
electrodes	  were	  sewn	  parallel	  to	  a	  left	  marginal	  vein	  to	  simulate	  the	  bi-­‐ventricular	  
pacing	  lead.	  	  	  Electrode	  pairs	  were	  chosen	  for	  a	  cross-­‐ventricular	  chamber	  tetrapolar	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measurement	  with	  a	  current-­‐producing	  and	  a	  voltage-­‐sensing	  electrode	  on	  both	  the	  
anterior	  and	  the	  posterior	  epicardium.	  Each	  group	  of	  4	  possible	  vectors	  (without	  
reflection)	  is	  referred	  to	  as	  a	  measurement	  “vector”	  in	  the	  rest	  of	  this	  dissertation.	  
There	  are	  9	  vectors	  total,	  each	  one	  representing	  a	  separate	  measurement	  of	  impedance	  
across	  the	  LV.	  In	  an	  open	  chest	  experiment,	  the	  heart	  sits	  on	  top	  of	  the	  lungs,	  which	  are	  
expanding	  and	  contracting	  with	  each	  breath.	  Because	  there	  is	  no	  pressure	  from	  the	  
front	  of	  the	  chest	  to	  keep	  the	  heart	  in	  the	  correct	  position,	  motion	  artifact	  is	  created	  
from	  the	  lungs,	  which	  is	  readable	  in	  both	  the	  impedance	  measurement	  and	  the	  
sonomicrometry	  measurements.	  
The	  pigs	  were	  also	  instrumented	  with	  two	  dimensional	  endocardial	  crystals	  as	  
outlined	  above,	  a	  left	  carotid	  pressure	  sensor	  (3F,	  Scisense,	  London,	  ON),	  a	  6F	  sheath	  in	  
the	  jugular	  vein.	  	  A	  right	  ventricular	  pressure	  sensor	  was	  inserted	  directly	  through	  the	  
anterior	  RV	  wall	  (1.2	  F,	  Scisense,	  London,	  ON).	  	  A	  descending	  thoracic	  saline	  filled	  
balloon	  occluder	  (16	  or	  18	  mm	  diameter,	  In	  Vivo	  Metric,	  Healdsburg,	  CA)	  was	  tied	  
around	  the	  descending	  thoracic	  aorta	  to	  generate	  transient	  occlusion	  as	  an	  alternative	  
method	  to	  produce	  LV	  dilation.	  An	  aortic	  flow	  probe	  was	  placed	  in	  the	  descending	  
thoracic	  aorta	  (Transonic,	  Ithaca,	  NY)	  immediately	  distal	  to	  the	  balloon	  occluder	  to	  
document	  that	  occlusion	  was	  obtained.	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5.2.4 Calibration	  
There	   are	   many	   possible	   sources	   of	   error	   in	   a	   measurement	   of	   admittance,	  
including	   offset	   or	   gain	   error,	  which	   is	   brought	   on	   by	   the	  measurement	   system	   itself	  
(discussed	  in	  Section	  5.2.4.1),	  and	  error	  from	  the	  electrode-­‐electrolyte	  interface	  effects	  
(discussed	   for	  each	  probe	   individually	   in	  Sections	  5.2.4.2,	  and	  5.2.5).	  These	  sources	  of	  
error	  must	  be	  accounted	  for	  in	  order	  to	  make	  an	  accurate	  measurement.	  
5.2.4.1 Admittance	  Instrument	  Calibration	  
A	   5-­‐segment	   multiple	   gain	   conductance	   measurement	   system	   called	   a	   GX5	  
(Scisense,	  London,	  ON)	  was	  retrofitted	  with	  a	  5-­‐segment	  phase	  measurement	  system	  by	  
Erik	  Larson	  to	  create	  a	  5	  channel	  admittance	  measurement	  system.	  In	  order	  to	  ensure	  
proper	   functionality,	   the	   input	   of	   this	   system	   was	   attached	   to	   a	   potentiometer	   and	  
capacitor	  and	  the	  total	  impedance	  was	  varied	  over	  the	  range	  of	  the	  real	  and	  imaginary	  
planes	   of	  measurement.	   These	  were	   then	   checked	   against	   the	   theoretical	   admittance	  
which	  would	   be	   produced	   by	   each	   RC	   load,	   to	  make	   sure	   that	   no	   significant	   error	   is	  
introduced	  by	  the	  system	  itself.	  In	  the	  GX5	  system,	  the	  error	  introduced	  by	  the	  system	  is	  
minimal.	  
5.2.4.2 LV	  Epicardial	  Lead	  Calibration	  
There	  is	  no	  offset	  present	  in	  the	  measurement	  because	  of	  the	  system	  itself.	  	  At	  
the	   point	   where	   previous	   step	   (5.2.4.1)	   is	   complete,	   the	   measurement	   is	   essentially	  
calibrated	  out	  to	  the	  plane	  of	  the	  input	  terminals	  to	  the	  GX5.	  However,	  there	  is	  still	  the	  
effect	   of	   the	   electrodes	   and	   electrode/electrolyte	   interface	   to	   consider.	   Because	   the	  
assumption	   of	   the	   impedance	   separation	   equations	   (Equations	   30	   and	   31)	   is	   that	   the	  
electrode	  capacitance	  is	  negligible,	  this	  assumption	  was	  tested	  before	  each	  experiment.	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In	  order	   to	   check	   this	   assumption,	   the	  electrodes	  were	   submerged	   in	   saline	  of	  
conductivity	   σ	   =	   .8	   S/m	  and	   the	  output	   of	   the	  GX5	   is	   checked	   for	   a	   phase	   angle	   shift	  
(indicating	   measurable	   capacitance	   from	   the	   electrodes	   or	   the	   electrode/electrolyte	  
interface	   effect).	   The	   conductivity	   of	   pig	   blood	   averages	   around	   this	   value	   of	  
conductivity,	   and	   saline	   was	   used	   because	   it	   does	   not	   introduce	   a	   phase	   shift	   in	   an	  
impedance	  measurement	  (εr	  ≈	  80,	  	  the	  same	  as	  water).	  Because	  all	  complex	  impedance	  
in	  this	  system	  must	  be	  capacitive,	  and	  because	  the	  electrodes	  never	  produce	  more	  than	  
1	   degree	   of	   phase	   shift	   on	   the	   output,	   regardless	   of	   orientation,	   they	   do	   not	   require	  
calibration	   beyond	   this	   point	   in	   the	   study.	   	   Ideally,	   the	   catheter	   and	   the	   instrument	  
should	   not	   contribute	   to	   the	   measured	   phase	   in	   an	   experiment.	   The	   best	   known	  
methods	  for	  removing	  their	  contribution	  is	  outlined	  in	  Chapter	  2.	  
5.2.5 Surface	  Probe	  Calibration	  
The	  biggest	  difference	  between	  a	  pig	  probe	  and	  the	  previous	  mouse	  probe	  is,	  of	  
course,	  the	  size.	  The	  length	  between	  the	  current	  stimulating	  electrodes	  on	  the	  surface	  
probe	  determines	  the	  penetration	  depth	  of	  the	  measurement	  field,	  and	  this	  electrode	  is	  
designed	  for	  a	  deeper	  penetration	  because	  the	  pig	  LV	  myocardium	  is	  roughly	  1	  cm	  thick.	  
This	  larger	  spacing	  also	  reduces	  the	  amount	  of	  interwire	  capacitance	  in	  the	  probe,	  which	  
increases	   the	   standard	   deviation	   of	  muscle	   properties	   over	   that	   observed	   in	   a	  mouse	  
measurement.	  
The	  surface	  probe	   is	  calibrated	  exactly	  as	  the	  surface	  probe	   is	  calibrated	   in	  the	  
mouse	  study	  in	  Chapter	  2.	  Saline	  solutions	  of	  conductivity	  σ	  =	  2000,	  4000,	  6000,	  8000,	  
and	   10000	   µS/cm	   span	   the	   range	   of	   conductivities	   necessary	   to	  measure	  myocardial	  
properties,	   and	   the	   phase	   offset	   due	   to	   the	   surface	   probe	   is	   recorded	   after	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measurement	   on	   the	   surface	   of	   these	   5	   solutions.	   This	   phase	   offset	   is	   then	   removed	  
from	  the	  measurement	  by	  subtracting	  the	  probe’s	  contribution	  to	  the	  susceptance.	  
5.2.6 Properties	  Measurement	  and	  Hematocrit	  
A	   custom-­‐designed	   epicardial	   probe	   was	   applied	   to	   the	   surface	   of	   the	   intact	  
beating	  open-­‐chest	  heart	  of	  all	  n	  =	  15	  pigs	  studied	  (for	  calibration	  see	  Section	  5.2.5).	  The	  
technique	  used	  is	  similar	  to	  the	  technique	  used	  in	  the	  mouse	  experiments	  in	  Chapter	  2.	  
The	   pig	   anatomy	   is	   large	   enough	   that	   an	   area	   of	   the	  muscle	   that	   is	   devoid	   of	   blood	  
vessels	   is	   easily	   found.	   	   This	   is	   usually	   an	   area	   near	   the	   placement	   of	   the	   anterior	  
electrodes,	  but	   lateral	   to	   the	   Left	  Anterior	  Descending	  Artery.	  N=3	  measurements	  are	  
taken	   in	   two	   positions	   that	   are	   perpendicular	   to	   each	   other	   on	   a	   large	   patch	   of	  
myocardium	  (not	  over	  a	  coronary	  blood	  vessel),	  to	  ensure	  that	  myocardial	  properties	  do	  
not	   change	   with	   probe	   orientation.	   These	   measurements	   are	   retaken	   before	   each	  
procedure	  in	  the	  protocol	  because	  any	  extended	  period	  of	  surgery	  can	  cause	  noticeable	  
changes	  in	  the	  health	  and	  hydration	  of	  the	  myocardium.	  These	  measurements	  are	  taken	  
to	   ensure	   that	   the	   preparation	   is	   not	   compromised	   because	   of	   changing	   physiologic	  
conditions.	  
	  
The	  measurement	  current	  was	  generated	  using	  the	  instrumentation	  previously	  
described	  [9].	  	  Real-­‐time	  |Y|	  and	  θ	  were	  measured	  and	  myocardial	  permittivity	  (εm)	  and	  
conductivity	  (σm)	  were	  calculated	  as	  described	  previously	  [33].	  Briefly,	  the	  surface	  probe	  
“cell	  constant”,	  k	  (m-­‐1),	  determined	  in	  saline	  of	  known	  electrical	  conductivity,	  is	  used	  to	  
calculate:	  !! = !×!!	  and	  	  !! = !×!!	  ,	  where	  !! = !"{! }  and	  !! = !" ! /!  	  	  
and	  ω	  =	  2πf,	  where	  k	  is	  the	  cell	  constant	  of	  the	  probe	  used	  (1/m),	  Gm	  is	  the	  conductance	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of	  muscle	  (S),	  Cm	  is	  the	  capacitance	  of	  the	  muscle,	  and	  f	  is	  the	  frequency	  of	  
measurement	  (Hz).	  Hematocrit	  was	  determined	  both	  at	  baseline	  and	  at	  the	  end	  of	  the	  
experiment	  via	  capillary	  tubes	  and	  a	  Clay	  Adams	  Readacrit	  centrifuge	  (model	  CT-­‐3400,	  
Becton	  Dickinson	  &	  Company,	  Sparks,	  MD).	  Whole	  blood	  samples	  were	  spun	  for	  5	  
minutes	  at	  8,500	  rpm,	  and	  the	  volume	  of	  packed	  red	  cells	  was	  expressed	  as	  a	  
percentage	  of	  total	  volume.	  
5.2.7 Neosynephrine	  (Phenylephrine)	  for	  LV	  dilatation	  
Neosynephrine	  was	  chosen	  to	  increase	  afterload	  and	  secondarily	  dilate	  the	  LV	  in	  a	  
dose-­‐response	  fashion	  to	  simulate	  LV	  dilation	  as	  would	  occur	  in	  a	  heart	  failure	  patient.	  
Neosynephrine	  was	  infused	  at	  constant	  flow	  rates	  of	  75,	  150,	  and	  300	  µg/min	  in	  the	  first	  
n=2	  pigs.	  For	  the	  later	  n=9	  pigs,	  a	  lower	  dose	  of	  37.5	  µg/min	  was	  added	  to	  this	  infusion	  
protocol.	  	  Baseline	  and	  data	  from	  at	  least	  2	  doses	  of	  Neosynephrine	  where	  LV	  dilation	  
occurred,	  as	  defined	  by	  endocardial	  crystals,	  were	  required	  for	  data	  analysis.	  	  Some	  
doses	  of	  Neosynephrine	  did	  not	  result	  in	  LV	  dilation	  and	  this	  varied	  in	  every	  pig.	  	  Thus,	  
the	  doses	  given	  in	  the	  results	  section	  are	  the	  baseline,	  and	  mean	  low	  and	  high	  doses	  of	  
Neosynephrine	  that	  achieved	  LV	  dilation,	  as	  defined	  by	  endocardial	  crystals.	  	  Each	  dose	  
of	  Neosynephrine	  was	  infused	  for	  10	  minutes	  to	  achieve	  steady	  state,	  and	  then	  data	  
were	  acquired	  over	  the	  subsequent	  5	  minutes	  for	  a	  total	  of	  15	  minutes	  per	  dose.	  	  
Data	  acquired	  at	  baseline	  and	  at	  each	  dose	  of	  Neosynephrine	  included	  heart	  rate,	  
carotid	  pressure	  (AoP),	  descending	  thoracic	  aortic	  flow	  (Ao	  Flow),	  short	  and	  long	  axis	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endocardial	  crystals,	  epicardial	  impedance	  magnitude	  ( ! )	  and	  phase	  angle	  (∠! ).	  	  
Data	  were	  acquired	  while	  the	  respirator	  was	  suspended	  at	  end-­‐expiration	  for	  at	  least	  5	  
cardiac	  cycles.	  	  	  
5.2.8 Alternative	  methods	  for	  LV	  dilation	  
To	  determine	  if	  LV	  dilation	  could	  be	  detected	  by	  epicardial	  admittance	  preceding	  
increases	  in	  right	  ventricular	  pressures,	  two	  additional	  preparations	  were	  examined	  –	  
acute	  LAD	  occlusion	  and	  transient	  aortic	  occlusion.	  	  The	  question	  could	  not	  be	  posed	  in	  
the	  Neosynephrine	  dose-­‐response	  study	  because	  this	  medication	  acts	  as	  an	  α2	  receptor	  
agonist,	  and	  this	  receptor	  is	  present	  in	  both	  the	  systemic	  and	  pulmonary	  vasculature.	  	  
Thus,	  it	  was	  not	  possible	  to	  obtain	  an	  isolated	  increase	  in	  LV	  afterload	  without	  a	  
simultaneous	  increase	  in	  RV	  afterload	  [49,	  50]	  using	  Neosynephrine.	  	  
5.2.8.1 LAD	  occlusion	  
A	  suture	  was	  placed	  under	  the	  middle	  LAD,	  above	  the	  level	  of	  the	  epicardial	  
admittance	  electrodes,	  and	  tied	  off	  to	  produce	  an	  acute	  dilation	  of	  the	  middle	  and	  distal	  
anterior	  myocardium.	  	  Data	  obtained	  were	  identical	  to	  the	  Neosynephrine	  protocol,	  but	  
right	  ventricular	  pressure	  was	  also	  measured.	  	  Due	  to	  ventricular	  fibrillation,	  complete	  
data	  was	  only	  obtained	  in	  n=6	  experiments.	  	  
5.2.8.2 Transient	  Aortic	  Occlusion	  
Transient	   aortic	   occlusions	   were	   needed	   to	   supplement	   the	   Neosynephrine	  
because	  they	  are	  a	  “purer”	  method	  of	  volume	  increase.	  	  One	  cannot	  use	  the	  occlusions	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as	  a	  steady	  state	  intervention	  because	  reflex	  changes	  in	  the	  heart	  do	  not	  allow	  the	  heart	  
to	  reach	  steady	  state	  for	  any	  length	  of	  time.	  	  
Transient	  aortic	  occlusion	  was	  performed	  successfully	   in	  n	  =	  11	  pigs.	  Occlusion	  
was	   controlled	   by	   a	   water	   filled	   balloon	   occluder,	   sutured	   around	   the	   descending	  
thoracic	  aorta	  and	  inflated	  slowly	  until	  the	  LV	  end-­‐systolic	  pressure	  (measured	  from	  the	  
Aortic	  Pressure	  tracing)	  reaches	  roughly	  150%	  of	  its	  baseline	  value.	  Successful	  occlusion	  
was	   defined	   by	   an	   average	   descending	   thoracic	   aorta	   flow	   of	   less	   than	   1	   L/min.	   This	  
briefly	  causes	  the	  volume	  to	  increase,	  and	  at	  the	  same	  time,	  measurements	  are	  taken	  as	  
in	  the	  previous	  protocol.	  The	  flow	  probe	  was	  always	   located	   immediately	  distal	   to	  the	  
balloon	  occluder	  to	  quantify	  the	  degree	  of	  ligation.	  
	  
5.2.9 Pleural	  Effusion	  Simulation	  
Pleural	  effusions	  are	  common	  in	  heart	  failure	  patients,	  and	  are	  a	  common	  source	  of	  
artifact	  in	  the	  measurement	  of	  lung	  conductance	  by	  systems	  such	  as	  Optivol™	  [25,	  26,	  
28]	  and	  CorVue™	  since	  the	  electric	  field	  generated	  by	  these	  devices	  extends	  into	  the	  
lungs.	  	  Epicardial	  admittance	  generates	  an	  electric	  field	  that	  extends	  across	  the	  LV	  and	  
thus	  should	  not	  include	  this	  artifact.	  	  To	  test	  this	  hypothesis,	  the	  chest	  cavity	  was	  filled	  
with	  saline	  during	  the	  measurement	  of	  epicardial	  admittance.	  The	  animal	  model	  in	  this	  
study	  is	  not	  a	  model	  of	  chronic	  heart	  failure,	  therefore	  a	  real	  pleural	  effusion	  cannot	  be	  
produced.	  The	  pericardium	  was	  used	  as	  a	  sling	  to	  keep	  the	  saline	  from	  coming	  into	  
direct	  contact	  with	  the	  electrodes,	  similar	  to	  the	  final	  implementation	  of	  epicardial	  
admittance.	  	  Immediately	  after	  baseline	  measurements	  as	  outlined	  above,	  saline	  of	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conductivity	  close	  to	  that	  of	  blood	  (7941	  ±	  124	  µS/cm)	  was	  introduced	  into	  the	  chest	  
until	  respiration	  nearly	  caused	  the	  saline	  to	  spill	  into	  the	  pericardial	  sack.	  	  This	  volume	  
for	  n	  =	  7	  pigs	  was	  425	  ±	  90	  mL,	  and	  following	  introduction	  all	  measurements	  were	  
repeated.	  	  	  
5.2.10 Data	  Analysis	  
The	  slope	  relating	  blood	  conductance	  (mS)	  and	  endocardial	  crystal	  volume	  (mL)	  
was	  determined	  in	  11	  animals	  at	  up	  to	  three	  doses	  of	  neosynephrine	  in	  each	  of	  up	  to	  6	  
vectors,	  yielding	  a	  total	  of	  99	  paired	  measures	  of	  blood	  conductance	  and	  crystal	  volume	  
(Figure	  23).	  	  Data	  were	  analyzed	  based	  on	  a	  repeated	  measures	  linear	  model	  with	  a	  
compound	  symmetric	  autocorrelation	  matrix	  and	  fixed	  intercepts	  for	  each	  pig	  and	  
vector.	  The	  significance	  of	  the	  relation	  between	  blood	  conductance	  and	  crystal	  volume	  
was	  assessed	  using	  a	  Wald	  statistic	  for	  testing	  the	  null	  hypothesis	  that	  the	  coefficient	  of	  
LV	  blood	  conductance	  in	  the	  repeated	  measures	  linear	  model	  is	  zero.	  	  Statistical	  testing	  
was	  two-­‐sided	  with	  a	  significance	  level	  of	  5%	  using	  SAS	  Version	  9.2	  for	  Windows	  (SAS	  
Institute,	  Cary,	  North	  Carolina).	  For	  LAD	  occlusion,	  transient	  Ao	  occlusion,	  and	  pleural	  
effusion	  simulation,	  paired	  baseline	  and	  intervention	  data	  was	  compared	  using	  a	  
Student’s	  t	  test,	  again	  with	  a	  level	  of	  significance	  of	  5%.	  All	  results	  are	  reported	  as	  mean	  
±	  standard	  deviation.	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5.3 RESULTS	  
5.3.1 Baseline	  Hemodynamics	  	  
The	  mean	  peak	  aortic	  pressure	  was	  80	  ±	  13	  mmHg,	  and	  the	  heart	  rate	  was	  86	  ±	  17	  
bpm.	  The	  mean	  LV	  end	  diastolic	  and	  end	  systolic	  long	  axis	  dimensions	  by	  crystals	  were	  
82	  ±	  6	  and	  74	  ±	  5	  cm,	  respectively;	  and	  the	  	  mean	  LV	  end	  diastolic	  and	  end	  systolic	  short	  
axis	  distance	  by	  crystals	  were	  47	  ±	  4	  and	  40	  ±	  4	  cm,	  respectively.	  The	  calculated	  mean	  
LV	  EDV	  was	  100	  ±	  31	  mL,	  and	  the	  mean	  LV	  ESV	  was	  69	  ±	  25	  mL	  measured	  via	  
sonomicrometry.	  The	  mean	  EF	  was	  31	  ±	  6%,	  consistent	  with	  a	  depressed	  but	  non-­‐
dilated	  LV	  preparation	  from	  the	  amiodarone	  and	  anesthetics	  given	  to	  minimize	  
ventricular	  fibrillation.	  The	  mean	  descending	  thoracic	  aorta	  flow	  was	  8.0	  ±	  1.8	  L/min,	  
and	  the	  mean	  RV	  systolic	  pressure	  was	  19	  ±	  3	  mm	  Hg.	  	  
Hematocrit	  at	  the	  initiation	  of	  the	  protocol	  was	  30	  ±	  2.3	  %,	  and	  at	  the	  end	  of	  the	  
protocol	  33	  ±	  4.7%,	  consistent	  with	  hemo-­‐concentration	  due	  to	  minimal	  fluid	  
administration	  during	  the	  protocol	  to	  mitigate	  against	  changes	  in	  blood	  and	  myocardial	  
electrical	  properties	  as	  a	  source	  of	  artifact.	  The	  mean	  distance	  from	  the	  LV	  apex	  to	  the	  
most	  apical	  epicardial	  admittance	  electrode	  on	  the	  anterior	  surface	  was	  3.0	  ±	  
0.9	  cm,	  and	  on	  the	  posterior	  surface	  was	  3.0	  ±	  0.5	  cm,	  consistent	  with	  the	  admittance	  
electrodes	  being	  parallel	  to	  one	  another	  on	  either	  side	  of	  the	  LV	  epicardium.	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The	  end	  diastolic	  and	  end	  systolic	  epicardial	  LV	  admittance	  magnitude	  ( ! =   1/ ! )	  
were	  15.8	  ±	  2.0	  and	  14.5	  ±	  1.9	  mS,	  respectively;	  and	  the	  mean	  phase	  angle	  (∠! 	  =	  -­‐∠
! )	  were	  9.2	  ±	  3.0	  and	  7.4	  ±	  3.21	  degrees,	  respectively.	  	  	  
5.3.2 Properties	  summary	  
The	  properties	  of	  myocardium	  were	  determined	  in	  each	  pig	  for	  use	  in	  the	  equations	  
to	  	  	  separate	  	  	  the	  blood	  and	  muscle	  admittance	  as	  described	  previously	  [33].	  In	  the	  n	  =	  
15	  pigs	  studied,	  the	  myocardial	  conductivity	  was	  σm	  =	  0.33	  ±	  0.03	  S/m,	  the	  myocardial	  
permittivity	  was	  εm	  =	  (19710	  ±	  2786)*ε0	  F/m,	  and	  the	  calculated	  ratio	  of	  σ/ε	  for	  
myocardium	  was	  1,923,320	  ±	  179,592	  S/F.	  	  
5.3.3 Neosynephrine	  for	  LV	  dilatation	  
Neosynephrine	   is	  a	  positive	   inotrope	   that	   increases	  afterload	  by	   increasing	   the	  
pressure	  in	  the	  heart.	  There	  is	  not	  much	  published	  literature	  which	  supports	  the	  use	  of	  
Neosynephrine	  to	   increase	  the	  volume	  of	  a	  pig	  LV,	  and	  this	   is	  because	  most	  drugs	  are	  
not	  given	  for	  the	  purpose	  of	  inducing	  heart	  failure.	  Neosynephrine	  affects	  the	  afterload	  
of	  the	  heart	  only	  during	  the	  time	  it	  is	  being	  infused,	  and	  it	  took	  roughly	  20	  minutes	  for	  
the	  pigs	   in	  our	  study	   for	   the	  effect	  of	  Neosynephrine	  to	  wear	  off	   (i.e.	   for	   the	  baseline	  
pressure	  to	  be	  achieved).	  Neosyneprine	  is	  also	  given	  at	  a	  lower	  dose	  (10-­‐25	  µg/min)	  to	  
keep	  the	  pressures	  high	  for	  survivability	  early	  in	  the	  surgical	  preparation,	  so	  this	  dosage	  
was	  stopped	  20	  minutes	  before	  the	  first	  baseline	  for	  this	  study	  was	  performed.	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Example	  data	   are	   shown	   in	   Figure	  24,	  which	   also	  demonstrates	  how	   the	   short	  
and	  long	  axis	  crystals	  were	  used	  to	  derive	  the	  standard	  for	  LV	  volume	  (LV	  Crystal	  Vol),	  
and	  that	  epicardial	  impedance	  ( ! )	  and	  phase	  angle	  (∠! )	  were	  used	  to	  derive	  LV	  blood	  
conductance.	  	  
	  
Figure	  24.	  Typical	  Neosynephrine	  dose-­‐response	  (Neo	  D-­‐R)	  data	  obtained	  from	  a	  single	  porcine	  study	  which	  
demonstrates	  the	  raw	  signals,	  and	  which	  signals	  are	  used	  to	  derive	  final	  LV	  blood	  conductance	  (LV	  Gblood).	  The	  Ao	  
pressure	  increased	  with	  the	  Neo	  D-­‐R,	  while	  aortic	  flow	  was	  constant.	  	  Both	  short	  and	  long	  axis	  LV	  endocardial	  
crystals	  increased	  in	  distance	  with	  Neo	  D-­‐R,	  as	  did	  calculated	  LV	  volume	  (LV	  Crystal	  Vol,	  mL).	  The	  epicardial	  
impedance	  (|Z|)	  and	  phase	  angle	  (Z	  Phase)	  also	  changed	  in	  response	  to	  the	  Neo	  D-­‐R,	  as	  did	  calculated	  LV	  Gblood	  
(mS),	  with	  greater	  sensitivity	  (see	  Figure	  23)	  than	  the	  LV	  volume	  standard.	  	  	  	  
Data	  from	  all	  porcine	  studies	  are	  shown	  in	  Figure	  25.	  	  For	  data	  to	  be	  included	  in	  
this	  figure,	  at	  least	  n=2	  doses	  of	  Neosynephrine	  (Neo)	  were	  administered	  that	  resulted	  
in	  LV	  dilation	  as	  defined	  by	  endocardial	  crystals.	  The	  low	  dose	  Neo	  was	  90	  ±	  54	  µg/min,	  
the	  high	  dose	  Neo	  was	  180	  ±	  107	  µg/min.	  The	  blood	  conductance	  was	  computed	  from	  
the	  epicardial	   impedance	   ( ! )	   and	  phase	  angle	   (∠! ),	   and	  plotted	  against	   LV	   volume	  
	   82	  
calculated	  from	  endocardial	  crystals.	  As	  is	  apparent	  from	  the	  figure,	  a	  dose-­‐dependent	  
relationship	   was	   obtained	   for	   multiple	   electrode	   locations	   in	   multiple	   animals.	   The	  
conductance	  of	  blood	  (Gb),	  expressed	  in	  milli-­‐Siemens	  (mS),	  and	  left	  ventricular	  volume	  
(V),	  expressed	  in	  milliliters	  (mL),	  	  were	  measured	  at	  multiple	  values	  of	  LV	  volume	  using	  
between	  1	  and	  6	  vectors	  on	  each	  pigs	  and	  the	  within-­‐animal	  mean	  slope	  was	  computed.	  	  
The	   slope	   relating	   Gb	   (mS)	   and	   the	   adjusted	   volume	   (mL),	   1.16	   ±	   0.48	   ms/mL,	   was	  
significantly	  different	  from	  zero	  (p=0.017).	  
	  
Figure	  25.	  Demonstration	  that	  blood	  conductance,	  Gb,	  determined	  from	  epicardial	  admittance,	  
detects	  LV	  dilation	  in	  response	  to	  Neosynephrine	  dose-­‐response	  (see	  text	  for	  greater	  detail).	  
The	  pig	  number	  and	  electrode	  pair	  are	  identified	  in	  the	  legend.	  
	  
5.3.3.1 LAD	  Occlusion	  for	  LV	  Dilatation	  
Hemodynamic	  parameters	   are	   shown	   in	   Table	  4	   at	  baseline	   and	   following	   LAD	  
occlusion.	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Table	  4.	  LAD	  Occlusion.	  Data	  from	  n=6	  pigs	  with	  13	  electrode	  positions	  are	  shown.	  HR	  is	  heart	  
rate,	  AoP	  is	  systolic	  right	  carotid	  pressure,	  Echo	  Vol	  is	  2D	  endocardial	  crystal	  LV	  volume,	  Ao	  
Flow	  is	  descending	  thoracic	  aortic	  flow,	  RVSP	  is	  right	  ventricular	  systolic	  pressure,	  and	  Gblood	  is	  
LV	  blood	  conductance	  derived	  from	  epicardial	  admittance.	  ‡	  p	  <	  0.01	  
LAD	  Occlusion	  (n	  	  =	  6	  pigs,	  13	  electrode	  positions,	  2	  per	  pig)	  
	  	   	  	   Baseline	   Occlusion	   Difference	  
	  	   HR	  (bpm)	   87.7	  ±	  18.5	   87.4	  ±	  20.2	  	   -­‐0.2	  ±	  4.2	  	  
	  	   AoP	  (mmHg)	   88.3	  ±	  9.2	   82.8	  ±	  11.1	   -­‐5.6	  ±	  5.2	  ‡	  
	  	   Echo	  Vol(mL)	   87.7	  ±	  11.5	   91.3	  ±	  12.2	   3.5	  ±	  2.0	  ‡	  
	  	   Ao	  Flow	  (L/min)	   7	  ±	  1.3	   6.4	  ±	  1.3	   -­‐0.6	  ±	  0.5	  ‡	  
	  	   RVSP	  (mmHg)	   24.5	  ±	  3.9	   23.7	  ±	  5	   -­‐0.8	  ±	  1.5	  	  
	  	   G	  blood	  (mS)	   73.6	  ±	  39.8	   85	  ±	  51.1	   11.4	  ±	  12.8	  ‡	  
	  
Acute	   LAD	  occlusion	   produced	   a	   significant	   decrease	   in	   aortic	   pressure	   and	   flow.	   The	  
anticipated	   increase	   in	   LV	   volume	   was	   detected	   by	   both	   the	   volume	   standard	  
(endocardial	   crystals)	   and	   blood	   conductance.	   The	   large	   standard	   deviations	   in	   the	  
blood	   conductance	   are	   a	   result	   of	   the	   wide	   range	   of	   electrode	   positions	   and	   offset,	  
which	   may	   be	   caused	   by	   contact	   resistance	   in	   the	   surface	   electrode	   geometry.	   	   On	  
average,	   an	   increase	  of	   17%	   from	  baseline	   LV	  blood	   conductance	   can	  be	   expected	   to	  
correspond	  to	  an	  LV	  volume	  increase	  of	  4%.	  	  	  
5.3.3.2 Transient	  Ao	  Occlusion	  
Hemodynamic	  parameters	  are	  shown	  in	  Table	  5	  at	  baseline	  and	  peak	  transient	  Ao	  
occlusion.	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Table	  5.	  Ao	  Occlusion	  Data	  from	  n=11	  pigs	  from	  27	  electrode	  positions	  are	  shown.	  Occlusion	  data	  
was	  defined	  at	  the	  time	  of	  peak	  AoP.	  HR	  is	  heart	  rate,	  AoP	  is	  systolic	  right	  carotid	  pressure,	  
Echo	  Vol	  is	  2D	  endocardial	  crystal	  LV	  volume,	  Ao	  Flow	  is	  descending	  thoracic	  aortic	  flow,	  RVSP	  
is	  right	  ventricular	  systolic	  pressure,	  and	  Gblood	  is	  LV	  blood	  conductance	  derived	  from	  
epicardial	  admittance.	  ‡	  p	  <	  0.01	  
Aortic	  Occlusion	  (n	  =	  11	  pigs,	  27	  electrode	  positions,	  2	  per	  pig)	  
	  	   	  	   Baseline	   Occlusion	   Difference	  
	  	   HR	  (bpm)	   90.1	  ±	  28.4	   97	  ±	  23.7	   6.9	  ±	  28.1	  	  
	  	   AoP	  (mmHg)	   86.1	  ±	  10.9	   123.5	  ±	  17.5	  	   37.4	  ±	  9.9	  ‡	  
	  	   Echo	  Vol(mL)	   88.7	  ±	  20.5	   97.8	  ±	  21.8	  	   9.1	  ±	  4.6	  ‡	  
	  	   Ao	  Flow	  (L/min)	   6.3	  ±	  1.2	   0.7	  ±	  0.6	  	   -­‐5.6	  ±	  1.1	  ‡	  
	  	   RVSP	  (mmHg)	   22.9	  ±	  4.4	   23.8	  ±	  4.4	  	   0.9	  ±	  0.7	  ‡	  	  
	  	   G	  blood	  (mS)	   53.5	  ±	  18.6	   57.4	  ±	  21.6	  	   3.9	  ±	  4.3	  ‡	  
	  
HR	  decreases,	  while	  AoP	  and	  the	  crystal	  derived	  LV	  volume	  all	  increase.	  Ao	  flow	  
decreased	  below	  1	  L/min	  since	  that	  was	  the	  definition	  for	  a	  successful	  aortic	  occlusion.	  
The	  increased	  afterload	  increases	  the	  crystal	  volume	  by	  an	  average	  of	  9%,	  and	  the	  blood	  
conductance	  increases	  similarly	  by	  7%.	  RV	  systolic	  pressure	  also	  increased	  slightly.	  
5.3.3.3 Pleural	  Effusion	  Simulation	  
Hemodynamic	  parameters	  are	  shown	  in	  Table	  6	  at	  baseline	  and	  pleural	  effusion	  
simulation.	  	  The	  LV	  blood	  conductance	  did	  not	  change	  with	  saline	  placed	  around	  the	  
heart,	  nor	  did	  the	  crystal	  derived	  LV	  volume.	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Table	  6.	  Pleural	  Effusion	  Simulation.	  Data	  from	  n=7	  pigs	  from	  54	  electrode	  positions	  are	  shown.	  
HR	  is	  heart	  rate,	  AoP	  is	  systolic	  right	  carotid	  pressure,	  Echo	  Vol	  is	  2D	  endocardial	  crystal	  LV	  
volume,	  and	  Gblood	  is	  LV	  blood	  conductance	  derived	  from	  epicardial	  admittance.	  †	  p	  <	  0.05,	  ‡	  p	  
<	  0.01	  
Pleural	  Effusion	  Simulation	  (n	  =	  7	  pigs,	  54	  electrode	  configurations,	  7	  per	  pig)	  
	  	   	  	   Baseline	   Pleural	  Effusion	   Difference	  
	  	   HR	  (bpm)	   95.2	  ±	  19.0	   	  96.1	  ±	  20.6	   0.8	  ±	  2.6	  †	  
	  	   AoP	  (mmHg)	   87.4	  ±	  4.9	   	  86.1	  ±	  5.9	   -­‐1.3	  ±	  3.4	  ‡	  
	  	   Echo	  Vol(mL)	   100.0	  ±	  28.5	   	  100.2	  ±	  27.4	   0.1	  ±	  2.6	  	  
	  	   G	  blood	  (mS)	   53.2	  ±	  33.5	   	  52.6	  ±	  27.8	   -­‐0.5	  ±	  18.9	  	  
	  
5.4 DISCUSSION	  
This	  study	  has	  demonstrated	  that	  LV	  blood	  conductance	  can	  be	  successfully	  
estimated	  from	  the	  epicardial	  position,	  despite	  the	  current	  generating	  and	  sensing	  
electrodes	  being	  in	  constant	  motion	  with	  the	  heart,	  and	  with	  dynamic	  removal	  of	  the	  
myocardial	  component	  of	  the	  returning	  voltage	  signal.	  Specifically,	  it	  has	  been	  
demonstrated	  that:	  (a)	  a	  physiologic	  LV	  blood	  conductance	  signal	  can	  be	  derived,	  (b)	  LV	  
dilation	  in	  response	  to	  dose-­‐response	  iv	  Neosynephrine	  can	  be	  detected	  by	  blood	  
conductance	  in	  a	  similar	  fashion	  to	  the	  standard	  of	  endocardial	  crystals,	  (c)	  the	  
physiologic	  impact	  of	  acute	  LAD	  occlusion	  can	  be	  detected	  by	  blood	  conductance	  as	  LV	  
dilation,	  but	  not	  as	  a	  secondary	  rise	  in	  RV	  systolic	  pressure,	  and	  (d)	  pleural	  effusions	  
simulated	  by	  placing	  saline	  outside	  the	  pericardium	  did	  not	  serve	  as	  a	  source	  of	  artifact	  
for	  blood	  conductance	  measurements.	  
The	  blood	  and	  myocardium	  affect	  the	  electric	  field	  generated	  from	  the	  epicardial	  
electrode	  position	  differently	  than	  in	  the	  traditional	  intra-­‐ventricular	  fixed	  electrode	  
catheter	  measurement.	  	  In	  the	  epicardial	  lead	  configuration,	  the	  field	  travels	  completely	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through	  the	  entire	  thickness	  of	  the	  myocardial	  wall	  on	  both	  sides	  of	  the	  LV,	  while	  in	  an	  
intra-­‐ventricular	  configuration,	  only	  a	  part	  of	  the	  field	  enters	  the	  myocardium	  (i.e.,	  
traditional	  parallel	  conductance).	  	  This	  dictates	  the	  evolution	  of	  unique	  circuit	  models	  to	  
explain	  the	  new	  electrode	  positions.	  The	  real	  part	  of	  the	  impedance	   ! 	  (more	  
commonly	  known	  by	  its	  inverse,	  traditional	  conductance),	  is	  used	  to	  determine	  LV	  
volume	  from	  the	  intra-­‐ventricular	  position	  by	  creating	  a	  circuit	  model	  of	  the	  blood	  and	  
muscle	  resistance	  in	  parallel.	  	  The	  traditional	  approach	  has	  not	  included	  the	  capacitance	  
of	  the	  myocardium,	  introduced	  by	  the	  admittance	  approach	  laid	  out	  in	  Chapter	  2.	  	  In	  
contrast,	  the	  circuit	  model	  used	  in	  the	  epicardial	  approach	  introduced	  in	  the	  current	  
study	  is	  more	  complex	  (see	  Chapter	  4).	  	  The	  capacitive	  component	  of	  the	  myocardium	  is	  
in	  parallel	  with	  the	  muscle	  resistance.	  Further,	  the	  blood	  resistance	  is	  now	  in	  series	  with	  
the	  parallel	  muscle	  resistive	  and	  capacitive	  components,	  leading	  to	  different	  equations	  
for	  dynamic	  separation	  of	  blood	  and	  muscle	  components.	  	  
Right	  sided	  pressures	  (RV,	  RA)	  are	  used	  in	  many	  implanted	  devices	  to	  predict	  
future	  episodes	  of	  heart	  failure	  in	  patients	  [22,	  24,	  51].	  	  The	  backwards	  heart	  failure	  
theory[18]	  argues	  that	  heart	  failure	  initiates	  in	  the	  LV	  in	  these	  patients,	  and	  
subsequently	  elevates	  left	  atrial	  pressure,	  resulting	  in	  pulmonary	  edema,	  and	  finally	  
elevates	  right	  sided	  pressures,	  all	  downstream	  from	  LV	  volume	  or	  preload	  and	  hence	  
less	  sensitive	  measures	  of	  future	  heart	  failure	  episodes.	  This	  theory	  is	  best	  tested	  in	  a	  
chronic	  heart	  failure	  model	  since	  LV	  diastolic	  compliance	  is	  increased	  by	  this	  condition,	  
	   87	  
and	  hence	  a	  greater	  change	  in	  LV	  volume	  will	  produce	  a	  less	  robust	  elevation	  of	  right	  
sided	  pressures.	  	  Despite	  the	  study	  being	  an	  acute	  preparation	  examining	  normal	  sized	  
LVs	  (despite	  depression	  of	  ventricular	  function	  by	  amiodarone	  and	  anesthetics),	  acute	  
LAD	  occlusion	  was	  able	  to	  confirm	  this	  theory	  by	  demonstrating	  an	  elevation	  of	  both	  LV	  
blood	  conductance	  and	  echo	  crystal	  volume	  but	  no	  increase	  in	  RV	  systolic	  pressures.	  
These	  results	  are	  consistent	  with	  the	  hypothesis	  that	  an	  increasing	  LV	  blood	  
conductance	  will	  be	  a	  more	  sensitive	  indicator	  of	  impending	  future	  episodes	  of	  heart	  
failure	  than	  alternative	  upstream	  pressure	  and	  lung	  conductance	  approaches.	  	  
Pleural	  effusions	  are	  frequent	  findings	  in	  patients	  with	  advanced	  heart	  failure.	  	  
Devices	  that	  interrogate	  the	  lungs	  for	  pulmonary	  edema	  use	  a	  trans-­‐thoracic	  resistance	  
measurement	  from	  the	  tip	  of	  the	  RV	  AICD	  lead	  to	  the	  case	  of	  the	  battery	  pack	  for	  the	  
pacemaker/defibrillator,	  and	  thus	  provide	  a	  wide	  electric	  field	  including	  the	  LV,	  left	  
atrium,	  thoracic	  skeletal	  muscle,	  ipsilateral	  lung	  tissue,	  intravascular	  blood	  volume	  in	  
the	  lung,	  pulmonary	  interstitial	  edema	  and	  finally	  pleural	  effusions	  to	  measure	  a	  
changing	  fluid	  index.	  Having	  an	  electrical	  approach	  that	  is	  focused	  on	  the	  LV	  
myocardium	  and	  blood	  volume	  would	  be	  preferable,	  but	  still	  has	  some	  electric	  field	  
extension	  into	  other	  sources	  of	  artifact	  such	  as	  pleural	  effusions.	  To	  determine	  whether	  
epicardial	  admittance	  will	  artifactually	  detect	  pleural	  effusion,	  fluid	  was	  placed	  outside	  
the	  pericardium	  in	  the	  chest	  cavity	  to	  simulate	  this	  clinical	  condition.	  No	  alteration	  in	  
the	  measurement	  of	  LV	  blood	  conductance	  occurred	  in	  these	  studies,	  arguing	  that	  
epicardial	  admittance	  does	  indeed	  focus	  its	  interrogation	  on	  the	  LV	  itself.	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There	  are	  several	  limitations	  in	  this	  study.	  First,	  although	  an	  increase	  in	  LV	  
volume	  could	  be	  distinguished	  from	  an	  increase	  in	  RV	  systolic	  pressure	  with	  Ao	  
occlusion,	  this	  pressure	  increase	  was	  not	  present	  in	  the	  LAD	  occlusion	  study.	  	  However,	  
while	  RV	  systolic	  pressure	  increase	  was	  statistically	  significant,	  the	  absolute	  mean	  
increase	  was	  0.9	  mm	  Hg,	  which	  is	  not	  clinically	  significant.	  It	  was	  not	  possible	  to	  use	  
Neosynephrine	  infusion	  to	  test	  the	  theory	  that	  LV	  preload	  will	  be	  a	  more	  sensitive	  
indicator	  of	  impending	  heart	  failure	  than	  right	  sided	  pressures	  since	  both	  the	  systemic	  
and	  pulmonary	  circuits	  have	  α2	  receptors	  [49,	  50].	  Ultimately,	  this	  hypothesis	  is	  best	  
tested	  in	  a	  dilated	  LV	  where	  reduced	  chamber	  compliance	  will	  further	  favor	  LV	  preload	  
as	  being	  the	  most	  sensitive	  endpoint	  for	  impending	  heart	  failure.	  	  Second,	  the	  
admittance	  electrodes	  were	  not	  placed	  onto	  ACID	  and	  bi-­‐ventricular	  pacing	  leads	  
deployed	  in	  their	  appropriate	  locations.	  However,	  as	  the	  transition	  is	  made	  to	  this	  next	  
preparation	  during	  future	  chronic	  studies,	  improved	  admittance	  electrode	  contact	  is	  
anticipated,	  which	  was	  a	  source	  of	  error	  in	  the	  current	  study	  due	  to	  air	  acting	  as	  an	  
insulator	  between	  the	  electrode	  –	  myocardial	  interface	  in	  the	  open	  chest	  porcine	  
preparation	  employed.	  	  Finally,	  LV	  blood	  conductance	  was	  not	  converted	  to	  LV	  volume.	  
Baan’s	  equation	  [4,	  12]	  is	  not	  applicable	  since	  L	  is	  not	  a	  constant.	  Future	  studies	  will	  
require	  derivation	  of	  a	  new	  blood	  conductance	  to	  LV	  volume	  equation.	  	  
In	  conclusion,	  a	  new	  electrical	  approach	  to	  impending	  heart	  failure	  detection	  has	  
been	  developed,	  taking	  advantage	  of	  pre-­‐existing	  AICD	  and	  bi-­‐ventricular	  pacing	  lead	  
locations,	  and	  maturing	  the	  conductance	  approach	  to	  moving	  source	  and	  sensing	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electrodes	  while	  instantaneously	  removing	  the	  myocardial	  component	  to	  generate	  a	  
final	  LV	  blood	  conductance	  signal.	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 Chapter	  6:	  Conclusion	  and	  Future	  Work	  
6.1 FUTURE	  WORK	  
The	   methodology	   for	   determining	   LV	   preload	   using	   an	   epicardial	   admittance	  
measurement	  in	  large	  animals	  has	  been	  shown	  using	  acute	  studies	  in	  this	  dissertation.	  
To	   apply	   this	  measurement	   to	   humans	   for	   use	   in	   detecting	   heart	   failure,	  more	   work	  
needs	   to	   be	   done.	   First,	   heart	   remodeling	   happens	   over	   the	   course	   of	   weeks	   (if	   not	  
months)	   and	   not	   in	   an	   acute	   setting,	  which	   occurs	   in	  minutes.	   The	   possibility	   of	   long	  
term	  measurement	  of	  heart	   remodeling	   remains	  a	  question,	  and	  a	  new	  animal	  model	  
may	   be	   needed	   for	   long	   term	   implantation	   and	   testing.	   Secondly,	   the	   length	   vs.	   area	  
effect	   on	  measured	   conductance	   is	   still	   not	   completely	   understood	   and	   a	  method	   for	  
converting	   the	   admittance	   to	   a	   calibrated	   volume	   is	   not	   forthcoming.	   This	   problem	   is	  
less	   important	   because	   blood	   conductance	   has	   already	   been	   shown	   to	   be	   well	  
correlated	   with	   volume	   increase.	   Finding	   the	   electrode	   placement	   with	   the	   greatest	  
long-­‐term	  change	  may	  be	  affected	  by	  other	  variables	  as	  well	  such	  as	  changing	  electrode	  
impedance	   over	   time,	   tissue	   necrosis	   causing	   electrical	   muscle	   property	   change,	   and	  
placement	  location	  drift.	  	  
All	   of	   these	   problems	   point	   toward	   a	   long	   term	   heart	   failure	   protocol	   and	  
experiment	   for	   an	   answer.	   The	  method	   would	   then	   need	   to	   be	   reduced	   to	   practice,	  
developing	   and	   incorporating	   low-­‐power	   low-­‐noise	   electronics	   into	   existing	   implanted	  
devices.	  The	  heart	  failure	  detection	  system	  would	  need	  a	  communication	  channel	  to	  the	  
patient	  and/or	  the	  doctor.	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6.2 CONCLUSION	  
There	  are	  three	  important	  questions	  regarding	  admittance	  measurement	  that	  this	  
dissertation	  answers.	  The	  first	  question	  is:	  “Which	  method	  for	  determining	  volume	  
using	  traditional	  bio-­‐impedance	  measurements	  is	  closest	  to	  the	  truth?”	  The	  answer	  is	  
detailed	  in	  Chapter	  2,	  where	  the	  use	  of	  a	  time-­‐varying	  parallel	  conductance	  (GP)	  removal	  
method	  and	  a	  nonlinear	  conductance	  to	  volume	  equation	  (Wei’s	  equation)	  is	  shown	  to	  
have	  less	  error	  when	  compared	  with	  2-­‐D	  echocardiography	  in	  mice.	  	  
The	  second	  question	  is:	  “Will	  the	  measurement	  scale	  to	  larger	  animals,	  and	  if	  so,	  is	  
a	  new	  electrode	  configuration	  of	  admittance	  measurement	  that	  will	  not	  enter	  the	  left	  
ventricle	  possible?”	  The	  answer	  to	  this	  question	  is	  given	  in	  Chapter	  3.	  Through	  modeling	  
work,	  it	  is	  shown	  that	  the	  admittance	  measurement	  does	  scale	  to	  larger	  animals.	  With	  
the	  addition	  of	  multiple	  unused	  electrodes,	  the	  field	  is	  pulled	  away	  from	  the	  
surrounding	  myocardium	  and	  closer	  to	  the	  catheter.	  This	  causes	  a	  change	  in	  the	  value	  of	  
α	  used	  in	  the	  conductance	  to	  volume	  equation,	  and	  underlines	  the	  importance	  of	  
careful	  calibration.	  A	  new	  electrode	  configuration	  of	  admittance	  is	  also	  modeled,	  and	  
these	  models	  show	  that	  only	  a	  small	  portion	  of	  the	  signal	  will	  be	  due	  to	  surgical	  
placement	  error.	  	  
The	  third	  question	  posed	  by	  this	  dissertation	  is	  its	  main	  focus.	  	  “Is	  it	  possible,	  using	  
an	  electrode	  configuration	  that	  mimics	  pacemaker	  leads,	  to	  detect	  impending	  heart	  
failure?”	  This	  question	  is	  explored	  in	  depth	  using	  three	  forms	  of	  volume	  modulation	  to	  
determine	  that	  no	  secondary	  effects	  have	  caused	  conductance	  change.	  The	  three	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methods	  to	  increase	  volume	  acutely	  in	  pigs	  were	  Neosynephrine	  injection,	  aortic	  
banding,	  and	  LAD	  coronary	  artery	  occlusion.	  All	  three	  methods	  show	  an	  increase	  in	  
volume	  causes	  an	  increase	  in	  measured	  blood	  conductance	  using	  the	  admittance	  
technique,	  even	  when	  current	  methodology	  (RV	  pressure	  measurement,	  LV	  pressure	  
measurement,	  and	  lung	  conductance	  measurement)	  fails	  to	  detect	  these	  volume	  
increases.	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Appendix	  1:	  Full	  Protocols	  
The	  complete	  mouse	  and	  pig	  protocols	  for	  all	  studies	  are	  here,	  for	  reference	  for	  
future	   graduate	   students	   interested	   in	   completing	   studies	   of	   their	   own	   which	   are	  
similar.	  	  Many	  of	  the	  mistakes	  made	  over	  the	  course	  of	  the	  author’s	  career	  could	  have	  
been	  avoided	  with	  knowledge	  like	  this.	  
 	  
7.1 OPEN	  CHEST	  ACUTE	  PREPARATION	  IN	  PIGS	  
The	   open	   chest	   surgical	   preparation	   for	   a	   pig	   is	   a	   complicated	   mix	   of	   anti-­‐
arrythmic	   agents	   (for	   hemodynamic	   stability)	   and	   positive	   inotropes	   (for	   increased	  
blood	   pressure).	   It	   is	   often	   quite	   difficult	   to	   find	   the	   right	   proportion	   of	   stability	   and	  
signal	  degradation	  which	  will	  give	  acceptable	  results	  and	  keep	  the	  subject	  alive	  for	  the	  
duration	  of	  the	  experiment.	  In	  this	  experiment,	  the	  following	  protocol	  was	  used:	  
1. Pig	  is	  given	  Tealazol	  (0.5	  ml)	  via	   intramuscular	   injection	  and	  transferred	  to	  the	  
operating	  suite.	  
2. Isoflurane	  is	  given	  to	  induce	  an	  appropriate	  plane	  of	  anesthesia.	  
3. After	  the	  right	  carotid	  artery	  is	  cannulated	  and	  a	  pressure	  sensor	  is	  introduced	  
for	   Aortic	   Pressure	   to	   monitor	   the	   pig’s	   condition,	   a	   150mg	   bolus	   of	  
Amiodarone	  (an	  anti-­‐arrythmic)	  is	  given	  to	  prevent	  fibrillation	  upon	  opening	  the	  
chest.	  
4. The	  chest	  is	  opened	  via	  sternotomy,	  and	  we	  let	  30	  minutes	  pass	  total	  to	  ensure	  
that	  the	  pig	  has	  time	  to	  recover	  before	  the	  next	  Amiodarone	  bolus.	  
5. A	  second	  150	  mg	  bolus	  of	  Amiodarone	  is	  given.	  	  At	  this	  point,	  the	  hemodynamic	  
system	  is	  severely	  depressed	  because	  Amiodarone	  is	  also	  a	  negative	  inotrope.	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6. If	  the	  blood	  pressure	  ever	  dips	  below	  about	  70	  mmHg	  systolic,	  a	  1mg	  bolus	  of	  
Atropine	   is	   given	   to	   raise	   pressures.	   Normal	   systolic	   blood	   pressure	   in	  
mammalian	  hearts	   is	  usually	   above	  100	  mmHg,	  but	  under	  anesthesia,	  we	   can	  
expect	  a	  much	  lower	  number.	  
7. After	  the	  last	  bolus	  of	  Amiodarone	  is	  given,	  the	  pig	  is	  put	  on	  IV	  Lidocaine	  drip	  1	  
mg/min	   for	   the	   remainder	   of	   the	   experiment.	   	   The	   Lidocaine	   acts	   as	   an	  
analgesic	  without	  depressing	  the	  hemodynamic	  system.	  	  
8. Additionally,	   Lidocaine	   is	  used	  as	  a	   topical	   analgesic	   to	  prevent	  pain	   response	  
when	   sewing	   an	   electrode	   patch	   or	   sonomicrometry	   crystal	   directly	   to	   the	  
myocardium.	  	  
9. At	   this	   point,	   the	   rest	   of	   the	   instrumentation	   is	   added	   to	   the	   preparation.	   If,	  
during	  the	  experiment,	  the	  additional	  Atropine	  and	  Lidocaine	  is	  not	  enough	  to	  
increase	   pressures	   to	   a	   point	   which	   ensures	   survivability	   within	   about	   5-­‐10	  
minutes	   of	   the	   dose,	   Neosynephrine	   is	   given	   at	   10-­‐25	   µg/min	   (a	   positive	  
inotrope).	  
7.2 CLOSED	  CHEST	  ACUTE	  CONTRACTILITY	  STUDIES	  IN	  MICE	  
1. Anesthetize	   mouse	   using	   Isoflurane	   container	   and	   maintain	   anesthesia	   using	  
isoflurane	  delivered	  via	  respirator.	  
2. Record	  body	  weight,	  length,	  and	  sex	  in	  lab	  notebook	  and	  in	  Chart	  in	  Window	  >	  
Notebook.	  
3. Insert	  IV	  for	  dobutamine	  	  
4. The	  chest	  will	  be	  opened	  via	  an	  anterior	  thoracotomy.	  	  
5. Insert	  catheter	  into	  LV	  via	  apical	  stick.	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6. Record	  baseline	  admittance	  magnitude	  (conductance)	  and	  phase	  at	  20	  kHz,	  and	  
pressure	  data,	  and	  analyze	  loops	  to	  ensure	  correct	  catheter	  placement.	  
7. Start	  Dobutamine	  drip	  	  
8. Wrap	  the	  IVC	  with	  umbilical	  tape	  for	  occlusions.	  
9. TIME	  =	  00:00:00	  
10. TIME	  =	  00:06:00	  
11. Unplug	  the	  Admittance	  Catheter	  from	  the	  RamsES	  box	  and	  replace	  with	  mouse	  
surface	  probe.	  	  	  
12. Record	   admittance	  magnitude	   and	   phase	   using	   the	  mouse	   surface	   probe	   (for	  
myocardial	  properties	  measurement).	  Mark	  the	  digital	  record	  with	  information	  
about	  the	  data.	  
13. Re-­‐seat	  the	  surface	  probe	  
14. Repeat	  steps	  12-­‐13	  a	  total	  of	  N=2	  times.	  	  (Last	  2	  steps	  
15. Unplug	   the	  mouse	   surface	   probe	   from	   the	   RamsES	   box	   and	   replace	  with	   the	  
Scisense	  admittance	  catheter.	  	  
16. Occlude	  the	  IVC	  for	  3	  seconds	  (or	  long	  enough	  to	  ensure	  ESPVR	  is	  calculable).	  	  
17. Record	  pressure,	  admittance	  magnitude,	  and	  admittance	  phase	  data	  at	  20	  kHz	  
during	  the	  occlusions	  and	  mark	  the	  record	  for	  future	  analysis.	  	  	  
18. Repeat	  steps	  16-­‐17	  for	  N	  =	  3	  times	  total.	  	  (Last	  2	  steps)	  
19. TIME	  =	  00:12:00	  
20. Increase	  the	  dobutamine	  drip	  
21. Repeat	  steps	  9-­‐20	  for	  a	  total	  of	  N	  =	  4	  times	  (3	  more	  times).	  
22. Attach	  flow	  probe.	  
23. Measure	  aortic	  flow	  using	  EM	  flow	  probe.	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24. Extract	  blood	  from	  LV,	  measure	  conductivity	  using	  surface	  probe	  in	  37oC	  water	  
bath.	  
25. Euthanize	  animal	  and	  measure	  heart	  weight	  and	  LV	  weight.	  
7.3 OPEN	  CHEST	  1	  WK	  AORTIC	  BAND	  HEART	  FAILURE	  MICE	  
1. Anesthetize	   mouse	   using	   Isoflurane	   container	   and	   maintain	   anesthesia	   using	  
isoflurane	  delivered	  via	  respirator.	  
2. Record	  body	  weight,	  length,	  and	  sex	  in	  lab	  notebook	  and	  in	  Chart	  in	  Window	  >	  
Notebook.	  
3. The	  chest	  will	  be	  opened	  via	  an	  anterior	  thoracotomy.	  	  
4. Insert	  catheter	  into	  LV	  via	  apical	  stick.	  
5. Record	  baseline	  admittance	  magnitude	  (conductance)	  and	  phase	  at	  20	  kHz,	  and	  
pressure	  data,	  and	  analyze	  loops	  to	  ensure	  correct	  catheter	  placement.	  
6. Wrap	  the	  IVC	  with	  umbilical	  tape	  and	  occlude	  for	  3	  seconds	  (or	  long	  enough	  to	  
ensure	  ESPVR	  is	  calculable).	  	  
7. Record	  pressure,	  admittance	  magnitude,	  and	  admittance	  phase	  data	  at	  20	  kHz	  
during	  the	  occlusion	  and	  mark	  the	  record	  for	  future	  analysis.	  	  	  
8. Repeat	  steps	  7-­‐8	  for	  N	  =	  3	  times	  total.	  
9. Analyze	  Pressure-­‐Conductance	   loops	   to	  ensure	   that	   a	   good	  data	   set	  has	  been	  
taken,	  otherwise,	  reposition	  catheter	  and	  repeat	  steps	  7-­‐9.	  
10. Record	   admittance	  magnitude	   and	   phase	   using	   the	  mouse	   surface	   probe	   (for	  
myocardial	  properties	  measurement).	  Mark	  the	  digital	  record	  with	  information	  
about	  the	  data.	  
11. Re-­‐seat	  the	  surface	  probe	  
12. Repeat	  steps	  10-­‐11	  a	  total	  of	  N=2	  times.	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13. Attach	  flow	  probe.	  
14. Measure	  aortic	  flow	  using	  EM	  flow	  probe.	  
15. Extract	  blood	  from	  LV,	  measure	  conductivity	  using	  surface	  probe	  in	  37oC	  water	  
bath.	  
16. Euthanize	  animal	  and	  measure	  heart	  weight	  and	  LV	  weight.	  
	   	  
	   98	  
References	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
[1]	   P.	  A.	  McCullough,	  E.	  F.	  Philbin,	  J.	  A.	  Spertus,	  S.	  Kaatz,	  K.	  R.	  Sandberg,	  and	  W.	  D.	  
Weaver,	   "Confirmation	  of	  a	  heart	   failure	  epidemic:	   findings	   from	   the	  Resource	  
Utilization	   Among	   Congestive	   Heart	   Failure	   (REACH)	   study,"	   J	   Am	   Coll	   Cardiol,	  
vol.	  39,	  pp.	  60-­‐9,	  Jan	  2	  2002.	  
[2]	   D.	  Lloyd-­‐Jones,	  R.	  Adams,	  M.	  Carnethon,	  G.	  De	  Simone,	  T.	  B.	  Ferguson,	  K.	  Flegal,	  
E.	  Ford,	  K.	  Furie,	  A.	  Go,	  K.	  Greenlund,	  N.	  Haase,	  S.	  Hailpern,	  M.	  Ho,	  V.	  Howard,	  B.	  
Kissela,	  S.	  Kittner,	  D.	  Lackland,	  L.	  Lisabeth,	  A.	  Marelli,	  M.	  McDermott,	  J.	  Meigs,	  D.	  
Mozaffarian,	  G.	  Nichol,	  C.	  O'Donnell,	  V.	  Roger,	  W.	  Rosamond,	  R.	  Sacco,	  P.	  Sorlie,	  
R.	   Stafford,	   J.	   Steinberger,	   T.	   Thom,	   S.	  Wasserthiel-­‐Smoller,	  N.	  Wong,	   J.	  Wylie-­‐
Rosett,	  and	  Y.	  Hong,	  "Heart	  disease	  and	  stroke	  statistics-­‐-­‐2009	  update:	  a	  report	  
from	  the	  American	  Heart	  Association	  Statistics	  Committee	  and	  Stroke	  Statistics	  
Subcommittee,"	  Circulation,	  vol.	  119,	  pp.	  480-­‐6,	  Jan	  27	  2009.	  
[3]	   J.	  Baan,	  T.	  T.	  Jong,	  P.	  L.	  Kerkhof,	  R.	  J.	  Moene,	  A.	  D.	  van	  Dijk,	  E.	  T.	  van	  der	  Velde,	  
and	   J.	   Koops,	   "Continuous	   stroke	   volume	   and	   cardiac	   output	   from	   intra-­‐
ventricular	  dimensions	  obtained	  with	  impedance	  catheter,"	  Cardiovasc	  Res,	  vol.	  
15,	  pp.	  328-­‐34,	  Jun	  1981.	  
[4]	   J.	  Baan,	  E.	  T.	  Vandervelde,	  H.	  G.	  Debruin,	  G.	  J.	  Smeenk,	  J.	  Koops,	  A.	  D.	  Vandijk,	  D.	  
Temmerman,	   J.	   Senden,	   and	   B.	   Buis,	   "Continuous	   Measurement	   of	   Left-­‐
Ventricular	   Volume	   in	   Animals	   and	   Humans	   by	   Conductance	   Catheter,"	  
Circulation,	  vol.	  70,	  pp.	  812-­‐823,	  1984.	  
[5]	   M.	   D.	   Feldman,	   J.	   M.	   Erikson,	   Y.	   Mao,	   C.	   E.	   Korcarz,	   R.	   M.	   Lang,	   and	   G.	   L.	  
Freeman,	  "Validation	  of	  a	  mouse	  conductance	  system	  to	  determine	  LV	  volume:	  
comparison	   to	  echocardiography	  and	  crystals,"	  Am	  J	  Physiol	  Heart	  Circ	  Physiol,	  
vol.	  279,	  pp.	  H1698-­‐707,	  Oct	  2000.	  
[6]	   A.	   T.	   Kottam,	   J.	   Porterfield,	   K.	   Raghavan,	   D.	   Fernandez,	   M.	   D.	   Feldman,	   J.	   W.	  
Valvano,	   and	   J.	   A.	   Pearce,	   "Real	   time	   pressure-­‐volume	   loops	   in	   mice	   using	  
complex	   admittance:	  measurement	   and	   implications,"	  Conf	  Proc	   IEEE	  Eng	  Med	  
Biol	  Soc,	  vol.	  1,	  pp.	  4336-­‐9,	  2006.	  
[7]	   K.	  Raghavan,	  A.	  T.	  Kottam,	  J.	  W.	  Valvano,	  and	  J.	  A.	  Pearce,	  "Design	  of	  a	  wireless	  
telemetric	   backpack	   device	   for	   real-­‐time	   in	   vivo	   measurement	   of	   pressure-­‐
volume	   loops	   in	   conscious	   ambulatory	   rats,"	  Conf	   Proc	   IEEE	   Eng	  Med	  Biol	   Soc,	  
vol.	  2008,	  pp.	  993-­‐6,	  2008.	  
[8]	   K.	  Raghavan,	  J.	  E.	  Porterfield,	  A.	  T.	  G.	  Kottam,	  M.	  D.	  Feldman,	  D.	  Escobedo,	  J.	  W.	  
Valvano,	   and	   J.	   A.	   Pearce,	   "Electrical	   Conductivity	   and	   Permittivity	   of	   Murine	  
Myocardium,"	   Ieee	   Transactions	   on	   Biomedical	   Engineering,	   vol.	   56,	   pp.	   2044-­‐
2053,	  Aug	  2009.	  
	   99	  
[9]	   K.	  Raghavan,	  C.	  L.	  Wei,	  A.	  Kottam,	  D.	  G.	  Altman,	  D.	  J.	  Fernandez,	  M.	  Reyes,	  J.	  W.	  
Valvano,	  M.	  D.	  Feldman,	  and	  J.	  A.	  Pearce,	  "Design	  of	  instrumentation	  and	  data-­‐
acquisition	  system	  for	  complex	  admittance	  measurement,"	  Biomed	  Sci	   Instrum,	  
vol.	  40,	  pp.	  453-­‐7,	  2004.	  
[10]	   M.	  Reyes,	  M.	  E.	  Steinhelper,	  J.	  A.	  Alvarez,	  D.	  Escobedo,	  J.	  Pearce,	  J.	  W.	  Valvano,	  
B.	  H.	  Pollock,	  C.	  L.	  Wei,	  A.	  Kottam,	  D.	  Altman,	  S.	  Bailey,	  S.	  Thomsen,	  S.	  Lee,	  J.	  T.	  
Colston,	   J.	   H.	   Oh,	   G.	   L.	   Freeman,	   and	  M.	   D.	   Feldman,	   "Impact	   of	   physiological	  
variables	  and	  genetic	  background	  on	  myocardial	  frequency-­‐resistivity	  relations	  in	  
the	   intact	  beating	  murine	  heart,"	  Am	   J	  Physiol	  Heart	  Circ	   Physiol,	  vol.	   291,	  pp.	  
H1659-­‐69,	  Oct	  2006.	  
[11]	   C.	  L.	  Wei,	  J.	  W.	  Valvano,	  M.	  D.	  Feldman,	  D.	  Altman,	  A.	  Kottam,	  K.	  Raghavan,	  D.	  J.	  
Fernandez,	  M.	  Reyes,	  D.	   Escobedo,	   and	   J.	  A.	  Pearce,	   "Evidence	  of	   time-­‐varying	  
myocardial	  contribution	  by	  in	  vivo	  magnitude	  and	  phase	  measurement	  in	  mice,"	  
Conf	  Proc	  IEEE	  Eng	  Med	  Biol	  Soc,	  vol.	  5,	  pp.	  3674-­‐7,	  2004.	  
[12]	   J.	   Baan,	   T.	   T.	   A.	   Jong,	   P.	   L.	   M.	   Kerkhof,	   R.	   J.	   Moene,	   A.	   D.	   Vandijk,	   E.	   T.	  
Vandervelde,	  and	  J.	  Koops,	  "Continuous	  Stroke	  Volume	  and	  Cardiac-­‐Output	  from	  
Intraventricular	  Dimensions	  Obtained	  with	  Impedance	  Catheter,"	  Cardiovascular	  
Research,	  vol.	  15,	  pp.	  328-­‐334,	  1981.	  
[13]	   C.	   L.	  Wei,	   J.	  W.	  Valvano,	  M.	  D.	   Feldman,	  M.	  Nahrendorf,	   R.	   Peshock,	   and	   J.	   A.	  
Pearce,	  "Volume	  catheter	  parallel	  conductance	  varies	  between	  end-­‐systole	  and	  
end-­‐diastole,"	   Ieee	   Transactions	   on	   Biomedical	   Engineering,	   vol.	   54,	   pp.	   1480-­‐
1489,	  Aug	  2007.	  
[14]	   P.	   Pacher,	   T.	   Nagayama,	   P.	   Mukhopadhyay,	   S.	   Batkai,	   and	   D.	   A.	   Kass,	  
"Measurement	  of	  cardiac	  function	  using	  pressure-­‐volume	  conductance	  catheter	  
technique	  in	  mice	  and	  rats,"	  Nat	  Protoc,	  vol.	  3,	  pp.	  1422-­‐34,	  2008.	  
[15]	   J.	   Baan	   and	   E.	   T.	   Van	   der	   Velde,	   "Sensitivity	   of	   left	   ventricular	   end-­‐systolic	  
pressure-­‐volume	  relation	  to	  type	  of	   loading	   intervention	   in	  dogs,"	  Circ	  Res,	  vol.	  
62,	  pp.	  1247-­‐58,	  Jun	  1988.	  
[16]	   C.	   L.	   Wei,	   J.	   W.	   Valvano,	   M.	   D.	   Feldman,	   and	   J.	   A.	   Pearce,	   "Nonlinear	  
conductance-­‐volume	   relationship	   for	   murine	   conductance	   catheter	  
measurement	  system,"	  Ieee	  Transactions	  on	  Biomedical	  Engineering,	  vol.	  52,	  pp.	  
1654-­‐1661,	  Oct	  2005.	  
[17]	   J.	   E.	   Porterfield,	   A.	   T.	   Kottam,	   K.	   Raghavan,	   D.	   Escobedo,	   J.	   T.	   Jenkins,	   E.	   R.	  
Larson,	  R.	   J.	  Trevino,	   J.	  W.	  Valvano,	   J.	  A.	  Pearce,	  and	  M.	  D.	  Feldman,	  "Dynamic	  
Correction	   for	   Parallel	   Conductance,	   GP,	   and	   Gain	   Factor,	   {alpha},	   in	   Invasive	  
Murine	  Left	  Ventricular	  Volume	  Measurements,"	  J	  Appl	  Physiol,	  Aug	  20	  2009.	  
	   100	  
[18]	   E.	  Braunwald,	   "Braunwald's	  Heart	  Disease.	  A	  Textbook	  of	  Cardiovascular	  Medicine	  ",	  
7th	  ed:	  Saunders	  (Elsevier),	  2005,	  p.	  540.	  
[19]	   E.	  Braunwald,	   "Braunwald's	  Heart	  Disease.	  A	  Textbook	  of	  Cardiovascular	  Medicine	  ",	  
7th	  ed:	  Saunders	  (Elsevier),	  2005,	  p.	  499.	  
[20]	   E.	  Braunwald,	   "Braunwald's	  Heart	  Disease.	  A	  Textbook	  of	  Cardiovascular	  Medicine	  ",	  
7th	  ed:	  Saunders	  (Elsevier),	  2005,	  p.	  515.	  
[21]	   J.	  G.	  Cleland,	  J.	  C.	  Daubert,	  E.	  Erdmann,	  N.	  Freemantle,	  D.	  Gras,	  L.	  Kappenberger,	  
and	   L.	   Tavazzi,	   "The	   effect	   of	   cardiac	   resynchronization	   on	   morbidity	   and	  
mortality	  in	  heart	  failure,"	  N	  Engl	  J	  Med,	  vol.	  352,	  pp.	  1539-­‐49,	  Apr	  14	  2005.	  
[22]	   P.	   B.	   Adamson,	   A.	   Magalski,	   F.	   Braunschweig,	   M.	   Bohm,	   D.	   Reynolds,	   D.	  
Steinhaus,	   A.	   Luby,	   C.	   Linde,	   L.	   Ryden,	   B.	   Cremers,	   T.	   Takle,	   and	   T.	   Bennett,	  
"Ongoing	   right	   ventricular	   hemodynamics	   in	   heart	   failure:	   clinical	   value	   of	  
measurements	   derived	   from	   an	   implantable	   monitoring	   system,"	   J	   Am	   Coll	  
Cardiol,	  vol.	  41,	  pp.	  565-­‐71,	  Feb	  19	  2003.	  
[23]	   D.	  Lloyd-­‐Jones,	  R.	  Adams,	  M.	  Carnethon,	  G.	  De	  Simone,	  T.	  B.	  Ferguson,	  K.	  Flegal,	  
E.	  Ford,	  K.	  Furie,	  A.	  Go,	  K.	  Greenlund,	  N.	  Haase,	  S.	  Hailpern,	  M.	  Ho,	  V.	  Howard,	  B.	  
Kissela,	  S.	  Kittner,	  D.	  Lackland,	  L.	  Lisabeth,	  A.	  Marelli,	  M.	  McDermott,	  J.	  Meigs,	  D.	  
Mozaffarian,	  G.	  Nichol,	  C.	  O'Donnell,	  V.	  Roger,	  W.	  Rosamond,	  R.	  Sacco,	  P.	  Sorlie,	  
R.	   Stafford,	   J.	   Steinberger,	   T.	   Thom,	   S.	  Wasserthiel-­‐Smoller,	  N.	  Wong,	   J.	  Wylie-­‐
Rosett,	  and	  Y.	  Hong,	  "Heart	  disease	  and	  stroke	  statistics-­‐-­‐2009	  update:	  a	  report	  
from	  the	  American	  Heart	  Association	  Statistics	  Committee	  and	  Stroke	  Statistics	  
Subcommittee,"	  Circulation,	  vol.	  119,	  pp.	  e21-­‐181,	  Jan	  27	  2009.	  
[24]	   A.	   Magalski,	   P.	   Adamson,	   F.	   Gadler,	   M.	   Boehm,	   D.	   Steinhaus,	   D.	   Reynolds,	   K.	  
Vlach,	  C.	  Linde,	  B.	  Cremers,	  B.	  Sparks,	  and	  T.	  Bennett,	   "Continuous	  ambulatory	  
right	  heart	  pressure	  measurements	  with	  an	  implantable	  hemodynamic	  monitor:	  
a	  multicenter,	  12-­‐month	  follow-­‐up	  study	  of	  patients	  with	  chronic	  heart	  failure,"	  J	  
Card	  Fail,	  vol.	  8,	  pp.	  63-­‐70,	  Apr	  2002.	  
[25]	   L.	   Luthje,	   T.	   Drescher,	   D.	   Zenker,	   and	  D.	   Vollmann,	   "Detection	   of	   heart	   failure	  
decompensation	  using	   intrathoracic	   impedance	  monitoring	  by	  a	   triple-­‐chamber	  
implantable	  defibrillator,"	  Heart	  Rhythm,	  vol.	  2,	  pp.	  997-­‐9,	  Sep	  2005.	  
[26]	   D.	   Vollmann,	   H.	   Nagele,	   P.	   Schauerte,	   U.	   Wiegand,	   C.	   Butter,	   G.	   Zanotto,	   A.	  
Quesada,	  A.	  Guthmann,	  M.	  R.	  Hill,	  and	  B.	  Lamp,	  "Clinical	  utility	  of	   intrathoracic	  
impedance	   monitoring	   to	   alert	   patients	   with	   an	   implanted	   device	   of	  
deteriorating	  chronic	  heart	  failure,"	  Eur	  Heart	  J,	  vol.	  28,	  pp.	  1835-­‐40,	  Aug	  2007.	  
[27]	   L.	  Wang,	  S.	  Lahtinen,	  L.	  Lentz,	  N.	  Rakow,	  C.	  Kaszas,	  L.	  Ruetz,	  L.	  Stylos,	  and	  W.	  H.	  
Olson,	   "Feasibility	   of	   using	   an	   implantable	   system	   to	   measure	   thoracic	  
	   101	  
congestion	   in	   an	   ambulatory	   chronic	   heart	   failure	   canine	   model,"	   Pacing	   Clin	  
Electrophysiol,	  vol.	  28,	  pp.	  404-­‐11,	  May	  2005.	  
[28]	   C.	  M.	  Yu,	  L.	  Wang,	  E.	  Chau,	  R.	  H.	  Chan,	  S.	  L.	  Kong,	  M.	  O.	  Tang,	  J.	  Christensen,	  R.	  
W.	  Stadler,	  and	  C.	  P.	  Lau,	  "Intrathoracic	   impedance	  monitoring	   in	  patients	  with	  
heart	   failure:	   correlation	   with	   fluid	   status	   and	   feasibility	   of	   early	   warning	  
preceding	  hospitalization,"	  Circulation,	  vol.	  112,	  pp.	  841-­‐8,	  Aug	  9	  2005.	  
[29]	   A.	  T.	  G.	  Kottam,	  "Measurement	  of	  Electrical	  Admittance	  to	  Study	  the	  Onset	  and	  
Progression	   of	   Myocardial	   Ischemia,"	   in	   Biomedical	   Engineering.	   vol.	   Ph.D.	  
Austin:	  The	  University	  of	  Texas,	  2006,	  p.	  103.	  
[30]	   A.	   Kottam	   and	   J.	   A.	   Pearce,	   "Electric	   field	   penetration	   depth	   of	   myocardial	  
surface	   catheters	   and	   the	   measurement	   of	   myocardial	   resistivity,"	   Biomed	   Sci	  
Instrum,	  vol.	  40,	  pp.	  155-­‐60,	  2004.	  
[31]	   J.	  W.	  Gaynor,	  M.	  P.	  Feneley,	  S.	  A.	  Gall,	  Jr.,	  G.	  W.	  Maier,	  J.	  A.	  Kisslo,	  J.	  W.	  Davis,	  J.	  
S.	   Rankin,	   and	   D.	   D.	   Glower,	   Jr.,	   "Measurement	   of	   left	   ventricular	   volume	   in	  
normal	  and	  volume-­‐overloaded	  canine	  hearts,"	  Am	  J	  Physiol,	  vol.	  266,	  pp.	  H329-­‐
40,	  Jan	  1994.	  
[32]	   J.	  G.	  Lainchbury,	  D.	  M.	  Meyer,	  M.	  Jougasaki,	  J.	  C.	  Burnett,	  Jr.,	  and	  M.	  M.	  Redfield,	  
"Effects	  of	  adrenomedullin	  on	   load	  and	  myocardial	  performance	   in	  normal	  and	  
heart-­‐failure	  dogs,"	  Am	   J	  Physiol	  Heart	  Circ	  Physiol,	  vol.	   279,	  pp.	  H1000-­‐6,	   Sep	  
2000.	  
[33]	   K.	  Raghavan,	   J.	   E.	  Porterfield,	  A.	   T.	  Kottam,	  M.	  D.	   Feldman,	  D.	   Escobedo,	   J.	  W.	  
Valvano,	   and	   J.	   A.	   Pearce,	   "Electrical	   conductivity	   and	   permittivity	   of	   murine	  
myocardium,"	  IEEE	  Trans	  Biomed	  Eng,	  vol.	  56,	  pp.	  2044-­‐53,	  Aug	  2009.	  
[34]	   C.	  Jacoby,	  A.	  Molojavyi,	  U.	  Flogel,	  M.	  W.	  Merx,	  Z.	  Ding,	  and	  J.	  Schrader,	  "Direct	  
comparison	   of	  magnetic	   resonance	   imaging	   and	   conductance	  microcatheter	   in	  
the	  evaluation	  of	   left	   ventricular	   function	   in	  mice,"	  Basic	  Res	  Cardiol,	  vol.	   101,	  
pp.	  87-­‐95,	  Jan	  2006.	  
[35]	   J.	   M.	   Nielsen,	   S.	   B.	   Kristiansen,	   S.	   Ringgaard,	   T.	   T.	   Nielsen,	   A.	   Flyvbjerg,	   A.	   N.	  
Redington,	  and	  H.	  E.	  Botker,	   "Left	   ventricular	  volume	  measurement	   in	  mice	  by	  
conductance	  catheter:	  evaluation	  and	  optimization	  of	  calibration,"	  Am	  J	  Physiol	  
Heart	  Circ	  Physiol,	  vol.	  293,	  pp.	  H534-­‐40,	  Jul	  2007.	  
[36]	   E.	   B.	   Lankford,	   D.	   A.	   Kass,	   W.	   L.	   Maughan,	   and	   A.	   A.	   Shoukas,	   "Does	   volume	  
catheter	   parallel	   conductance	   vary	   during	   a	   cardiac	   cycle?,"	  Am	   J	   Physiol,	   vol.	  
258,	  pp.	  H1933-­‐42,	  Jun	  1990.	  
	   102	  
[37]	   D.	  Georgakopoulos	  and	  D.	  A.	  Kass,	  "Estimation	  of	  parallel	  conductance	  by	  dual-­‐
frequency	   conductance	   catheter	   in	  mice,"	  Am	   J	   Physiol	   Heart	   Circ	   Physiol,	   vol.	  
279,	  pp.	  H443-­‐50,	  Jul	  2000.	  
[38]	   D.	   Georgakopoulos,	  W.	   A.	  Mitzner,	   C.	   H.	   Chen,	   B.	   J.	   Byrne,	   H.	   D.	  Millar,	   J.	  M.	  
Hare,	  and	  D.	  A.	  Kass,	  "In	  vivo	  murine	   left	  ventricular	  pressure-­‐volume	  relations	  
by	   miniaturized	   conductance	   micromanometry,"	   Am	   J	   Physiol,	   vol.	   274,	   pp.	  
H1416-­‐22,	  Apr	  1998.	  
[39]	   P.	   Steendijk,	   G.	   Mur,	   E.	   T.	   Van	   Der	   Velde,	   and	   J.	   Baan,	   "The	   four-­‐electrode	  
resistivity	  technique	  in	  anisotropic	  media:	  theoretical	  analysis	  and	  application	  on	  
myocardial	   tissue	   in	   vivo,"	   IEEE	   Trans	   Biomed	   Eng,	   vol.	   40,	   pp.	   1138-­‐48,	   Nov	  
1993.	  
[40]	   WhitePa	   and	   A.	   N.	   Redington,	   "Right	   ventricular	   volume	   measurement:	   can	  
conductance	  do	  it	  better?,"	  Physiol	  Meas,	  vol.	  21,	  pp.	  R23-­‐41,	  Aug	  2000.	  
[41]	   K.	   Uemura,	   T.	   Kawada,	   M.	   Sugimachi,	   C.	   Zheng,	   K.	   Kashihara,	   T.	   Sato,	   and	   K.	  
Sunagawa,	   "A	  self-­‐calibrating	   telemetry	   system	  for	  measurement	  of	  ventricular	  
pressure-­‐volume	  relations	   in	  conscious,	   freely	  moving	  rats,"	  Am	  J	  Physiol	  Heart	  
Circ	  Physiol,	  vol.	  287,	  pp.	  H2906-­‐13,	  Dec	  2004.	  
[42]	   Millar,	   "Published	   papers:	   Pressure	   -­‐	   mouse	   /	   rat,"	   in	  
http://www.millarinstruments.com/papers/papers_pres_m_r.php.	   vol.	   2008,	   M.	  
Instruments,	  Ed.	  Houston,	  TX,	  2008.	  
[43]	   S.	  Kun	  and	  R.	  A.	  Peura,	  "Analysis	  of	  conductance	  volumetric	  measurement	  error	  
sources,"	  Med	  Biol	  Eng	  Comput,	  vol.	  32,	  pp.	  94-­‐100,	  Jan	  1994.	  
[44]	   B.	   Hille,	   Ion	   channels	   of	   excitable	   membranes,	   3rd	   ed.	   Sunderland,	   Mass.:	  
Sinauer,	  2001.	  
[45]	   C.	   L.	  Wei	   and	  M.	  H.	   Shih,	   "Calibration	   Capacity	   of	   the	   Conductance-­‐to-­‐Volume	  
Conversion	   Equations	   for	   the	   Mouse	   Conductance	   Catheter	   Measurement	  
System,"	   Ieee	   Transactions	   on	   Biomedical	   Engineering,	   vol.	   56,	   pp.	   1627-­‐1634,	  
Jun	  2009.	  
[46]	   T.	  J.	  Faes,	  H.	  A.	  van	  der	  Meij,	  J.	  C.	  de	  Munck,	  and	  R.	  M.	  Heethaar,	  "The	  electric	  
resistivity	  of	  human	  tissues	  (100	  Hz-­‐10	  MHz):	  a	  meta-­‐analysis	  of	  review	  studies,"	  
Physiol	  Meas,	  vol.	  20,	  pp.	  R1-­‐10,	  Nov	  1999.	  
[47]	   P.	   Steendijk,	   E.	   T.	   van	   der	   Velde,	   and	   J.	   Baan,	   "Dependence	   of	   anisotropic	  
myocardial	  electrical	  resistivity	  on	  cardiac	  phase	  and	  excitation	  frequency,"	  Basic	  
Res	  Cardiol,	  vol.	  89,	  pp.	  411-­‐26,	  Sep-­‐Oct	  1994.	  
[48]	   M.	  R.	  Graham,	  R.	  K.	  Warrian,	  L.	  G.	  Girling,	  L.	  Doiron,	  G.	  R.	   Lefevre,	  M.	  Cheang,	  
and	  W.	  A.	  Mutch,	  "Fractal	  or	  biologically	  variable	  delivery	  of	  cardioplegic	  solution	  
	   103	  
prevents	   diastolic	   dysfunction	   after	   cardiopulmonary	   bypass,"	   J	   Thorac	  
Cardiovasc	  Surg,	  vol.	  123,	  pp.	  63-­‐71,	  Jan	  2002.	  
[49]	   E.	   Glusa	   and	   F.	   Markwardt,	   "Characterisation	   of	   postjunctional	   alpha-­‐
adrenoceptors	   in	   isolated	   human	   femoral	   veins	   and	   arteries,"	   Naunyn	  
Schmiedebergs	  Arch	  Pharmacol,	  vol.	  323,	  pp.	  101-­‐5,	  Jun	  1983.	  
[50]	   J.	   Pepke-­‐Zaba,	   T.	  W.	   Higenbottam,	   A.	   T.	   Dinh-­‐Xuan,	   C.	   Ridden,	   and	   T.	   Kealey,	  
"Alpha-­‐adrenoceptor	   stimulation	   of	   porcine	   pulmonary	   arteries,"	   Eur	   J	  
Pharmacol,	  vol.	  235,	  pp.	  169-­‐75,	  Apr	  28	  1993.	  
[51]	   R.	  C.	  Bourge,	  W.	  T.	  Abraham,	  P.	  B.	  Adamson,	  M.	  F.	  Aaron,	   J.	  M.	  Aranda,	   Jr.,	  A.	  
Magalski,	  M.	  R.	  Zile,	  A.	  L.	  Smith,	  F.	  W.	  Smart,	  M.	  A.	  O'Shaughnessy,	  M.	  L.	  Jessup,	  
B.	  Sparks,	  D.	  L.	  Naftel,	  and	  L.	  W.	  Stevenson,	  "Randomized	  controlled	  trial	  of	  an	  
implantable	  continuous	  hemodynamic	  monitor	   in	  patients	  with	  advanced	  heart	  




	   	  
	   104	  
Vita	  
John	  Edward	  Porterfield	  is	  a	  native	  Texan	  and	  was	  born	  at	  Methodist	  Hospital	  in	  
San	  Antonio,	  across	  the	  street	   from	  the	   laboratory	  at	  UT	  Health	  Science	  Center	   in	  San	  
Antonio	  where	   the	  bulk	  of	  his	  experimental	  work	  was	  completed.	   In	  2000	  he	  entered	  
Oklahoma	  State	  University	  in	  Stillwater,	  OK	  where	  he	  received	  his	  B.S.	  in	  Electrical	  and	  
Computer	   Engineering	   in	   2004.	   After	   this	   degree	   he	   continued	   his	   education	   at	   The	  
University	  of	  Texas	  at	  Austin	  and	  in	  2006	  received	  his	  M.S.	  in	  Electrical	  Engineering	  (with	  
Biomedical	   Instrumentation	   focus)	   under	   guidance	   from	   Dr.	   John	   Pearce,	   who	   also	  
advised	  his	  Ph.D.	  
	  
Permanent	  Address:	  2916	  W.	  Lexington	  Way,	  Edmond,	  OK	  73003	  
	  
This	  manuscript	  was	  typed	  by	  the	  author.	  
